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Abstract 
The overall aim of this PhD thesis was to conduct a comprehensive investigation 
of decision-making impairment in long term opiate users, using three studies. The first 
study aimed to determine the extent of the decision-making impairment and to establish 
whether other co-morbid factors impacted on the severity of this deficit. Using meta-
analysis, the results indicated that opiate use is associated with relatively severe 
decision-making impairment, and that co-morbid factors, such as head injury and poly-
substance dependence did not significantly change the magnitude of the impairment. 
Furthermore, the decision-making impairment in opiate users was not mitigated by 
abstinence, and the duration of opiate use and the duration of abstinence did not have a 
significant impact on size of the impairment. The second study analysed whether the 
somatic marker hypothesis, an emotion-based model of decision-making, could provide 
an explanation for the decision-making impairment in opiate users. This empirical study 
found that, although decision-making was impaired in a group of long term opiate users 
relative to a group of healthy controls, this impairment was not due to reduced 
emotional responsiveness, nor an inability to form anticipatory warning signals (i.e., 
somatic markers), as measured by the skin conductance response. Notably, stronger 
somatic responses when contemplating making disadvantageous choices were 
associated with worse decision-making in opiate users, which does not support the 
predictions of the somatic marker model of decision-making. Finally, the third study 
analysed decision-making under conditions of risk, to determine whether the 
impairment in opiate users was restricted to certain types of decision-making. This 
empirical study found that opiate users, although impaired in decision-making under 
conditions of ambiguity, were not impaired on decision making tasks involving 
calculable risk, relative to healthy controls. This study also demonstrated that opiate 
users’ decisions were not driven by an increased responsiveness to reward. Together, 
the results of this thesis suggest that opiate users are particularly impaired in situations 
of decision-making under ambiguity, but not risk, and this is not due to impairment in 
emotional processing. This has implications for the treatment of opiate users, who may 
need additional training to appropriately utilise physiological signals to make adaptive 
decisions. The results of this thesis may therefore be used to inform treatment practice 
to better support opiate users during ambiguous decision-making situations in daily life. 
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CHAPTER 1: Introduction and Thesis Outline 
1.1 Background to Opiate Dependence and Rationale for the Thesis 
Opiates are naturally occurring chemicals found in poppy plants, but may also be 
synthesised to produce semi-synthetic illicit opiates such as heroin (Koob & Le Moal, 
2005). Opiates, in particular heroin, can produce pleasurable sensations or a “rush” 
(World Health Organization, 2004) as they mimic the effect of endogenous opiates 
which signal reward and pleasure (Di Chiara & North, 1992; Kosten & George, 2002). 
These properties make exogenously introduced opiates susceptible to abuse and 
addiction.  
The most recent estimate suggests that 15.5 million people worldwide are 
dependent on opiates (Degenhardt et al., 2014), the most heavily abused of which  is 
heroin (United Nations Office on Drugs and Crime, 2010, 2012). Opiate dependence is 
therefore a major public health concern globally (Bart, 2012). Despite recent declines in 
opium production in key supply areas (Afghanistan, South-East Asia and Latin 
America), opiate use is rising in the United States and other countries, (Jones, Logan, 
Gladden, & Bohm, 2015; United Nations Office on Drugs and Crime, 2016). Indeed, the 
United States is currently part of an “opioid epidemic” with a 150% increase in the 
number of people abusing or dependent on heroin between 2007 and 2013, and 
overdose rates nearly doubling between 2011 and 2013 (Jones et al., 2015). This 
epidemic may be driven by the over prescription of opioid analgesics such as 
oxycodone, with users shifting to heroin following a period of opioid misuse (Compton, 
Boyle, & Wargo, 2015). A key issue is the perseverative nature of opiate dependence, 
with users typically cycling through periods of heavy use, then moving to treatment, and 
even cessation, but then relapsing, therefore starting the cycle again (Darke, 2011). In 
this cycle, treatment often involves the prescription of therapeutic drugs, such as 
methadone, buprenorphine or naltrexone. 
Opiate use is associated with a range of high risk behaviours. For example, opiate 
users may choose to administer the drug intravenously, therefore placing them at 
increased risk of infection with hepatitis C and HIV (Gowing, Farrell, Bornemann, & 
Ali, 2008). Many opiate users also often engage in property and other crime to finance 
their opiate use (Gossop, Marsden, Stewart, & Rolfe, 2000; Stewart, Gossop, Marsden, 
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& Rolfe, 2000), placing them at higher risk of incarceration (Klee & Morris, 1994; 
Maradiaga, Nahvi, Cunningham, Sanchez, & Fox, 2016). In addition, polysubstance 
abuse is very common (Veilleux, Colvin, Anderson, York, & Heinz, 2010), with a large 
proportion of opiate users also dependent on cocaine, alcohol and other sedatives 
(Astals et al., 2008). Combined, all of these issues contribute to the “cycle of addiction”, 
and ultimately poor quality of life (De Maeyer, Vanderplasschen, & Broekaert, 2010) 
and to individual and societal burden (which are discussed in more detail in Chapter 2). 
Although current and past opiate users may understand the consequences of 
actions, it appears that they have difficulty making adaptive decisions when it comes to 
abstaining from drug use and other maladaptive behaviours. It has been suggested that 
difficulty making adaptive decisions may contribute to the high risk behaviours and the 
day-to-day difficulties that opiate users experience (e.g., Wilson & Vassileva, 2016). 
Poor decision-making and high risk behaviours occur at all points in the cycle of opiate 
dependence (e.g., Baldacchino, Balfour, & Matthews, 2015; Zhang, Shi, et al., 2011).  
Decision-making can be viewed as a cognitive process, and it can be measured in 
controlled laboratory settings to assess the presence and extent of impairment. A 
number of studies using laboratory-based measures have demonstrated decision-making 
impairment in opiate users. However, the nature and causes of this impairment are not 
well understood.  
1.2 Aims of the Thesis 
The overarching aim of this PhD thesis was to investigate the nature and the 
causes of impaired decision-making in opiate users, with a specific focus on people who 
were using legally prescribed opiates in the context of treatment for heroin dependence. 
This overall thesis aim was addressed in three studies. The aim of Study 1 in this PhD 
thesis was to determine the magnitude of the decision-making impairment in current and 
in past users of opiates, and to determine whether factors such as the presence of poly-
drug use, head injury, duration of opiate use, or the phase of opiate use (i.e., past or 
present use) influenced the magnitude of this impairment. Following on from this, the 
aim of Study 2 was to investigate the cognitive and physiological mechanisms that may 
contribute to the decision-making impairment. It has been suggested that decision-
making ability relies on more than a logical or rational evaluation of options, and that 
emotional responding can be critical to making adaptive decisions. Therefore, the 
3 
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second study adopted a neurobiological model of decision-making (specifically, the 
somatic marker hypothesis; Damasio, 1994) to determine whether underlying 
abnormalities in the emotional response system could help to explain the decision-
making impairment in opiate users. Finally, Study 3 aimed to clarify the nature of the 
decision-making impairment in opiate users. Decision-making is not a unitary construct 
and, although a range of studies have analysed decision-making impairment in opiate 
users, the pattern of the decision-making impairment across different types of decision-
making tasks in this group remains unclear. By comparing opiate users’ performance on 
two different types of decision-making tasks, the third study therefore aimed to provide 
a more fine-grained profile of the decision-making impairment in opiate users.  
1.3 Structure of the Thesis 
This thesis comprises published and unpublished scholarly works and is presented 
as a thesis with publication, in accordance with section five of the Australian Catholic 
University’s Guidelines on the Preparation and Presentation of a Research or Doctoral 
Thesis for Examination (Australian Catholic University, 2015). It includes a meta-
analysis study (Chapter 3), and results from two empirical studies that adopted a group-
comparison design, comparing the performance of current opiate users and controls 
(Chapters 5 and 6).  
A review of what is currently known about the consequences and effects of opiate 
dependence, and the associated neurological abnormalities, cognitive deficits, and 
emotion processing difficulties, is presented in Chapter 2. Chapter 3 presents the 
published meta-analysis describing factors associated with decision-making impairment 
in current and ex-users of opiates (Biernacki, McLennan, Terrett, Labuschagne, & 
Rendell, 2016). Chapter 4 provides a detailed description of the methodology of the 
empirical studies. Chapter 5 presents a manuscript accepted for publication, which 
describes findings from the first group-comparison study which assessed physiological 
and emotional responses and their relationship to decision-making in opiate users and 
controls. It also presents results of additional investigation of interoceptive ability in 
both groups. Chapter 6 presents findings from the second empirical study, which 
analysed performance on a different type of decision-making in opiate users. Finally, 
Chapter 7 presents a discussion of all the findings presented in the thesis and provides 
future directions for research in this field.   
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CHAPTER 2: Cognitive, Neurological and Emotional Impairment in Opiate 
Users and Their Relationship to Decision-Making 
2.1 Chapter Introduction 
The research presented in this thesis investigates the nature and causes of the 
decision-making impairment commonly observed in long-term users of opiates. 
Impaired decision-making may contribute to the poor health, social, and treatment 
outcomes commonly observed in this group. While there is limited evidence of a broad 
cognitive impairment in opiate users, there is substantial evidence of decision-making 
impairment. However, the mechanism that causes this impairment remains unclear. It 
has been suggested that reduced capacity to emotionally respond to the rewarding 
and/or punishing outcomes of decisions may impair decision-making ability. However, 
while there is some evidence of emotional blunting and an inability to tune into 
emotional signals in opiate users, the current literature is limited and inconclusive. 
Similarly, it is unclear whether decision-making is impaired under all conditions; for 
example in situations of calculable risk. This chapter summarises existing research 
about the neurological abnormalities, cognitive deficits, and emotional processing 
difficulties that are associated with long-term opiate use, with a focus on their relevance 
to decision-making, and describes the limitations of the existing literature. The aim of 
this chapter is to provide a foundation for the subsequent investigations of impaired 
decision-making in opiate users reported in this thesis. 
2.2 Cycle of Addiction in Opiate Users 
Many opiate users are engaged in a persistent cycle of addiction and treatment. 
The trajectory of opiate dependence is sometimes referred to as an opiate user’s 
“career” and people who use opiates typically cycle in and out of heavy heroin use, 
treatment with opiate substitutes, abstinence, and relapse over the course of adulthood 
(Darke, 2011; Darke et al., 2009). While some are able to maintain abstinence for long 
periods of time following multiple repetitions of the cycle (Hser, Huang, Brecht, Li, & 
Evans, 2008; Hser, Huang, Chou, & Anglin, 2007), others ultimately die from overdose, 
trauma, suicide or disease (Darke, Mills, Ross, & Teesson, 2011; Degenhardt et al., 
2011). For heroin users receiving treatment in the community, poor decision-making 
has been shown to predict relapse during the treatment phase (Passetti et al., 2011; 
Passetti, Clark, Mehta, Joyce, & King, 2008). Thus, although opiate substitute programs 
5 
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provide a window for support and meaningful change, poor decision-making appears to 
be an ongoing issue, placing people engaged in such programs at risk of relapse and 
contributing to the addiction cycle. Thus, a better understanding of the factors which 
may contribute to this decision-making impairment has the potential to lead to improved 
outcomes1.  
2.3 Consequences of Opiate Use 
2.3.1 Health and social problems associated with opiate use 
People in all phases of the opiate addiction cycle, face a number of challenges 
which are thought to stem from cognitive impairments, in particular impaired judgement 
and decision-making (Ahn et al., 2014; Brand, Roth-Bauer, Driessen, & Markowitsch, 
2008). For example, opiate users often choose to inject opiates, which can lead to 
collapsed veins, bacterial infection of blood vessels, abscesses and even arthritis (U.S. 
Department of Health and Human Services, National Institutes of Health, & National 
Institute of Drug Abuse, 2014). Poor decision-making may also lead to a higher risk of 
contracting blood-borne viruses through risky sexual practices (Gowing et al., 2008) 
and higher rates of poly-drug dependence through engagement in polysubstance abuse 
(Astals et al., 2008; Veilleux et al., 2010). Opiate users are also exposed to more 
violence (Darke, Sims, McDonald, & Wickes, 2000), which may lead to increased rates 
of traumatic brain injury (Darke, McDonald, Kaye, & Torok, 2012b). They also 
experience reduced employment levels (De Maeyer et al., 2011; Meulenbeek, 2000). 
These issues all contribute to reduced quality of life in opiate users (De Maeyer et al., 
2010). Reduced quality of life can also precede drug abuse, with opiate users often 
experiencing physical and sexual abuse, social disadvantage and exposure to parental 
substance abuse from an early age (see Darke, 2011 for a review). These early 
experiences are often predictive of heroin and other drug dependence later in life 
(Darke, 2011; Dube et al., 2003), suggesting these experiences may be contribute to 
impaired judgement which pre-dates drug abuse (Edalati & Krank, 2016; Verdejo-
Garcia, Lawrence, & Clark, 2008) 
                                                 
1 It should be noted here that the term “opiate” refers to natural extracts of the opium poppy (such as 
heroin and morphine), whereas “opioid” refers to any natural or synthetic drug that has morphine-like 
actions, such as methadone (Darke, 2011; Koob & Le Moal, 2005). Given that the participants under 
investigation in this thesis identified primarily as heroin users (who also used other opioids), they will be 
referred to as “opiate users” throughout the thesis.  
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2.3.2 Neurological abnormalities associated with opiate use 
In addition to health and occupational issues, opiate use, particularly use of 
heroin, is associated with abnormalities in both the structure and function of the brain 
(Pandria, Kovatsi, Vivas, & Bamidis, 2016). Imaging studies assessing the acute and 
long-term effects of opiates have demonstrated abnormalities in key areas associated 
with emotional responding (Lubman, Allen, Peters, & Deakin, 2008; Schmidt et al., 
2014), and cognitive processing (Wollman et al., 2016). The presence of these 
abnormalities provides a basis for expecting that neurobiological factors may contribute 
to the decision-making difficulties experienced by long-term opiate users.  
Available imaging studies indicate that functional abnormalities are concentrated 
in the frontal cortices of the brains of opiate users. The frontal cortices are areas critical 
for higher-order cognitive functions, such as decision-making. Research conducted to 
date in opiate users has consistently reported abnormalities in cerebral blood flow 
(Daglish et al., 2001; Gerra et al., 1998; Pezawas et al., 2002), disruptions to white 
matter integrity in frontal regions (Li et al., 2016; Lin, Chou, Chen, Huang, Chen, et al., 
2012; Liu et al., 2008; Lyoo et al., 2004; Qiu, Jiang, Su, Lv, Zhang, et al., 2013; 
Schlaepfer et al., 2006; Sun, Wang, et al., 2015; Wang et al., 2011; Wollman et al., 
2015) and abnormal functional connectivity between the anterior cingulate cortex, the 
orbitofrontal cortex and other frontal areas that are involved in cognitive control (Cheng 
et al., 2013; Jiang et al., 2011; Liu, Liang, et al., 2009; Ma et al., 2010; MacDonald, 
Cohen, Stenger, & Carter, 2000). Additionally, positron emission topography imaging 
studies have demonstrated reduced function of dopamine transporters in the basal 
ganglia of opiate users (Liu et al., 2013; Yeh et al., 2012; Yuan et al., 2015), which may 
also contribute to reduced cognitive function (Liang et al., 2016). Research has also 
found abnormalities in the grey matter of the prefrontal cortex and medial frontal cortex 
of current and ex-users of opiates (Lin, Chou, Chen, Huang, Lu, et al., 2012; Liu, Hao, 
et al., 2009; Lyoo et al., 2006; Qiu, Jiang, Su, Lv, Tian, et al., 2013; Wang et al., 2012; 
Yuan et al., 2010; Yuan et al., 2009). In addition, a recent meta-analysis found that, 
across a range of studies, there were reductions in grey matter volume in opiate users in 
areas critical to cognitive and affective processing (Wollman et al., 2016). Several 
studies have also found that duration of heroin use correlates negatively with grey 
matter volume in the prefrontal cortex (Ma et al., 2015; Qiu, Jiang, Su, Lv, Tian, et al., 
2013; Yuan et al., 2010; Yuan et al., 2009), which may suggest that opiate use directly 
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causes the neurological abnormalities seen in imaging studies. The neurological 
abnormalities seen in the frontal lobes of opiate users may contribute to their reduced 
decision-making capacity. 
2.4 Decision-Making: Definition and Types 
Decision-making, as a psychological construct, has been studied for the better part 
of the last century (Goldstein & Hogarth, 1997). While many definitions have been 
offered, the one that best defines effective decision-making in the context of research is 
that it is the process that combines desires (personal values, goals) and beliefs 
(expectations, knowledge) to choose a course of action that will have long term positive 
outcomes (Hastie, 2001). In order to make a decision, a decision-maker must assess 
possible alternative actions and make a judgement about how likely it is that a certain 
outcome will occur if that alternative is chosen. Thus, the anticipated consequences of 
choices play a key role in decision-making. 
However, it has been argued that decision-making should not be viewed as a 
unitary construct (Bechara, 2004; Einhorn & Hogarth, 1985; Ellsberg, 1961). As such, 
the mental processes (and underlying neurological processes) involved in making 
decisions probably vary, depending on the conditions under which a decision is being 
made. Indeed, decision-making involves the integration of a number of complex 
cognitive processes (such as working memory and problem solving, e.g., Brand, 
Recknor, Grabenhorst, & Bechara, 2007). However, these processes are not the focus of 
the current thesis. While the field of decision-making is still evolving, there is general 
agreement that there are at least three relevant sets of decision-making conditions. The 
first set of conditions is referred to as ambiguous, and it involves scenarios where the 
likelihood of reward or punishment is unknown. Decision-making under ambiguous 
conditions has most commonly been  measured using the Iowa Gambling Task (IGT; 
Bechara, Damasio, Damasio, & Anderson, 1994). The second set of conditions is 
referred to as conditions of delayed discounting, where people must choose between 
small rewards delivered immediately and larger rewards delivered after a delay. A third 
set of conditions is known as conditions of calculable risk, and involves scenarios 
where the likelihood of reward can be predicted with a relatively high degree of 
accuracy. Decision-making under conditions of risk has been measured using the 
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Balloon Analogue Risk Task (BART; Lejuez et al., 2002), the Cambridge Gambling 
Task, and the Game of Dice Task.  
2.5 Empirical Studies of Decision-Making in Opiate Users across Different Types 
of Decision-Making 
Most studies of decision-making in opiate users have investigated decision-
making under conditions of ambiguity and have generally used the IGT as the decision-
making measure. The bulk of these studies have found that opiate users perform more 
poorly than controls under conditions of ambiguity (Barry & Petry, 2008; Lemenager et 
al., 2011; Li, Zhang, et al., 2013; Ma et al., 2015; Pirastu et al., 2006; Rotheram-Fuller, 
Shoptaw, Berman, & London, 2004; Sun, Zhao, et al., 2015; Upton, Kerestes, & Stout, 
2012; Verdejo-Garcia, Perales, & Perez-Garcia, 2007; Yan et al., 2014; Zhang et al., 
2012), regardless of whether they are completely detoxified or are still using actively 
heroin or other opiate substitutes (even up to 12 hours before the session). However, 
some studies have found that opiate users perform no differently to controls on this task 
(Ahn & Vassileva, 2016; Pirastu et al., 2006; Zeng et al., 2013; Zeng, Su, Jiang, Zhu, & 
Ye, 2016). Other studies have found that opiate users in treatment make poor decisions 
on delay discounting measures, with opiate users choosing smaller short-term rewards 
over larger delayed rewards (Cheng, Lu, Han, Gonzalez-Vallejo, & Sui, 2012; Kirby & 
Petry, 2004; Kirby, Petry, & Bickel, 1999; Madden, Petry, Badger, & Bickel, 1997). In 
general, however, the weight of evidence is that opiate users are impaired under 
conditions of ambiguity. In the case of decision-making under conditions of risk, as 
measured by tasks such as the BART and Cambridge Gambling Task, results are more 
limited and more varied.  On the Cambridge Gambling Task and Game of Dice Task, 
opiate users make poorer quality decisions than controls by consistently choosing 
options that are unlikely to result in reward (Baldacchino et al., 2015; Brand et al., 
2008; Tolomeo, Gray, Matthews, Steele, & Baldacchino, 2016). However, in other 
studies, the quality of opiate users’ decision-making mirrors that of controls (Ahn & 
Vassileva, 2016; Ersche et al., 2005). Only two studies exist which analyse opiate users’ 
performance on the BART, and the two sets of results conflict (Ahn & Vassileva, 2016; 
Khodadadi, Dezfouli, Fakhari, & Ekhtiari, 2010).   
 While evidence suggests that decision-making is impaired in opiate users (at least 
in some types of decision-making), the severity of this impairment, and whether other 
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factors contribute to worsened or improved decision-making ability in this group, are as 
yet unclear. For example, previous research has demonstrated that a longer duration of 
opiate use is negatively correlated with grey and white matter volume in the prefrontal 
cortex of opiate users (Ma et al., 2015; Qiu, Jiang, Su, Lv, Tian, et al., 2013; Yuan et al., 
2010; Yuan et al., 2009), which may in turn contribute to more severe decision-making 
impairment (Ma et al., 2015). However, while some studies have found that duration of 
use is negatively correlated with decision-making capacity in opiate users (Cheng et al., 
2012; Yan et al., 2014), others have found no significant relationship (Brand et al., 
2008; Lemenager et al., 2011). Similarly, it is thought that common co-morbid health 
issues such as head injury or poly-substance dependence may compound cognitive 
deficits. There is some evidence to suggest that head injury and poly-substance 
dependence in opiate users may impair other cognitive functions reliant on the frontal 
lobes, such as inhibitory control, planning ability and working memory, over and above 
the effect of opiates (Darke et al., 2012b; Darke et al., 2000; Henry et al., 2012; Loeber 
et al., 2012). However, their impact on decision-making has not been investigated. 
Furthermore, it is also unclear whether abstinence from opiates leads to improvements 
in decision-making. It has been argued that abstinence from opiate use may lead to 
better decision-making capacity (Zhang, Shi, et al., 2011), possibly due to some 
recovery in neurological function (Shi et al., 2008; Yeh et al., 2012). However, some 
neuroimaging studies have found enduring functional abnormalities in ex-users tested 
after 6 or 12 months of abstinence (Cheng et al., 2013; Liu, Liang, et al., 2009). Cross-
sectional studies of decision-making capacity in ex-users have produced mixed results, 
with some studies finding that ex-users demonstrate no decision-making impairment 
relative to controls (Zeng et al., 2013; Zhang, Shi, et al., 2011), suggesting a degree of 
recovery in function, while others have found that decision-making remains impaired in 
ex-users (Li, Zhang, et al., 2013; Verdejo-Garcia & Perez-Garcia, 2007; Yan et al., 
2014). Thus, although decision-making impairment appears relatively severe in opiate 
users, the impact of a number of factors on this impairment require further clarification.    
2.5.1 Theories to describe (impaired) decision-making 
A number of theoretical approaches have been offered to explain the mental 
processes involved in decision-making, and to isolate the part of the decision-making 
process may become impaired in opiate users. The first of these approaches used 
mathematical and economical models, such as the Expected Utility Model (Von 
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Neumann & Morgenstern, 1947), to describe how people would make decisions if they 
behaved rationally. The main aim of these theories was to provide a series of rules for 
decision-making that could be used by researchers to mathematically predict how 
people would behave and what decisions they would make in a given situation (Plous, 
1993), in particular to avoid risk (risk aversion; Schoemaker, 1982). However, 
simplifying human decision-making into a set of mathematically-predictable problems 
with solvable solutions was rather restrictive and did not describe how people actually 
made decisions (Plous, 1993). Later theories, such as the Subjective Expected Utility 
model (Savage, 1954) and Prospect Theory (Kahneman & Tversky, 1979), incorporated 
subjective probabilities of outcomes, and allowed the subjective wants of a decision-
maker to be included in the decision process to help understand how decision-makers 
avoided choosing risky options. However, these theories often ignored important 
components of the decision-making process, such as emotion (Zeelenberg, Nelissen, 
Breugelmans, & Pieters, 2008), and lacked predictive power. In other words, these 
mathematically-based rational theories were unable to predict the choices normal 
decision-makers make in real life, and so could not be used to explain normal (or indeed 
impaired) decision-making.  
Another approach to describe the mental processes involved in decision-making 
focused on cognitive functioning. Similar to mathematical models of decision-making, 
researchers investigating cognitive processing initially believed that decision-making 
was a relatively logical and process-driven cognitive function (Chan, Shum, 
Toulopoulou, & Chen, 2008; Norman & Shallice, 1986), and was related to other 
logical and mechanistic cognitive functions, such as cognitive flexibility, inhibitory 
control, and planning. These cognitive functions were termed “cold” cognitive 
functions, as they lacked emotional involvement (Chan et al., 2008; Roiser & Sahakian, 
2013). However, researchers found that some groups with impaired decision-making, in 
particular people with damage to the ventromedial prefrontal cortex, were able to 
successfully carry out most of these cold cognitive processes, but were nevertheless 
unable to make adaptive decisions (Bechara et al., 1994; Bechara, Damasio, Tranel, & 
Anderson, 1998). Similarly, studies assessing cold cognitive functions have found these 
cognitive abilities are not always impaired in opiate users (Brand et al., 2008; Darke, 
McDonald, Kaye, & Torok, 2012a; Ersche, Clark, London, Robbins, & Sahakian, 2006; 
Fishbein et al., 2007; Gupta et al., 2014; Messinis et al., 2009; Mintzer, Copersino, & 
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Stitzer, 2005; Mintzer & Stitzer, 2002; Pau, Lee, & Chan, 2002; Rotheram-Fuller et al., 
2004; Verdejo-Garcia, Perales, et al., 2007; Verdejo-Garcia & Perez-Garcia, 2007), 
therefore suggesting that deficits in cold cognitive functions may not underpin decision-
making impairment in this group. Consequently, investigations of the mental processes 
involved in decision-making have been approached from a “hot” cognitive processing 
viewpoint.  
Hot cognitive functions involve more emotive components such as the experience 
of reward and punishment (Bechara, 2004; Chan et al., 2008; Grafman & Litvan, 1999) 
and the processing of motivationally and emotionally-salient stimuli (Hunter & 
Sparrow, 2012). Decision-making tasks in the laboratory present decision-makers with 
rewards and punishments for their choices, which often evoke an emotional response 
(Naqvi, Shiv, & Bechara, 2006). Rewarding outcomes (wins) are associated with 
positive emotional response, while punishing outcomes (losses) trigger negative 
emotional responses. These emotional responses might help inform future decisions. 
Thus, it has been argued that decision-making falls under the umbrella of “hot” 
cognitive functioning (Chan et al., 2008; Grafman & Litvan, 1999), and good decision-
making may be more reliant on the ability to appropriately process emotional 
information based on the punishing and rewarding outcomes of choices (Bechara, 2004; 
Bechara & Damasio, 2005), than on cold cognitive functions. Consequently, in opiate 
users, poor decision-making may stem from an inability to process emotionally-salient 
information related to the punishing and rewarding outcomes of choices, which itself 
may stem from a broader emotion processing deficit (Verdejo-Garcia, Perez-Garcia, & 
Bechara, 2006). However, very few studies have analysed the emotion processing 
capacity of opiate users, and so their emotion processing capacity (and consequently 
any relation to their decision-making ability) remains unclear.  
2.6 Emotion Processing in Opiate Users  
Studies have only recently started to focus on the emotional responding capacity 
of opiate users, and results are inconsistent. The following section summarises what is 
currently known about the emotional responding capacity of this group. 
2.6.1 Subjective emotional experience in opiate users 
Emotional response is often assessed via subjective ratings of static images, such 
as the International Affective Picture System (IAPS) images. Study participants are 
12 
DECISION-MAKING AND OPIATE USE 
asked to subjectively rate these images for valence (how pleasant or unpleasant the 
images are) and arousal (how calming or exciting the images are) (Britton, Taylor, 
Sudheimer, & Liberzon, 2006). Blunted emotional responses to these images may be 
indicative of a general emotional blunting, which may extend to emotional responses to 
reward and punishment in decision-making tasks, and may in turn lead to impaired 
decision-making (Verdejo-Garcia, Rivas-Perez, Vilar-Lopez, & Perez-Garcia, 2007). 
As noted, thus far only a few studies have analysed the emotional responses of 
opiate users. Gerra et al. (2003) found a significant effect of valence, where opiate users 
rated unpleasant images as more unpleasant, and pleasant images as less pleasant, than 
controls. However, ratings of arousal were no different between groups. Conversely, 
Aguilar de Arcos et al. (2008) found that opiate users reported reduced arousal ratings 
for pleasant IAPS images but higher arousal ratings for negative images in comparison 
to healthy controls, although there were no differences between groups for ratings of 
valence. However, other studies have found no significant difference between opiate 
users and controls either for ratings of valence or of arousal in response to IAPS images 
(Carcoba, Contreras, Cepeda-Benito, & Meagher, 2011; Lubman et al., 2009; Smoski et 
al., 2011; Wang et al., 2010). It should be noted, however, that the studies which did not 
find a difference in subjective emotional responses presented images for relatively short 
periods of time (normally less than five seconds), which may not have allowed 
participants to fully experience the target emotion. Overall, while the findings from the 
two studies with the stronger methodology (i.e., Aguilar de Arcos et al., 2008; Gerra et 
al., 2003) suggest that subjective emotional experience may be abnormal in opiate users, 
there are currently too few methodologically sound studies available to make firm 
conclusions.  
2.6.2 Objective emotional experience in opiate users 
Emotional responses go beyond subjective awareness (Fernández et al., 2012) and 
can also be measured objectively via changes in physiology. This includes eye blinks, 
hormonal changes and changes in heart rate. Only two studies have assessed opiate 
users’ emotional response using objective measures. Gerra et al. (2003) assessed 
hormonal responses to IAPS images in addition to the measures of self-reported valence 
and arousal described above. There were no significant changes in neuroendocrine 
levels (noradrenaline, cortisol and adrenocorticotropic hormone) or cardiovascular 
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reactions (heart rate and blood pressure) following viewing of the emotional stimuli in 
the opiate users. In contrast, control participants displayed increased neuroendocrine 
and cardiovascular responses following unpleasant emotional stimuli. This suggests that 
opiate users respond differently to emotional stimuli, and that these differences can be 
measured physiologically. In contrast to this, however, Walter et al. (2011) failed to 
detect a significant difference between opiate users and controls when assessing the 
startle response to IAPS images via eye blinks. Thus, it may be the case that some 
physiological responses to emotional stimuli are impaired in opiate users, but others are 
preserved. It appears, however, that more research is needed, using more rigorous 
methodology, to better understand the objective and subjective aspects of emotional 
processing in opiate users.  
2.7 Emotional Model of Decision-Making: The Somatic Marker Hypothesis 
As described previously, rational theories of decision-making and cold cognitive 
functioning have been unable to explain the poor decision-making observed in opiate 
users. Given that people’s emotional evaluations of the outcomes of decisions are an 
important component of the decision-making process, alternative models of decision-
making incorporating emotion have been put forward to explain how people make 
decisions. One such model is the Somatic Marker Hypothesis (Damasio, 1994), which 
aims to provide a neurological account of normal decision-making and the impact on 
decision-making ability when specific neurological pathways become impaired.  
The somatic marker hypothesis proposes that decision-making, at least under 
conditions of ambiguity, relies on the ability to emotionally respond to rewards and 
punishments (Bechara, Damasio, Damasio, & Lee, 1999). This emotional response can 
be measured via changes in physiological arousal such as sweat on the skin (skin 
conductance response) and changes in heart rate (Bechara & Damasio, 2005). Crucially, 
when a decision-maker later contemplates making a decision similar to the one which 
resulted in reward or punishment, the model proposes that this same pattern of 
physiological response is activated in anticipation of the decision. This anticipatory 
somatic marker acts as a warning signal to inform the decision-maker of the likely 
outcome of a considered choice (Damasio, 2009). Thus, emotions serve as “gut 
feelings” which act to endorse some options and discourage others, and therefore bias 
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decision-making towards outcomes which are likely to be advantageous in the long run 
(Bechara & Damasio, 2005).  
The IGT simulates decision-making under ambiguous conditions (Bechara & 
Damasio, 2005) and has been used to test the somatic marker model of decision-
making. Previous research has found that, in healthy adults, the skin conductance 
response is greater after receiving a punishment than after receiving a reward on the 
IGT (Bechara, Tranel, Damasio, & Damasio, 1996; Crone, Somsen, Beek, & Van Der 
Molen, 2004). Importantly, it has also been found that the skin conductance response is 
higher before disadvantageous compared to advantageous decisions on the IGT in 
healthy adults (Carter & Smith Pasqualini, 2004; Crone et al., 2004). Thus, the skin 
conductance response can be used as an indicator of anticipatory somatic marking 
(Bechara et al., 1996). In addition, a larger difference in anticipatory somatic marking 
prior to disadvantageous relative to advantageous decisions has been associated with 
better decision-making in healthy adults (Carter & Smith Pasqualini, 2004; Guillaume et 
al., 2009; Miu et al., 2012). However, in groups with impaired decision-making, such as 
people with damage to the frontal lobes, people with obsessive-compulsive disorder and 
pathological gamblers, anticipatory somatic markers prior to disadvantageous decisions 
are reduced or absent (Bechara et al., 1999; Cavedini et al., 2012; Goudriaan, 
Oosterlaan, de Beurs, & van den Brink, 2006).  
It is thought that the abnormalities in the frontal lobes of these groups interfere 
with their ability to produce anticipatory somatic markers (or to respond emotionally to 
rewards and punishments), thus leading to poor decision-making (Bechara et al., 1999; 
Cavedini et al., 2012; Goudriaan et al., 2006). The orbitofrontal cortex is an area of the 
brain critical in the experience of emotion, in particular the emotional response to 
reward and punishment (Rolls, 2000, 2004). In the context of the somatic marker 
hypothesis, it is thought that the orbitofrontal cortex acts to pair the outcome of a 
decision, such as a reward or punishment, to the emotional state, or “what it feels like” 
to be in a given situation (Bechara & Damasio, 2005). Thus, damage to the orbitofrontal 
cortex may impair the formation of somatic markers either via emotional blunting in 
response to outcomes of decisions (i.e., reduced emotional response to reward and 
punishment), and/or reduced capacity to form anticipatory somatic makers. This may in 
turn lead to reduced decision-making capacity (Bechara, Damasio, & Damasio, 2000).  
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However, it is also possible that reduced awareness of somatic markers may 
contribute to reduced decision-making capacity. Interoception describes the process 
whereby individuals receive and interpret subtle bodily or physiological changes (e.g., 
changes in heart rate or skin temperature) (Craig, 2002; Verdejo-Garcia, Clark, & Dunn, 
2012), which ultimately allows them to use these signals to modify ongoing behaviour 
(Paulus & Stewart, 2014). The ability to perceive changes in bodily states seems to be 
an important part of the process in recognising a somatic marker. Indeed, researchers 
investigating the somatic marker hypothesis have recently begun to consider the role of  
interoceptive ability (Craig, 2009; Dunn et al., 2010), and have shown that more 
accurate perception of heartbeats in healthy adults is associated with better decision-
making ability (Werner, Jung, Duschek, & Schandry, 2009). However, other research 
has found no correlation (Dunn et al., 2010; Werner et al., 2013). While an association 
between interoceptive accuracy and decision-making has not been assessed in substance 
users, a recent study by Sönmez, Kahyacı Kılıç, Ateş Çöl, Görgülü, and Köse Çınar 
(2016) did demonstrate that a mixed group of abstinent substance users (including 
heroin users) showed reduced ability to perceive heartbeats (i.e. reduced interoceptive 
accuracy), relative to controls. 
In the context of the Somatic Marker Hypothesis, it appears that there are two 
points in the chain of events during the decision-making process that could break down 
in opiate users, and ultimately lead to poor decisions. The first point is at the beginning 
of the chain; specifically, a reduced capacity to emotionally respond to more general 
stimuli (as outlined in section 2.6.1) may also mean that opiate users are unable to 
emotionally respond to the consequences of choices (i.e., punishments and rewards). 
This may stem from abnormal function of the orbitofrontal cortex in opiate users (Ma et 
al., 2010; Qiu et al., 2011). Reduced emotional responses to rewards and punishments 
may then interrupt the production of anticipatory somatic markers, consequently leading 
to impaired decision-making. Previous research has found a link between emotion 
processing capacity and decision-making ability in users of other substances (Verdejo-
Garcia, Rivas-Perez, et al., 2007). However, the link between emotion processing 
capacity and decision-making ability in opiate users has not previously been examined. 
Alternatively, it may be that opiate users experience normal emotional responses, and 
create normal somatic markers but, at the very end of the chain of events, they are 
unable to perceive the changes in physiology as accurately as healthy adults (i.e., 
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reduced interoceptive accuracy). Thus, it is a failure to detect their somatic markers that 
may ultimately result in the decision-making impairment. Interoceptive accuracy has 
been linked to the functioning of the insula in healthy adults (Craig, 2009; Critchley, 
2005; Critchley, Wiens, Rotshtein, Öhman, & Dolan, 2004) and neuroimaging studies 
have demonstrated impaired insula structure and function in opiate users (Gardini & 
Venneri, 2012; Lin, Chou, Chen, Huang, Lu, et al., 2012; Wang et al., 2016; Xie et al., 
2011; Zhang, Tian, et al., 2011). Thus, while opiate users may produce normal 
physiological signals in response to reward and punishment, and normal physiological 
signals prior to making decisions (i.e., normal somatic markers), they may not be able to 
accurately “tune into” these somatic markers, thereby reducing decision-making ability. 
Furthermore, given that somatic markers are hypothesized to be necessary for decision-
making under conditions of ambiguity, but not under conditions of calculable risk, it 
may also be expected that opiate users are more impaired on tasks measuring this type 
of decision-making (i.e., the IGT) compared to tasks simulating conditions of risk (i.e., 
the BART).  
2.8 Chapter Summary 
In summary, opiate use is associated with a range of poor outcomes and reduced 
quality of life. Opiate users face a number of health and social issues every day, and 
opiate use is also associated with significant abnormalities of the structure and function 
of the brain. These brain abnormalities are centred in the frontal lobes, which control 
many complex cognitive functions, including decision-making. Given that opiate users 
demonstrate impaired neurological function, it is no surprise that they also demonstrate 
impaired decision-making ability on tasks in the laboratory which aim to simulate 
decision-making in real life. However, it is unknown whether a number of other factors 
may worsen or improve the decision-making capacity of opiate users. For example, co-
morbid factors such as head injury or polysubstance dependence may compound 
cognitive deficits. On the other hand, abstinence from opiates may lead to some 
recovery of neurological functioning, suggesting better decision-making capacity. 
However, the effects of these factors on decision-making have not been systematically 
analysed. Similarly, longer duration of use seems to be associated with more impaired 
neurological functioning, however the relative importance of duration of use on 
decision-making has not been explored. These outstanding questions will be addressed 
in Study 1. As good decision-making ability is critical to adaptive functioning, theorists 
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have tried to determine the mental processes involved in decision-making and how these 
process can become impaired. Rational and cold cognitive theories of decision-making 
have so far been unable to explain why opiate users consistently make poor decisions. 
Instead, it may be that reduced decision-making ability may stem from deficiencies in 
hot cognitive processing, which involves the emotional evaluation of outcomes. Thus, it 
can be suggested that the decision-making impairment observed in opiate users may be 
related to reduced emotional processing capacity. However, it is currently unclear 
whether opiate users have reduced emotional responding. Furthermore, the relationships 
between the capacity for emotional response, interoceptive ability, and the capacity for 
decision-making have not been analysed. These questions will be addressed in Study 2. 
Finally, opiate users have demonstrated some variation in performance on tasks 
assessing decision-making under different conditions (i.e., ambiguous vs. risky). This 
suggests that decision-making capacity may be differentially impaired under different 
conditions. This will be addressed in Study 3. 
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CHAPTER 3: Study 1 - Meta-Analysis of Decision-Making in Current and Ex-
Users of Opiates 
3.1 Preamble 
A number of studies have found that opiate users perform more poorly than 
controls on a range of decision-making measures (e.g Ahn & Vassileva, 2016; 
Baldacchino et al., 2015; Cheng et al., 2012; Sun, Zhao, et al., 2015). However, this is 
not always the case, with decision-making ability in opiate users sometimes comparable 
to that of healthy controls in some studies (Areias, Paixao, & Figueira, 2016; Ersche et 
al., 2005; Mintzer et al., 2005; Zeng et al., 2013). This may be due to the heterogeneity 
of samples used across studies. While some studies report data for current users of 
opiates (e.g. Baldacchino et al., 2015; Ma et al., 2015; Upton et al., 2012), others report 
data for opiate users who have been abstinent for some time (e.g. Ahn & Vassileva, 
2016; Li, Zhang, et al., 2013; Yan et al., 2014). It has been suggested that abstinence 
may reduce the decision-making impairment in opiate users (Mintzer et al., 2005; 
Zhang, Shi, et al., 2011), while other factors such as longer duration of heroin use may 
increase the severity of the impairment (Cheng et al., 2012; Yan et al., 2014). Given the 
heterogeneity of opiate-using samples included in previous studies, the exact level of 
the decision-making impairment in opiate users is, as yet, unknown. Therefore, the aim 
of the first study of this PhD thesis was to pool data from available studies to determine 
the level of the decision-making impairment in current and ex-users of opiates. 
Furthermore, this study aimed to determine whether additional factors such as length of 
heroin use, length of abstinence, head injury and polysubstance dependence, may have 
some impact on the severity of the decision-making impairment.  
This chapter presents the published manuscript which describes the results of the 
meta-analysis. This study was published in Neuroscience and Biobehavioral Reviews: 
Biernacki, K., McLennan, S. N., Terrett, G., Labuschage, I., Rendell, P. G. (2016). 
Decision-making ability in current and past users of opiates: A meta-analysis. 
Neuroscience and Biobehavioral Reviews, 71, 342-351. doi: 
10.1016/j.neubiorev.2016.09.011 
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3.3 Abstract 
Opiate use is associated with deficits in decision-making. However, the impact of 
abstinence and co-morbid factors, like head injury and poly-substance abuse, on this 
ability, is currently unclear. This meta-analysis aimed to assess 1) the magnitude of 
decision-making deficits in opiate users; 2) whether co-morbid factors moderate the 
severity of these deficits; 3) whether ex-opiate users demonstrate smaller decision-
making deficits than current users; and 4) whether the length of abstinence is related to 
the magnitude of decision-making deficits. We analysed 22 studies that compared the 
performance of current and ex-opiate users to healthy controls on decision-making 
measures such as the Iowa Gambling Task. Current users demonstrated a moderately 
strong impairment in decision-making relative to controls, which was not significantly 
moderated by co-morbid factors. The magnitude of the impairment did not significantly 
differ between studies assessing current or ex-users, and this impairment was not related 
to length of abstinence. Thus, it appears that opiate users have relatively severe 
decision-making deficits that persist at least 1.5 years after cessation of use. 
3.4 Introduction 
Long term opiate use is associated with a range of problems in everyday life, 
including poor physical and mental health, impaired social functioning, and high 
unemployment rates (De Maeyer et al., 2010; De Maeyer et al., 2011; Meulenbeek, 
2000). These difficulties may be linked to deficits in cognitive functioning, with a 
number of cognitive processes including attention, verbal memory, and executive 
functions shown to be impaired in both heroin and prescribed opiate users (see 
Baldacchino et al., 2012; and Wang et al., 2013 for reviews). Of the cognitive processes 
negatively impacted by opiate use, decision-making ability appears to be one of the 
most consistently and severely affected (Baldacchino et al., 2012). 
While it is relatively well-established that decision-making is compromised in 
opiate users (Baldacchino et al., 2012), little is known about which individuals within 
this heterogeneous population are most at risk. Similarly, the trajectory of the decision-
making impairment following treatment is currently unclear. In particular, it is not 
known whether decision-making deficits abate during periods of abstinence. Such 
information has the potential to improve understanding of the difficulties that opiate 
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users face and to assist policy makers and service providers to develop effective support 
services.  
A more detailed understanding of the relationship between opiate use and 
decision-making ability has been limited by the fact that most available studies in this 
field have relatively small sample sizes, and findings have been inconsistent, making it 
difficult to draw reliable conclusions. Therefore, the current study used a meta-analysis 
to pool and re-examine available data to investigate the temporal trajectory of decision-
making deficits in opiate users, and examine the potential influence of individual factors 
on the severity of these deficits.   
In the current context, effective decision-making refers to the ability to avoid 
making choices that result only in small or short-term benefits, and/or choices that carry 
a high risk of adverse outcomes. Studies of decision-making have shown that, compared 
to non-drug-using controls, opiate users tend to select options with short-terms gains but 
long term losses (e.g., Lemenager et al., 2011; Mintzer et al., 2005; Mintzer and Stitzer, 
2002; Verdejo-Garcia and Perez-Garcia, 2007) as well as smaller immediate rewards 
over larger delayed rewards (i.e. delay discounting, Kirby and Petry, 2004; Kirby et al., 
1999). In addition, opiate users generally choose riskier options, such as choosing a 
large but unlikely reward, over a smaller, but likely reward (Brand et al., 2008; Ersche 
et al., 2006; Ersche et al., 2005b). The magnitude of these decision-making difficulties 
is substantial, with medium to large effect sizes (Cohen’s d = 0.70) reported in studies 
that compare opiate users to non-drug-using controls (Baldacchino et al., 2012). These 
decision-making difficulties have the potential to impact on real life choices about 
money, housing, and health related behaviours (e.g. Wilson and Vassileva, 2016). 
Compromised decision-making ability in this population is not surprising given 
that opiate use is associated with abnormalities in the orbitofrontal cortex (OFC) and 
associated neural networks. The OFC supports the integration of sensory and emotional 
inputs when calculating the value of rewards (Elliott et al., 2000; Krawczyk, 2002; 
Rolls, 2000; Wallis, 2007). The OFC is also part of a larger neural network involving 
the dorsolateral prefrontal cortex (dlPFC) and nucleus accumbens (Cohen et al., 2005; 
Ernst and Paulus, 2005; Krawczyk, 2002) which is particularly important for planning 
behaviour that leads to distant, as opposed to immediate, rewards (Bechara, 2004, 2005; 
Bechara et al., 2000a; Bechara et al., 2000b; Gläscher et al., 2012; Wallis, 2007). Opiate 
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users show evidence of reduced OFC and dlPFC grey matter density (Lyoo et al., 2006; 
Yuan et al., 2010) and damage to white matter (Li et al., 2016; Liu et al., 2008; Lyoo et 
al., 2004; Qiu et al., 2013a). Abnormal functional connectivity in OFC networks has 
also been found in opiate users (Cheng et al., 2013; Liu et al., 2009; Ma et al., 2010), 
and this has been linked to poorer decision-making performance (Qiu et al., 2011). In 
addition, in comparison to controls, users of different types of opiates have 
demonstrated either hyper- or hypo-activation of the OFC while making risky decisions 
during a gambling task (Ersche et al., 2006). Furthermore, reductions in dopamine and 
serotonin transmission systems are also evident amongst opiate users (Liu et al., 2013; 
Shi et al., 2008; Yeh et al., 2012; Zaaijer et al., 2015). Although the relationship 
between neurotransmitters and decision-making has not been specifically investigated in 
opiate users, abnormalities, for example in dopamine transmission, have been linked to 
reduced performance in other aspects of cognitive functioning in opiate users (Liang et 
al., 2016). Taken together, the research reveals that there are abnormalities in relation to 
OFC and dlPFC structure, function, and neurotransmission in opiate users that might 
underpin, at least to some extent, their impaired decision-making ability. Although it 
should be noted that the extent to which neural pathology precedes opiate use is 
currently unclear, a recent longitudinal brain imaging study by Li et al. (2016) showed 
that opiate use was associated with white matter degeneration over the period of one 
year. This research has confirmed that at least some measurable degeneration occurs 
over a period of active opiate use.  
If neural pathology does contribute to the decision-making deficit in opiate users, 
it may be anticipated that people with a longer history of opiate use will display more 
severe decision-making impairments, given that structural brain changes have been 
shown to be greater in people who have used opiates for longer periods of time (Yuan et 
al., 2010; Yuan et al., 2009). However, findings from the five available studies directly 
addressing this relationship have been mixed. Some have reported a negative 
association between duration of opiate use and decision-making ability (Cheng et al., 
2012; Yan et al., 2014), whereas others failed to detect such a relationship (Brand et al., 
2008; Clark et al., 2006; Lemenager et al., 2011). The limited number of these studies 
however, makes it difficult to make firm conclusions regarding the relationship between 
decision-making and duration of opiate use. It is nevertheless possible to investigate this 
issue further by considering other studies of decision-making in opiate users that do not 
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directly investigate this relationship. More specifically, because the mean duration of 
opiate use across such studies varies, we were able to collate the data from these studies 
in the current meta-analysis and use meta-regression to further examine whether the size 
of the decision-making deficit varies as a function of the duration of opiate use. 
Over and above opiate use duration, co-morbid conditions may also affect the 
severity of decision-making deficits in opiate users. For example, a large proportion of 
people who use opiates are also dependent on other street drugs (Astals et al., 2008). In 
addition, many long term opiate users have experienced neurological damage, either as 
a result of overdose, or physical trauma (Darke et al., 2012b). To the best of our 
knowledge, the potential impact of poly-substance abuse and head injury on decision-
making has not been examined in this group to date (Darke et al., 2000; Loeber et al., 
2012). However, in opiate users, poly-substance abuse and head injury are both 
associated with greater levels of impairment in other cognitive domains including 
memory, information processing, verbal learning, and executive and general cognitive 
function (Darke et al., 2012b; Darke et al., 2000; Henry et al., 2012; Loeber et al., 
2012). Thus, it is possible that poly-substance abuse and head injury may also 
detrimentally affect decision-making. In the current meta-analysis, we compared the 
size of the decision-making impairment reported in studies that included only opiate 
users who were free of co-morbid issues, to that reported in studies that included people 
with poly-substance abuse and head injuries.   
A further issue that lacks clarity in relation to the decision-making ability of 
opiate users is whether deficits in this capacity abate when opiate-users enter a period of 
abstinence. There is evidence that there is some recovery of neurotransmitter receptor 
availability and function after opiate cessation (Shi et al., 2008; Yeh et al., 2012), and 
therefore some improvement in decision-making might be anticipated. However, 
abnormal neural connectivity has been observed in abstinent ex-users (Cheng et al., 
2013; Liu et al., 2009), perhaps reflecting permanent opiate-related damage to dlPFC 
regions, or abnormalities that predated drug use. On this basis, any improvement in 
decision-making would be expected to be limited. No research has yet tracked a cohort 
of opiate users from a period of active use through to a period of abstinence. However, 
some group comparison studies have reported that decision-making ability in ex-users is 
equivalent to that of non-drug-using controls (Zeng et al., 2013; Zhang et al., 2011), 
implying that recovery may occur. Contrary to this, other studies have reported that 
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decision-making ability in ex-users is poorer than controls (Ahn et al., 2014; Clark et 
al., 2006; Li et al., 2013; Verdejo-Garcia and Perez-Garcia, 2007; Yan et al., 2014). In 
the current meta-analysis, we brought together available group comparison studies to 
investigate whether decision-making deficits in ex-users (relative to controls) are 
smaller than decision-making deficits in current users (relative to controls). Such a 
pattern of results would imply that some recovery of decision-making ability following 
abstinence does occur. In addition, we also considered the possibility that functional 
brain changes may occur gradually following cessation of opiate use. If this is the case, 
decision-making ability may not improve immediately, but may instead improve slowly 
over a period of time. The current meta-analysis allowed us to investigate the extent to 
which any recovery of decision-making ability is related to length of abstinence. 
In summary, we expected that the current meta-analysis would show that (1) the 
magnitude of decision-making deficits (relative to controls) would be greater in studies 
that included opiate users with poly-substance dependence and head injury, than in 
studies that included only opiate users who were free from these co-morbidities; (2) the 
length of time using opiates would moderate the magnitude of the decision-making 
deficits (relative to controls), such that participants who had used opiates for longer 
would have more severe decision-making deficits; (3) the magnitude of the decision-
making deficits (relative to controls) would be greater in current users than in ex-users; 
and (4) in ex-users, the length of abstinence would moderate the magnitude of the 
decision-making deficits (relative to controls) such that longer periods of abstinence 
would be associated with smaller decision-making deficits. 
3.5 Method 
3.5.1 Literature search and study selection 
This meta-analysis was conducted following PRISMA guidelines (Liberati et al., 
2009; Moher et al., 2009). We searched for studies that measured decision-making and 
which compared a control group to a group that was dependent on opiates (current 
users) at the time of testing, and/or a group that had been dependent in the past but was 
now abstinent (ex-users). We used search terms related to opiate dependence, and 
specific decision-making measures commonly used in neuropsychological literature (see 
inclusion criteria), as well as terms related more broadly to decision-making and 
cognitive impulsivity. The following databases were searched: MEDLINE Complete, 
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PsychINFO, CINAHL Complete, Scopus, and Web of Science Core Collection. Final 
searches were performed in February 2016. Reference lists of included articles were 
screened to identify other studies that met criteria for inclusion. However, this did not 
result in any additional eligible studies.  
3.5.2 Inclusion criteria 
 Studies were eligible for inclusion if they: (a) included a comparison between an 
opiate group (current or ex-users) and healthy control group; (b) reported on participants 
aged between 18 and 65 years; (c) were available in full text format; (d) described 
quantitative results; (e) provided statistics from which an effect size could be calculated; 
for example, group means, standard deviations, F, t, or X statistics; and (f) were 
published in English.    
Additional inclusion criteria relating to the participant groups (current users, ex-
users, controls) were applied. Specifically: (a) current opiate users had to have been 
dependent on opiates at the time of testing; (b) current opiate users were required to 
have been regularly using heroin and/or an opiate substitute (such as methadone, 
buprenorphine or suboxone) in the month prior to testing; (c) ex-users had to have been 
dependent on opiates in the past; (d) ex-users had to have been completely abstinent 
from all drugs of abuse (except alcohol and nicotine) and not have used any opiate 
(including substitutes such as methadone) for a minimum average of one month. 
Studies were excluded if: (a) healthy controls had a significant history of drug or 
alcohol use, i.e. had been diagnosed with substance dependence or abuse (although past 
experimental use of illicit substances was tolerated); (b) healthy controls were using 
illicit substances at the time of testing; or (c) participants in any of the three groups had 
a concurrent psychiatric diagnosis (with the exception of depression and/or anxiety that 
was not being treated with medication). It is important to note that studies were not 
excluded if opiate user groups were concurrently using (or had concurrently used) other 
drugs, as poly-substance use is prevalent in this population (Veilleux et al., 2010). 
However, poly-substance use and poly-substance dependence were coded separately in 
analyses. Furthermore, unlike other reviews (Baldacchino et al., 2012), this meta-
analysis did not exclude based on head injury as this was a variable of interest.  
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3.5.3 Decision-making measures 
To be included in the meta-analysis, papers had to report on a decision-making 
measure that assessed the ability to make choices with a favourable long-term outcome, 
despite potential short-term losses. In the wider literature, such measures are sometimes 
referred to as tests of cognitive impulsivity (e.g. Baldacchino et al., 2012) because more 
impulsive individuals tend to select options that provide some immediate reward, but 
which also tend to have more negative long term consequences. Specifically, the tasks 
that were included assessed decision-making under conditions of ambiguity where 
outcomes are unknown or cannot be predicted (e.g., Iowa Gambling Task (IGT); 
Bechara et al., 1994), or under conditions of risk where probabilities may be estimated 
(e.g., Game of Dice Task (GDT); Brand et al., 2008; Balloon Analogue Risk Task 
(BART); Lejuez et al., 2002; Cambridge Gambling Task (CGT); Rogers et al., 1999). 
Tasks that assessed inadequate reflection before a choice is made (Information 
Sampling Task (IST); Clark et al., 2006) or where the value of a delayed reinforcer is 
worth less than an immediate (albeit smaller) reinforcer (i.e., delay discounting; Bickel 
and Marsch, 2001) were also included. 
3.5.4 Data screening and extraction 
 For each study, the following participant data for opiate and control groups were 
extracted: number of participants in each group; duration of opiate use for both current 
users and ex-users; duration of abstinence for ex-users; and poly-substance use and head 
injury status for current users. For decision-making measures, data extracted were group 
means (and standard deviations) of the main outcome measure or statistics that effect 
sizes could be calculated from (e.g., t, F). The first author (KB) extracted all data, and 
where needed, contacted the first or corresponding author of each article to request 
missing information. Three attempts were made to contact authors, after which studies 
were excluded if necessary data could not be obtained (the authors of the following 
studies could not be contacted: Heyman and Dunn, 2002; Robles et al., 2011; Zhang et 
al., 2011). Similarly, articles were excluded if data to calculate effect sizes were not 
available or not retained (Fishbein et al., 2007; Petry et al., 1998; Rogers et al., 1999). 
Data was extracted a second time by an independent reviewer (see acknowledgements). 
Discrepancies between the first and second reviewers were resolved by a third 
independent reviewer (SM). Studies where the same data were published across 
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multiple publications were combined to avoid reporting overlapping data (authors were 
contacted where appropriate to determine whether data overlapped; Ahn et al., 2014; 
Dai et al., 2015; Ersche et al., 2005a; Ersche et al., 2006; Qiu et al., 2011; Qiu et al., 
2013a; Sun et al., 2015a; Verdejo-Garcia et al., 2007; Wilson and Vassileva, 2016). 
 Where articles reported more than one control group, and one of these controls 
groups included some illicit drug use (Rotheram-Fuller et al., 2004), only the control 
group that reported no drug use was included. Where articles reported on multiple 
groups of current opiate users, these data were collapsed into a single group (Ersche et 
al., 2005b; Pirastu et al., 2006; Rotheram-Fuller et al., 2004). In studies that reported on 
groups that had been abstinent for an average of less than one month, these groups were 
classified as current users (Cheng et al., 2012; Kirby and Petry, 2004). For studies that 
reported baseline and follow-up testing using a behavioural measure, only the baseline 
values were entered into analyses (Baldacchino et al., 2015; Zhang et al., 2012). For 
studies that reported data for two or more decision-making measures (Ahn and 
Vassileva, 2016; Li et al., 2013; Upton et al., 2012), effect sizes for each separate 
decision-making measure were pooled to create a combined decision-making effect size 
estimate. 
3.5.5 Data analyses 
The data were run using Comprehensive Meta-Analysis Version 2 software 
(CMA; Borenstein et al., 2005). All analyses were conducted using random-effects 
models, including calculations of effect sizes, subgroup and moderator analyses, and 
assessment of publication bias. Random-effects models were used because of known 
variation amongst populations (Hedges and Olkin, 1985) and because this type of 
modelling has a less restrictive set of statistical assumptions. Effect sizes were 
calculated as Cohen’s d (standard difference in means; Cohen, 1992). Heterogeneity 
was assessed using the I2 statistic, which describes the percentage of total variation 
across studies due to heterogeneity rather than chance (Higgins et al., 2003).  
 To address the question of whether longer duration of opiate use is associated 
with greater decision-making deficits, meta-regression was run (with a Method of 
Moments correction for random-effects variance). To address the questions of whether 
current opiate users with head injury or poly-substance dependence have greater 
decision-making deficits than current opiate users without these co-morbidities, 
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subgroup analyses using a Q-test for heterogeneity were run (Qbetween; Borenstein et al., 
2009). Studies were grouped by participants’ head injury status (yes, no) and poly-
substance dependence status (dependent, intermittent use), and effect sizes for each 
group were compared. It should be noted that it is rare that an established opiate user 
exclusively uses opiates (Darke, 2011). More often than not, they concurrently use other 
drugs (Astals et al., 2008). Therefore, all participants in the opiate groups were coded as 
either users of, or dependent on, other drugs. Studies that did not explicitly specify 
criteria regarding poly-substance dependence status or head injury status were coded in 
the positive (dependent for poly-substance use or yes for head injury).  
To address the question of whether the magnitude of the decision-making deficit 
(the degree of difference from the control group) was smaller for ex-users than for 
current users, a subgroup analysis was run using the dichotomous predictor of ex-users 
versus current users. Additionally, a meta-regression was run (restricted to the studies 
involving ex-users) to assess the impact of years of abstinence on decision-making 
differences. 
3.5.6 Publication bias and outliers 
Publication bias was assessed by visually inspecting funnel plots and by 
calculating Orwin’s fail-safe N (Orwin, 1983; Zakzanis, 2001). The fail-safe N (Nfs) 
value provides a hypothetical number of unpublished studies with nonsignificant results 
(d ≤ 0.2) which would need to exist (outside of published literature) to call the current 
findings into question (Rosenthal, 1979; Zakzanis, 2001). A larger N indicates more 
confidence in the findings (McLennan and Mathias, 2010).  
The presence and influence of outliers was assessed by examining the 
standardised residual for each study (Viechtbauer and Cheung, 2010). In cases where a 
study had a z-score of greater than ±1.96, its influence was examined using the “one 
study removed” method. Studies were retained in the overall analyses if they did not 
substantially change the overall effect size. 
3.6 Results 
3.6.1 Included articles 
After an initial literature search, a total of 4635 articles were found, which was 
reduced to 3537 articles once duplicates were removed. Their titles and abstracts were 
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screened, and 192 articles were retained. These were examined to determine whether 
they met the inclusion criteria for the study. From this, 38 articles were subjected to a 
full-text analysis. Following full-text analysis, 22 studies were deemed to meet 
inclusion criteria (see Figure 1 for a summary of the screening process). Fifteen reported 
data for current users and 7 reported on ex-users. 
3.6.2 Participant and study characteristics 
Table 1 presents a summary of the main characteristics of each study. Cohen’s d 
represents the magnitude of the difference between the opiate and control groups on the 
decision-making measures. Overall, a total of 512 current users and 513 ex-users were 
compared to 969 controls. The majority of participants in both the current and ex-user 
groups were dependent on, or had been dependent on, heroin (93.46%). Most (71.23%) 
current users were also using an opiate substitute, such as methadone or buprenorphine. 
The most commonly used opiate substitute was methadone (68.77% of all opiate-
substitute participants).  
3.6.3 Influence of individual and temporal factors on decision-making in 
current users 
To assess the influence of outliers, the standardised residual was examined for all 
studies involving current users. One study was identified as an outlier in this group 
(Ersche et al., 2005b). However, results of the “one study removed” analysis indicated 
that it did not significantly influence the overall effect size and was therefore included 
in further analyses. Figure 2 presents the forest plot for studies assessing current users.  
Fifteen studies reported data for current users. The mean age of current users was 
34.55 years (14 studies). The overall effect size for the magnitude of the difference in 
decision-making performance between current users and controls was significant                  
(d = -0.70, 95% CI = -0.89, -0.51, p < .001). There was moderate heterogeneity (I2 = 
52.07) and the fail-safe N was 37.58. 
Eleven studies reported data for duration of opiate use for current opiate users. 
The mean duration of opiate use was 10.34 years (11 studies). There was moderate 
heterogeneity (I2 = 60.63) and the fail-safe N was 25.36. Meta-regression indicated that 
there was no significant relationship between years of opiate use and the magnitude of 
the difference in decision-making performance between current opiate users and 
controls: Qmodel = 0.73, Qresidual = 10.19, Z = 0.85, p = 0.39.  
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  Excluded articles (and reasons) 
All articles identiﬁed using study 
selection keywords:  
K = 4635 
  
    
All articles identified using study 
selection key words once duplicates 
removed: 
K =3537 
  
 
  Articles not relevant to search (animal studies, theoretical 
concepts, chronic pain, clinical decision making, non-drug use 
studies):  
K =3345 
  
Articles examined for 
inclusion/exclusion criteria:  
K = 192 
  
 
  
 Subjects non-human = 2 
 Conference paper not published = 6 
 No or inappropriate control group = 27 
 Qualitative/no data = 12 
 No heroin group or heroin group not specified = 
18 
 No behavioral decision-making measure = 79 
 Full text not available/not English = 10 
K = 154 
  
Articles on adult patients with heroin 
dependence & decision making 
deficits as in inclusion criteria:  
K = 38 
  
 
  
 Conference paper/procedia  (data not published) = 
1 
 Data not retained or cannot calculate effect size 
(following author email) = 3 
 Overlapping data (combined with other included 
articles) or decision-making data reported 
elsewhere = 9 
 Author reply not received = 3 
K = 16 
  
    
Articles included: K = 22   
Figure 1. Summary of studies excluded from the meta-analysis (with reasons for 
exclusion and number of studies in each category).
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Table 1.  
Sample Characteristics of Studies Included in the Meta-Analysis and Effect Sizes for Decision-Making Measures (Cohen’s d). 
    Features of opiate group  
Author (year) DM 
measure 
Opiate 
group n 
Control  
group n 
Opiate 
use 
(years) 
Abstinence 
(years) 
Head injury 
included 
Poly-substance 
use pattern  
Cohen’s d (95%CI)a 
Current Opiate Users         
Baldacchino et al. (2014) CGT 53 28 7.58 NA No Dependence -0.66 (-1.12, -0.19) 
Barry and Petry (2008) IGT 28 37 - NA Yes Dependence -0.57 (-1.07, -0.07) 
Brand et al. (2008) GDT 18 18 11.64 NA No Intermittent use -1.02 (-1.72, -0.33) 
Cheng et al. (2012) DDT 56 56 7.60 NA No Intermittent use -0.96 (-1.35, -0.56) 
Clark et al. (2006) IST 40 26 11.00 NA No Intermittent use -0.86 (-1.38, -0.35) 
Ersche et al. (2005b)c CRT 39 27 9.93 NA No Intermittent use 0.13 (-0.36, 0.63) 
Khodadadi et al. (2010) BART 25 50 - NA Yes Intermittent use -1.08 (-1.59, -0.57) 
Kirby et al. (2004) DDT 27 44 - NA Yes Dependence -0.91 (-1.41, -0.41) 
Kirby et al. (1999) DDT 56 60 8.30 NA Yes Dependence -0.55 (-0.92, -0.18) 
Lemenager et al. (2011) IGT 46 43 15.50 NA No Dependence -0.53 (-0.95, -0.11) 
Ma et al. (2015) IGT 14 14 8.79 NA No Intermittent use -1.58 (-2.43, -0.74) 
Madden et al. (1997) DDT 18 38 9.40 NA No Dependence -1.19 (-1.79, -0.58) 
Pirastu et al. (2006)c IGT 48 21 14.69 NA No Intermittent use -0.30 (-0.82, 0.22) 
Rotheram-Fuller et al. 
(2004)c 
IGT 18 10 - NA No Intermittent use -0.79 (-1.59, 0.01) 
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Upton et al. (2012)b IGT, SGT 26 27 9.35 NA Yes Dependence -0.31 (-0.85, 0.23) 
Ex Opiate Users         
Ahn and Vassileva  
(2016)b 
IGT, 
CGT, 
DDT, 
BART 
44 81 7.10 1.74 NA NA -0.13 (-0.50, 0.24) 
Li et al. (2013)b 
IGT, 
DDT 
124 43 6.42 1.06 NA NA -1.06 (-1.42, -0.69) 
Sun et al. (2015b) IGT 121 103 15.16 0.39 NA NA -0.47 (-0.74, -0.21) 
Verdejo-Garcia and 
Perez- Garcia (2007) 
IGT 27 36 - - NA NA -0.52 (-1.03, -0.02) 
Yan et al. (2014) IGT 58 60 7.50 1.09 NA NA -0.58 (-0.95, -0.21) 
Zeng et al. (2013) IGT 86 88 4.30 0.98 NA NA 0.18 (-0.12, 0.48) 
Zhang et al. (2012) IGT 53 56 7.54 0.44 NA NA -0.47 (-0.85, -0.09) 
a Represents the magnitude of the difference between the opiate and control groups on the decision-making measures, with negative values 
indicating poorer performance by the opiate group (compared to controls)  
b Where more than one decision-making measure was reported, a combined effect score was computed 
c Where more than one opiate group was reported, a combined decision-making score was computed and used for calculating effect size 
Abbreviations: BART = Balloon Analogue Risk Task; CGT = Cambridge Gambling Task; CRT = Cambridge Risk Task; DM = decision 
making; DDT = Delay Discounting Task; IGT = Iowa Gambling Task; IST = Information Sampling Task; NA = not applicable; SGT = Soochow 
Gambling Task
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 Ten studies excluded participants based on head injury, while 5 studies did not 
exclude opiate users based on this criterion (or did not report it as an exclusionary 
criterion). Subgroup comparison indicated that the magnitude of the difference between 
current opiate users and controls for studies which included participants with head 
injury (d =-0.68, 95% CI = -0.93, -0.42) did not significantly differ from studies which 
did not include participants with head injury (d = -0.73, 95% CI = -1.00, -0.45; 
Qbetween(1) = 0.07, p = 0.80). Heterogeneity was low for studies with head injury (I
2 = 
28.78) and the fail-safe N was 11.88, while for studies without head injury, 
heterogeneity was moderate (I2 = 61.83) and the fail-safe N was 26.25. 
 Eight studies reported data for current opiate users without current dependence 
on other substances (i.e. those coded as intermittent users), while 7 reported data for 
current opiate users who had other drug dependencies. Subgroup analysis indicated that 
there was no significant difference between studies that reported data for opiate users 
who did have a current or past poly-substance dependence (dependent: d = -0.64, 95% 
CI = -0.82, -0.46) compared to studies which reported data for opiate users who did not 
have a current or past poly-substance dependence (intermittent use: d = -0.77, 95% CI = 
-1.12, -0.41; Qbetween(1) = 0.40, p = 0.53). Heterogeneity was very low for studies with 
poly-substance dependence (I2 = 4.63) and the fail-safe N was 15.33, while for studies 
without poly-substance dependence heterogeneity was moderate (I2 = 68.81) and the 
fail-safe N was 22.68. 
3.6.4 Decision-making in ex-users 
 To assess the influence of outliers, the standardised residual was examined for 
all studies involving ex-users. One study was identified as an outlier in this group (Zeng 
et al., 2013). However, “one study removed” analysis indicated that it did not appear to 
significantly influence the overall effect size and it was therefore included in further 
analyses. 
Seven studies reported data for ex-users. The mean age of ex-users was 31.88 
years (6 studies), and mean duration of heroin use in ex-users was 8.00 years (6 studies). 
The mean duration of abstinence was 0.89 years (6 studies). Heterogeneity was 
relatively high for studies that assessed ex-users (I2 = 80.53) and the fail-safe N was 
7.98. Figure 2 presents the forest plot for current and ex-users. The analysis of overall 
effect size for ex-users was significant (d = -0.43, 95% CI = -0.73, -0.13, p = .006). 
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However, the subgroup analysis comparing studies which assessed current users to 
studies which assessed ex-users was not significant (Qbetween(1) = 2.23, p = 0.136). 
Duration of abstinence was not significantly associated with decision-making 
performance: Qmodel = 0.15, Qresidual = 4.01, Z = 0.38, p = 0.70. Heterogeneity was 
relatively high for studies reporting duration of abstinence (I2 = 83.63) and this finding 
was associated with a fail-safe N of 6.48. 
 
 
Figure 2. Forest plot of all studies included in the meta-analysis.  
Studies involving current opiate users are presented at the top, and those involving ex-
users are presented below. Each plot point represents the magnitude of the difference 
(effect size) between the opiate user group and control group on decision-making 
measures. The open diamond represents the pooled effect size for each subgroup and the 
closed diamond represents the pooled effect size for all studies. 
 
3.7 Discussion 
The primary aim of this meta-analysis was to explore the influence of co-
morbidities and temporal factors on the decision-making ability of opiate users. We 
identified 15 studies that compared the decision-making abilities of current opiate users 
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with controls. Consistent with an earlier meta-analysis, which applied stricter inclusion 
criteria (Baldacchino et al., 2012), we found that the size of the deficit in decision-
making in opiate users relative to non-drug-using controls was moderate to large. This 
confirms that when opiate users are faced with choices, they find it difficult to avoid 
making risky decisions, or to forgo small short-term gains in order to achieve larger 
gains in the long term. In real life, this pattern of decision-making behaviour has the 
potential to negatively impact many areas of life. Poor decision-making in the real 
world could play out as difficulty resisting non-essential purchases in order to save up a 
deposit for accommodation, or even difficulty forgoing the short-term benefits of drug 
use in order to maintain abstinence. Although the real world sequela of decision-making 
deficits in opiate users has received little research attention, a recent study by Wilson 
and Vassileva (2016) found that poor decision-making in opiate users predicted sexually 
risky behaviour, putting users at risk of contracting HIV. In other drug-using 
populations, poor performance on the lab-based decision-making tests considered in this 
meta-analysis has been linked to dropout from drug treatment services (Stevens et al., 
2013; Stevens et al., 2015b) and higher rates of relapse (Stevens et al., 2015a). 
Having confirmed decision-making as an area of substantial impairment in opiate 
users, we then assessed the influence of comorbid conditions on this ability. To do this, 
we included studies that reported on opiate users who had head injuries and those who 
had dependencies on other drugs. These co-morbidities are very common in this group, 
and thus including these studies (which were excluded from the previous meta-analysis; 
Baldacchino et al., 2012), allowed us to examine a more representative sample. We had 
anticipated that people with these co-morbidities may exhibit even more severe 
decision-making deficits than other opiate users. However, the magnitude of the deficit 
did not differ significantly between opiate users with poly-substance dependence or 
head injury, and those without these co-morbid issues. Although relatively few studies 
were available for these subgroup analyses and, as such, they may have been 
underpowered, the magnitude of the deficit between the opiate users and controls was 
similar (moderate to high) regardless of whether co-morbidities were present or not. 
These findings therefore suggest that poly-substance use and head injury do not play a 
key role in influencing the level of decision-making deficit in opiate users. This raises 
the possibility that the observed impairment in decision-making relates more directly to 
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opiate use, possibly through its impact on brain function (Cheng et al., 2013; Lyoo et 
al., 2006).  
Over and above co-morbidities, the current study also investigated whether 
decision-making deficits are related to the duration of opiate use. More specifically, 
given the established links between opiate use and brain abnormalities (Cheng et al., 
2013; Ersche et al., 2006; Liu et al., 2009; Liu et al., 2013; Lyoo et al., 2006; Ma et al., 
2010; Shi et al., 2008; Yeh et al., 2012; Yuan et al., 2010; Zaaijer et al., 2015), and 
findings showing that structural brain changes are more severe in people who have used 
opiates for longer periods of time (Yuan et al., 2010; Yuan et al., 2009), it was 
anticipated that the size of the decision-making deficit might increase in line with the 
length of opiate use. Our meta-regression did not show such a relationship. However, 
the duration of opiate use reported in the 11 studies included in this analysis ranged 
from a mean of 7.58 years (Baldacchino et al., 2015) to a mean of 15.5 years 
(Lemenager et al., 2011). One possible interpretation of these findings is that brain 
changes may happen relatively early in the trajectory of opiate use. It is therefore 
possible that, if opiate use is associated with brain changes (for example, in the OFC; 
Ersche et al., 2006; Liu et al., 2009; Ma et al., 2010), then such neuropathology may be 
well established at least within 7 years, with further adverse effects being minimal. 
Future studies investigating the trajectory of decision-making ability across the earlier 
years of opiate use, such as from the first week to 7 years post-initiation of opiate use, 
would help clarify this issue.  
The final question addressed in the current study was the impact of abstinence on 
the decision-making ability of opiate users. To do this, we examined decision-making 
deficits in ex-users who had previously been addicted to opiates, and found that 
abstinence from opiates (for an average of just under a year) was not associated with a 
smaller deficit in decision-making. More specifically, while the effect size for the 
difference in decision-making performance between ex-users and non-drug using 
controls was smaller than the effect size for the difference between current users versus 
controls, the difference between these effect sizes was minimal and failed to reach 
significance. These results suggest that decision-making deficits appear to continue 
even after opiate use ceases. These results are consistent with those of Mintzer et al. 
(2005) who found no significant difference in decision-making performance between 
current and ex-users on the IGT.  
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In addition, the duration of abstinence was not significantly associated with the 
magnitude of the decision-making deficit in opiate users. The period of abstinence in the 
available studies ranged from just over four and a half months (Sun et al., 2015b) to just 
over one and a half years (Ahn and Vassileva, 2016). Although previous research 
suggests recovery of decision-making ability may occur after extended periods of time 
(e.g. Zhang et al., 2011), the results of this meta-analysis suggest that, at least for the 
first 1.5 years of abstinence, improvements may be minimal. This is consistent with 
neuroimaging research conducted within the first 18 months of abstinence from opiates, 
which has found lasting impairments in the functional connectivity of the dlPFC and 
OFC, as well as reduced dopamine transmission (Cheng et al., 2013; Liu et al., 2009; 
Shi et al., 2008; Yeh et al., 2012). However, given that only 7 studies of ex-users were 
included in the analyses, and all but one of these focused on users who had been 
abstinent for a relatively short time, additional longitudinal research is needed in order 
to gain a clearer understanding of whether, and by what magnitude, decision-making 
abilities improve after longer periods of abstinence. 
This meta-analysis has confirmed an association between opiate use and decision-
making deficits, but it cannot address the direction of causality. Indeed, there are at least 
two possible causal pathways that may explain the current results. First, long-term 
opiate use may lead to decision-making deficits via structural brain changes. While not 
definitive, research showing an association between the duration of opiate use and the 
severity of structural abnormalities (Yuan et al., 2010; Yuan et al., 2009), as well as 
research showing measurable white matter degeneration in opiate users over a period of 
a year (Li et al., 2016), is consistent with  the pathway of structural brain changes. 
Furthermore, most (Harvey-Lewis et al., 2012; Kieres et al., 2004; Schippers et al., 
2012), although not all (Harty et al., 2011), animal studies have demonstrated that 
decision-making impairments can be experimentally induced by administering opiates. 
Additional research also shows that opiate administration in animals reduces function of 
the OFC (Sun et al., 2006), an area known to play a significant role in decision-making 
(Krawczyk, 2002; Wallis, 2007). A second possible pathway, however, may also be in 
operation, whereby people with long-standing poor decision-making ability may be 
more likely to begin, and to continue using opiates (Bechara, 2005). This may be due to 
an overactive impulsive system which weakens the influence of the executive control 
system in the PFC, leading to a focus on immediate, rather than delayed, consequences 
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of drug use (Bechara, 2005; Bickel et al., 2007). Longitudinal studies provide support 
for this model, with delayed discounting in childhood and adolescence predicting higher 
rates of drug use in adulthood (Audrain-McGovern et al., 2009; Ayduk et al., 2000). 
Additionally, people with developmental disorders characterised by decision-making 
deficits, such as Attention Deficit Hyperactivity Disorder (ADHD; see Mowinckel et al., 
2015, for a meta-analysis), demonstrate a higher propensity for drug use (Biederman et 
al., 1998; Biederman et al., 1995; Wilens et al., 1997). Therefore, at least for a subgroup 
of opiate users, poor decision-making seems to predate drug abuse. The results of the 
current meta-analysis are consistent with either, or indeed both, of these pathways. 
Clarification of their relevant influence, however, awaits further empirical research. 
Nevertheless, given that there was no clear indication of recovery after drug use was 
discontinued, and no effect of co-morbidities on decision-making differences, the results 
of the current study provide strong evidence that the observed decision-making deficits 
were not merely a result of transient drug effects or of co-morbid conditions.  
Although this meta-analysis provides new insights into the decision-making 
impairment in opiate users, results may not translate to all opiate-using groups. For 
example, studies were excluded from the current meta-analysis if they included opiate-
users who had a concurrent serious psychiatric diagnosis. Co-morbid psychiatric 
disorders are common in opiate users (Astals et al., 2008) and decision-making deficits 
are likely to be present in these groups as well, but may be more severe (e.g. Vassileva 
et al., 2007). Additionally, not enough studies were available to separately analyse the 
effect of different types of opiates (i.e. methadone, buprenorphine, or street heroin). 
While some studies suggest there may be differences in decision-making ability 
depending on the specific opiate used (Ersche et al., 2005b; Pirastu et al., 2006), other 
research suggests different opiates do not differentially affect cognitive function (Darke 
et al., 2012a; Soyka et al., 2008). Similarly, there were too few studies available to 
investigate the differences between different decision-making measures, with the 
majority of studies assessing performance on the IGT, and only a few studies using 
other measures. Future research should take both the opiate type and the decision-
making measures used into consideration when investigating decision-making ability in 
opiate users.  
Taken together, the results of this meta-analysis provide clear evidence that 
opiate-users display decision-making deficits. Furthermore, these deficits appear to be 
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relatively consistent, even when comparing opiate users who have other substance 
dependencies or head injury, to those without these co-morbid problems. Perhaps most 
importantly, the current research show that decision-making deficits persist even after 
drug use is discontinued, which may put opiate users at risk of drug use relapse (Passetti 
et al., 2008) and other risky behaviour (e.g., Wilson and Vassileva, 2016). Treatment 
programs for opiate users typically focus on the reduction, and eventual cessation of 
illicit drug use, and on reducing associated harms (such as crime, drug-related disease 
and mortality; Darke et al., 2007; Ford et al., 2011; Nicholls et al., 2010). However, the 
current research demonstrates that opiate users would benefit from support that goes 
beyond simply reducing their drug use or achieving abstinence. Even when this aim has 
been achieved, ex-opiate users are likely to struggle with making decisions in high-risk 
situations, and are likely to benefit from ongoing support. There is now a firm basis for 
treatment programs to consider decision-making difficulties in order to provide more 
relevant and targeted support to people seeking treatment for current or past opiate 
addiction. If decision-making is taken into account this may increase opiate users’ 
success in remaining in treatment and maintaining abstinence, as well as achieving 
broader life changes. 
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CHAPTER 4: Methodology for the Empirical Studies 
4.1 Preamble  
The previous chapter demonstrated that opiate users have relatively severe 
decision-making deficits, which were not accounted for by common co-morbidities such 
as head injury and poly drug dependence (see meta-analysis in Study 1). The next part 
of the thesis focuses on the empirical studies which analysed the emotion processing 
capacity of opiate users and how this relates to decision-making ability (Study 2), as 
well as opiate users’ decision-making capacity under conditions of predictable risk 
(Study 3). More specifically, Study 2 measured the subjective and objective emotional 
response of opiate users and controls, and their ability to produce somatic markers when 
making decisions on the Iowa Gambling Task via physiological responsiveness (the 
skin conductance response). Study 3 measured decision-making under conditions of 
predictable risk using the Balloon Analogue Risk Task, in addition to measuring 
personality in both groups. The current chapter outlines the methodology adopted to test 
the aims of Studies 2 and 3. The results of these studies are then presented in Chapters 5 
and 6. 
 
 
 
 
 
 
 
 
 
 
 
 
53 
DECISION-MAKING AND OPIATE USE 
4.2 Research and Study Design 
Two empirical studies were conducted (Studies 2 and 3). Both studies adopted a 
group-comparison, cross-sectional design that involved between-group comparisons 
comparing opiate users to healthy controls. Due to the difficulty of recruiting opiate-
using participants willing to attend two separate testing sessions, the data for both 
studies was collected in a single session. This allowed for the recruitment of a sample 
larger than would have otherwise been likely for this population.  
4.3 Participant Groups 
Two participant groups were included. The first was composed of long-term 
opiate users enrolled in an opiate substitution program. The second was a group of 
healthy adult controls. All participants were screened for a number of inclusion and 
exclusion criteria. These are outlined below. 
4.3.1 Eligibility criteria for opiate users 
To be eligible for the studies, long-term opiate users had to meet the following 
inclusion criteria: 
a) be at least 18 years of age; 
b) have a history of heroin dependence; 
c) be currently enrolled in an opiate substitution treatment program (methadone, 
buprenorphine or suboxone)b; 
d) be stable on their opiate substitute dose for at least two weeks; and  
e) have English as a first language.  
They were excluded if they had any of the following conditions: 
f) a diagnosis of traumatic or acquired brain injury;  
g) a history of stroke or epileptic seizures; and 
h) current diagnosis of a psychiatric disorder (participants reporting diagnoses of 
anxiety and/or depression were not excluded, given the prevalence of these 
                                                 
b One opiate-using participant had recently stopped taking his opiate substitute dose, and so at the time of 
testing was only using street heroin. 
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diagnoses in this population, however other Axis I disorders such as 
schizophrenia or bipolar were excluded). 
4.3.2 Eligibility criteria for healthy adults 
Healthy adults had to meet the following criteria to be included in the study: 
a) be at least 18 years of age; and 
b) have English as a first language. 
They were excluded if they had:  
c) a history of alcohol or drug dependence (however, past experimental use of 
illicit drugs was tolerated); 
d) a history of traumatic or acquired brain injury; 
e) a history of stroke or epileptic seizures; 
f) current or past periods of heavy drinking (i.e., regularly drinking to 
intoxication, or exceeding 28 standard drinks for a male per week, or 14 
standard drinks for a female per week, as per the guidelines set out by the 
Australian National Health and Medical Research Council (2001)); and 
g) a formal psychiatric diagnosis (including depression or anxiety). 
4.3.3 Participant recruitment 
Healthy control participants were recruited through personal networks, social 
media, classified advertisements (e.g., Gumtree), and via flyers posted in public spaces 
that healthy adults attended (such as gyms, libraries and community centres; see 
Appendix B 3.1 for a copy of the flyer). Opiate users were recruited from pharmacies 
that dispensed opiate substitute treatments (e.g., methadone) via flyers (see Appendix B 
3.2 for a copy of the flyer). It was at the discretion of the opiate-dispensing pharmacist 
where these flyers were placed, however most left them in the dispensing room. Flyers 
encouraged all potential participants to call or send a text message to the dedicated 
research phone used by the PhD candidate. Potential participants were then contacted 
and screened over the phone and booked for testing.  
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4.3.4 Protocols for the day of testing 
Participants who met criteria for inclusion were informed of further inclusion 
criteria for the day of testing that they were required to adhere to. For all participants 
these were: 
a) Not to use any illicit drugs for 24 hours before the testing session. 
For opiate users, additional inclusion criteria for the day of testing were: 
b) Not to take their opiate substitute dose for 3 hours before the session to ensure 
peak concentration of the opiate substitute in the body did not occur during the 
session. Participants were generally encouraged to take their dose early in the 
morning if they were booked for testing in the afternoon, or to wait to take 
their dose until after the testing session if they had a morning testing session. 
Participants who did not meet these criteria on the day of testing completed whole 
or part of the testing protocols but were excluded from further analyses. 
4.3.5 Participants included in the empirical studies 
Figure 3 presents a flow chart describing the recruitment process and the final 
number of participants included in each study. In total, 31 opiate users and 43 controls 
provided valid data for studies 2 and 3. 
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Figure 3. Flowchart of participant inclusion and exclusion process. 
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4.4 Procedure 
Figure 4 provides an overview of the assessment procedures during each testing 
session. At the start of each testing session, participants were given an information letter 
to read which outlined the details of the study (see Appendix B-1). Once the participants 
had read this, they were given a consent form to sign (see Appendix B-2) which 
confirmed their agreement to participate. Following consent, participants were asked to 
verbally complete a background questionnaire to confirm they met all eligibility criteria 
(e.g., that they had not taken illicit substances 24 hours prior to testing, and had not 
taken an opiate substitute less than 3 hours prior to testing), and to gather demographic 
information and drug use history. Following this, participants completed a measure of 
general (premorbid) intelligence (the National Adult Reading Task (NART); Nelson, 
1982), a questionnaire assessing personality (the Behavioural Activation/Behavioural 
Inhibition scale (BAS/BIS); Carver & White, 1994) and a measure of anxiety and 
depression symptoms (the Hospital Anxiety and Depression Scale (HADS); Zigmond & 
Snaith, 1983).  
Following completion of the background questionnaire, NART, BAS/BIS and 
HADS, participants were prepared for the physiological recordings of skin conductance 
(SCR) and heart beat (see section 4.6.1 below: ‘Equipment set-up and preparation of 
electrode sites’). After this, participants completed an interoceptive accuracy test while 
heart beats were recorded. Participants then completed a measure of ambiguous 
decision-making (i.e., the IGT) while the skin conductance response was recorded. 
Following this, participants rated subjective emotional experience in response to a series 
of emotion-eliciting videos while skin conductance was recorded. Once these tasks were 
completed, electrodes were removed. Next, participants completed a measure of risky 
decision-making (i.e., the BART). Following this, participants were given a break and 
then returned to the testing room, and measurement of cognitive functioning (using the 
CogState battery of tests) was completed. Participants were then thanked and paid 
$30AUD for participating. Details of the measures administered are described next.  
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Figure 4. Measures administered at each stage of the assessment.  
 
4.5 Background Characterisation Measures (Studies 2 and 3) 
4.5.1 Demographics and drug-use questionnaire 
A questionnaire was designed to collect background information for opiate users 
and controls across both empirical studies. This questionnaire collected data regarding 
demographics, such as age, sex and years of education. This questionnaire also collected 
detailed drug use history for all participants, and opiate substitute treatment history for 
opiate users. It also included a set of questions addressing eligibility criteria for the 
study (including questions about drug use in the 24 hours prior to testing). This set of 
eligibility questions was modified for each group. Appendix C-1 provides the 
questionnaire for opiate users and controls.  
4.5.2 General intelligence 
General (premorbid) intelligence was assessed using the National Adult Reading 
Test (NART; Nelson, 1982). It is a highly reliable word-recognition test that provides an 
estimate of pre-morbid IQ (Crawford, Deary, Starr, & Whalley, 2001; Crawford, 
Stewart, Cochrane, Parker, & Besson, 1989). Participants must read 50 English words 
with phonetically atypical pronunciation (e.g., cellist) and are scored on pronunciation. 
The number of words correctly pronounced was converted to an estimate of full-scale 
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IQ using formulas provided in the test manual. Higher scores indicate better 
performance.  
4.5.3 General cognitive function 
The following measures of cognitive function were used to characterise opiate 
users and controls.  
Response initiation and suppression. Initiation and suppression of cognitive 
responses, which is an aspect of executive function, was measured using the Hayling 
Sentence Completion Task (Burgess & Shallice, 1996). In this task, participants were 
read a series of sentences by the examiner with the last word omitted, and were 
instructed to complete each sentence. Participants were required to give a connected 
answer (initiation) in part A (e.g., He posted a letter without a STAMP), and an 
unconnected response (suppression) in part B (e.g., The captain wanted to stay with the 
sinking BANANA). The time taken to respond was recorded. Scores for Part A and B 
and the total number of errors were summed to give an overall efficiency score, with 
higher scores indicating greater efficiency. The Hayling task has demonstrated modest 
ecological validity and reliability (Burgess & Shallice, 1996; Odhuba, Broek, & Johns, 
2005). 
Cognitive flexibility and working memory. Two additional aspects of cognitive 
function were assessed using the CogState battery of measures (Cogstate ResearchTM, 
Cogstate Ltd 2009). This computerized battery is tailored to suit individual study needs, 
and researchers select specific tasks to be included in their study battery. The CogState 
measures of cognitive function have been shown to have good construct validity in 
clinical and healthy populations (Maruff et al., 2009; Pietrzak et al., 2009). For the 
current study, the Set Shift and Two-Back tasks were used. 
Set Shift was used to assess cognitive flexibility, i.e., the ability to adapt to 
changing rules. In this task, participants must determine whether a series of cards 
contains a target stimulus according to one of two dimensions (a colour or a number). A 
single playing card was presented in the middle of the screen, and the participant was 
asked to guess whether the presented card was the ‘correct’ card. Above the card, either 
“Colour” or “Number” was written, indicating to the participant which dimension was 
being assessed (i.e., numbers on the card, or red vs black). Participants made choices 
using the ‘Yes’ (K) or ‘No’ (D) keys. As participants made their choices, the program 
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signalled whether the choice was correct (flip over to the next card) or incorrect (error 
sound). As trials continued, the dimensions being assessed changed, so that there were 
changes in target colour (e.g., red to black) or number (e.g., 2 to 7; intra-dimensional 
shift) or between dimensions (e.g., from colour to number; extra-dimensional shift). The 
participant was not told when these dimension shifts occurred, and had to re-learn new 
‘rules’ as the task continued. The main index of performance was number of errors, with 
less errors indicating better performance.  
Working memory was assessed using the Two-Back Task. In this task, a series of 
playing cards was presented, one at a time, face up in the centre of the screen. The 
participant had to decide whether the card currently presented was identical to the one 
presented two cards before. Participants made selections using the ‘Yes’ (K) or ‘No’ (D) 
keys and correct choices were signalled by cards flipping over, while incorrect choices 
were signalled by an error sound. A higher accuracy score indicated better performance.  
4.5.4 Anxiety and depression 
Anxiety and depression symptoms were measured using the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983). This is a widely used self-report 
measure of anxiety and depression in adults. Participants respond to a series of 14 
statements such as “I can laugh and see the funny side of things” on a 4-point scale from 
“very often” to “not at all”. Given that opiate users tend to have concurrent psychiatric 
disorders, the most common of which are depression and anxiety (Astals et al., 2008), 
this measure was used to characterise the opiate-using sample. The HADS has been 
shown to be a valid and sensitive indicator of depression and anxiety in both clinical 
and healthy samples (Bjelland, Dahl, Haug, & Neckelmann, 2002). 
4.6 Characteristics of Included Participants 
Table 3 presents the demographic information, anxiety and depression symptoms, 
and scores on tasks of neuropsychological function for the opiate users and controls 
who were included in studies 2 and 3 of this thesis. Opiate users had significantly fewer 
years of education and lower estimated IQ than controls, and significantly higher 
depression and anxiety symptoms. Opiate users’ cognitive ability did not differ from 
controls’ in terms of initiation/suppression and cognitive flexibility, but opiate users did 
demonstrate significantly worse working memory than controls. Given this, 
performance on the two back task and performance on the IGT and BART were 
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correlated separately for opiate users and controls. Results indicated no significant 
correlation between working memory and decision-making performance for either 
group (all p’s ≥ .152). Thus, working memory was not included as a co-variate in the 
group-comparison analyses of decision-making performance (Tabachnick & Fidell, 
2013).  
Table 2.  
Background Characteristics of All Included Participants for Studies 2 and 3 
 
Opiate Group 
n = 31 
 
Control Group 
n = 43 
 
 
 
Proportion of men (%) 84%  53%    
 M SD  M SD  t d 
Age (years) 41.94 7.67  39.05 8.20  1.54 0.36 
Education (years) 12.58 2.22  16.65 2.66  6.95*** 1.66 
Premorbid IQa  101.40 9.19  105.71 8.73  2.04* 0.48 
Anxiety and Depression 
Symptoms 
        
Depressionb  6.63 3.48  2.93 2.38  5.43*** 1.24 
Anxietyb  9.58 3.41  6.49 3.48  3.85*** 0.90 
Cognitive function 
Initiation and 
suppressionc 
5.63 1.50  5.66 1.14  0.07 0.02 
Cognitive flexibilityd 27.38 16.38  24.77 15.60  0.65 0.16 
Working memorye 0.85 0.26  1.15 0.80  5.39*** 0.50 
a Pre-morbid IQ score as predicted from the number of errors made on the NART  
b Hospital Anxiety and Depression Scale subscale scores for anxiety and depression—range of 
scores was 0–21 for each subscale, 0–7 normal, 8–10 possible disorder and 11–21 presence of 
disorder 
c Hayling Sentence Completion Task overall scaled score 
d Set shift task number of errors 
e Two-back task accuracy score 
* p < .05, *** p < .001 
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4.7 Measures for Study 2 
4.7.1 Iowa Gambling Task 
In Study 2, ambiguous decision-making ability was assessed using the IGT 
(Bechara et al., 1994). The objective of this task is to earn as much money as possible 
over a series of trials. In the original version of this task, participants are told they have 
a balance of $2000 to play with in the game (note: they are told that the money is not 
real). They are instructed to maximize the amount of money that they win over the 
course of 100 trials by selecting cards from four decks (labelled A, B, C and D). Each 
card has a reward value, and some of the cards also have a punishment value. For decks 
A and B, the reward value is $100. For decks C and D, the reward value is $50. 
However, punishments vary across decks and also vary in frequency. For deck A, 
punishments are frequent, but not large ($150 to $350). For deck B, punishments are 
infrequent but large ($1250). Similarly, for deck C, punishments are frequent and small 
($25 to $75) whereas punishments in deck D are infrequent and large ($250). The 
schedule of punishment and rewards leads to decks being deemed “advantageous” (C 
and D) or “disadvantageous” (A and B), as repeated selection from “advantageous” 
decks leads to a net gain whereas repeated selection from “disadvantageous” decks 
leads to a net loss.  
A computerised version of the IGT was used, with the same schedule of rewards 
and punishments as described in Table 3 (for the first 20 choices), in order to replicate 
the methods originally used by Bechara and colleagues as closely as possible. This 
schedule was chosen to ensure that the outcome of decisions remained ambiguous, 
thereby allowing for the development of anticipatory somatic markers (Bechara & 
Damasio, 2005; Bechara et al., 2001; Bechara, Tranel, & Damasio, 2000). However, 
decks were labelled 1, 2, 3 and 4, and each of these decks corresponded with a lettered 
deck as in the original version (1=A, 2=C, 3=B, 4=D). Participants’ wins and losses 
along with the running total were displayed for the entire 12 second inter-trial interval 
(see Figure 5). This interval was necessary in order to allow for an adequate amount of 
time to collect skin conductance data before and after choices (see section 4.9.2 below). 
Participants selected decks using keys 1,2,3, and ENTER (decks 1,2,3, and 4 
respectively) on the right-hand side of the keyboard. This was to minimize movement 
throughout the game, thus allowing for cleaner recording of physiological signals.   
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Figure 5. Iowa Gambling Task as presented to participants via Presentation 18.0. 
 
Decision-making ability was indexed using the net score. This is the number of 
selections from advantageous minus the number of selections from disadvantageous 
decks [(C+D) – (A+B)]. Higher values indicate better decision-making. Participants 
who select more often from disadvantageous than advantageous decks receive net 
scores below 0 and are considered to have poor or impaired decision-making skills. 
Selecting from more advantageous than disadvantages decks results in a net score above 
0, and participants with positive scores are considered to perform in the “normal” or 
unimpaired range. The IGT is sensitive to decision-making impairment in populations 
with impaired frontal lobe function (Dunn, Dalgleish, & Lawrence, 2006), including in 
opiate users (e.g., Barry & Petry, 2008; Li, Li, et al., 2013; Ma et al., 2015), and has 
been found to measure a unique aspect of decision-making relative to other decision-
making measures (Buelow & Blaine, 2015). 
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Table 3.  
Schedule of Rewards and Punishments for the First 20 Selections from Each Deck of 
the IGT (adapted from Bechara et al., 1994;  Chiu et al., 2008) 
 Deck A    B    C   D   
Selection Rew Pun Rew Pun Rew Pun Rew Pun 
1 100   100   50   50   
2 100   100   50   50   
3 100 -150 100   50 -50 50   
4 100   100   50   50   
5 100 -300 100   50 -50 50   
6 100   100   50   50   
7 100 -200 100   50 -50 50   
8 100   100   50   50   
9 100 -250 100 -1250 50 -50 50   
10 100 -350 100   50 -50 50 -250 
Net outcome after 10 cards   -250   -250   250   250 
11 100   100   50   50   
12 100 -350 100   50 -25 50   
13 100   100   50 -75 50   
14 100 -250 100 -1250 50   50   
15 100 -200 100   50   50   
16 100   100   50   50   
17 100 -300 100   50 -25 50   
18 100 -150 100   50 -75 50   
19 100   100   50   50   
20 100   100   50 -50 50 -250 
Net outcome after 10 cards   -250   -250   250   250 
 
4.7.2 Emotional experience measure 
Study 2 assessed the emotional responses of opiate users and controls in response 
to dynamic stimuli. Eight short video clips were presented to participants, which were 
designed to elicit positive, negative and neutral emotions. Emotional responses to these 
video clips were measured both subjectively, using a self-report rating scale involving 
the Self-Assessment Manikin (see Figure 6), and objectively, using the skin 
conductance response (see section 4.9.2 below). The video clips were obtained from 
movies, TV shows and YouTube, and were 30-120 minutes in duration, with some clips 
(e.g., The Champ, Mr Bean) used in prior published studies  (Mergl, Mavrogiorgou, 
Hegerl, & Juckel, 2005; Nasoz, Alvarez, Lisetti, & Finkelstein, 2004). Videos were 
presented using Presentation 18.0 software and were presented in a set order so that a 
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neutral video always preceded and followed a positive or negative clip. All of the videos 
were piloted on a separate group of 8 healthy control participants within our laboratory. 
The videos successfully elicited the target emotions in the pilot participants (i.e., the 
positive videos were rated as more pleasant and arousing than neutral videos, and 
negative videos were rated as less pleasant and more arousing than neutral videos).  
 
 
Figure 6. Self-Assessment Manikin used for the subjective emotional rating task 
(adapted from Bradley & Lang, 1994). 
 
4.7.3 Interoceptive accuracy task 
In Study 2, interoceptive accuracy was measured using the heartbeat detection 
task as described in Schandry, Bestler, and Montoya (1993) and Werner et al. (2009). 
Participants were instructed to silently count their heart beats when the experimenter 
gave the signal to begin, and to stop counting when the experimenter told them to stop. 
Participants were instructed to only concentrate on their heartbeat, and were not allowed 
to take their pulse or use any other manipulations (such as touching the chest) to help 
detect their heartbeats. There were three periods of measurement, lasting 25, 35 and 45 
seconds respectively, with a 30 second break between each period of measurement. 
Heartbeat was measured continuously throughout each of these periods via electrodes 
attached to the chest and recorded in AcqKnowledge (see section 4.9 below). The 
66 
DECISION-MAKING AND OPIATE USE 
number of heart beats recorded in AcqKnowledge for each period was counted. Using 
the method outlined in Werner et al. (2009) and Pollatos and Schandry (2008), 
interoceptive accuracy was calculated using the following equation:  
𝐼𝑛𝑡𝑒𝑟𝑜𝑐𝑒𝑝𝑡𝑖𝑣𝑒 𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
1
3
∑ (1 − 
|𝑎𝑐𝑡𝑢𝑎𝑙 ℎ𝑒𝑎𝑟𝑡𝑏𝑒𝑎𝑟𝑡𝑠 − 𝑟𝑒𝑝𝑜𝑟𝑡𝑒𝑑 ℎ𝑒𝑎𝑟𝑡𝑏𝑒𝑎𝑡𝑠|
𝑎𝑐𝑡𝑢𝑎𝑙 ℎ𝑒𝑎𝑟𝑡𝑏𝑒𝑎𝑡𝑠
) 
Higher scores indicated better interoceptive accuracy. Results regarding these data 
are presented at the end of Chapter 5 (section 5.8). 
 
4.8 Measures for Study 3 
4.8.1 Balloon Analogue Risk Task  
In Study 3, decision-making under conditions of risk was measured using the 
BART (Lejuez et al., 2002), which is a reliable measure of  decision-making under 
conditions of calculable risk (Hunt, Hopko, Bare, Lejuez, & Robinson, 2005). The 
BART was presented on Inquisit 4.0 software. Participants were shown images of 30 
balloons, presented individually a computer screen. Participants ‘pumped’ each balloon 
by clicking on a button (Pump Balloon) below it. Each pump inflated the balloon 1 
degree (0.3cm in all directions) and earnt the participant 5 cents of imaginary money, 
which was placed in a temporary bank. The more the participant inflated the balloon, 
the more money they received. This money was held in the temporary bank until the 
person decided to ‘collect’ that money (by pressing the ‘Collect $$$’ button shown in 
Figure 7) and transfer it to a permanent bank (see Figure 7). However, for each trial, the 
balloon was randomly allocated a certain number of pumps after which the balloon 
would explode. If the participant reached this explosion point, the balloon exploded and 
the participant lost the money accrued in their temporary bank for that trial. The 
probably of the balloon exploding was randomly set for each trial (so the balloon could 
pop anywhere from 1 to 128 pumps), and the probability of the balloon exploding 
increased with each additional pump. In other words, the probability that the balloon 
would explode on the first pump was 1/128, but if the balloon did not explode, the 
probability of exploding would be 1/127 on the second pump, 1/126 on the third pump 
etc., until the 128th pump where the probability of an explosion was 1/1 (i.e., 100%). 
Consequently, a higher numbers of pumps indicated more risky decision-making. 
Because the number of pumps is constrained on trials where the balloon explodes, the 
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developers of the task recommend the use of the adjusted score to index risky decision-
making – that is, the average number of pumps across unexploded balloons. Therefore, 
the current study used the adjusted score as the measure of decision-making under 
conditions of risk. The BART has demonstrated good incremental and construct validity 
in healthy and clinical populations (Hunt et al., 2005; Lejuez et al., 2002).  
 
Figure 7. BART presentation screen as presented via Inquisit 4.0. 
 
4.8.2 Behavioural Activation and Inhibition System scale. 
In Study 3, sensitivity to punishment and reward was measured using the 
BAS/BIS scale (Carver & White, 1994), which is a frequently used personality measure. 
The 24-item scale measures sensitivity to reward on 3 subscales: Reward Response 
(BAS-RR), which focuses on positive responses to the occurrence or anticipation of 
reward, Fun Seeking (BAS-FS), which measures willingness to approach rewarding 
events on the spur of the moment, and Drive (BAS-D), which measures persistent 
pursuit of goals. The BIS measures sensitivity to punishment. Participants rate answers 
to each item on a four point Likert scale, ranging from 1 (‘strongly disagree’) to 4 
(‘strongly agree’). For example, “I’m always willing to try something new if I think it 
will be fun”. The purpose of including this measure was to provide a personality-based 
measure of impulsivity, as reward responsiveness may lead to drug dependence (Dawe, 
Gullo, & Loxton, 2004; Dawe & Loxton, 2004) and opiate users have been shown to be 
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more responsive to reward than controls (Dissabandara, Loxton, Dias, Daglish, & 
Stadlin, 2012; Dissabandara et al., 2014). The BAS/BIS scale has demonstrated good 
reliability (Cronbach’s alpha for BIS = 0.78 and for BAS =0.81) and validity as a 
measure of personality traits (Cooper, Gomez, & Aucote, 2007; Jorm et al., 1998). 
4.9 Psychophysiological Measurement and Analysis 
In Study 2, the aims were to determine whether opiate users displayed abnormal 
emotional responses to emotional stimuli (videos), abnormal emotional responses to 
reward and punishment (during the IGT), and reduced anticipatory somatic markers 
(during the IGT). An additional aim was to analyse whether opiate users demonstrated 
reduced interoceptive accuracy. Objective emotional response and anticipatory somatic 
markers were measured through psychophysiological arousal, specifically the skin 
conductance response (SCR), while interoceptive accuracy was measured using heart 
beat tracking.  The methods for collecting, extracting, cleaning and analysing this data, 
are detailed in the following sections (sections 4.6.1 to 4.6.3).  
4.9.1 Equipment set-up and preparation of electrode sites. 
All psychophysiological data was collected using the Biopac MP150 data 
acquisition system (Biopac, Goleta, GA). Skin conductance data was acquired via one 
GSR100C amplifier and heart beat data was acquired via one ECG100C amplifier. 
Shielded Ag/Ag-CL reusable electrodes were used for all recordings. Large (8mm) 
electrodes were used to acquire heart beat data, and finger electrodes with a plastic plate 
and Velcro straps were used for skin conductance acquisition. The skin conductance 
electrodes acted as ground for all participants. Ground electrodes are necessary in 
physiological data acquisition in order to reduce unwanted signals (Türker, Miles, & Le, 
1988). Data was acquired at 1000Hz for all physiological measures. For the ECG100C 
amplifier, GAIN was set to 1000, HP to 0.5Hz and MODE to NORM (according to the 
recommendations of Biopac Application Note 233). The GSR100C amplifier low pass 
filter was set to 1.0Hz and no high pass filters were applied (i.e. all HP filters were set 
to DC) (Figner & Murphy, 2011).  
Before electrodes were attached, each participant had their skin prepared in a 
specific manner, to ensure that the contact between skin and electrode was sufficient. 
Specifically:  
69 
DECISION-MAKING AND OPIATE USE 
1) Skin was cleansed using a cleansing wipe (i.e., make-up wipe) to remove any 
grease and/or make-up from the skin,  
2) Skin was exfoliated using a small piece of mildly abrasive sponge to remove 
dead skin cells. This step is critical in ensuring a clear signal is received from 
the skin, 
3) Skin was cleansed again with NuPrep skin preparation gel (Weaver and 
Company), 
4) Electrodes were filled with a conductive electrolyte gel to allow conductance 
of electrical signals between electrode plate and the skin and a double-sided 
adhesive collar was attached to the electrode. This was then used to attach the 
electrode to the participant’s skin, 
5) The electrodes were allowed to sit on the participant’s skin for up to 5 minutes 
before recording began, to allow the gel to soak into the skin and become 
more conductive. 
Skin conductance electrodes were attached to the distal phalanges of the first and 
second finger of the left hand, as these areas are more sensitive and produce higher SCR 
signals than other areas of the hand (Boucsein, 2012). The use of the left hand was 
necessary so that participants could use their right hand to select keys (make choices) 
during the IGT. Electrodes to measure heart beats were placed in a modified lead-II 
position, with one electrode place underneath the middle of the right collar bone (over 
the right carotid artery), and the other electrode placed on the second intercostal space 
on the ribs of the left side (Dellacherie, Roy, Hugueville, Peretz, & Samson, 2011). All 
electrodes were fixed in place using a double-sided adhesive collar. 
4.9.2 Skin conductance response: data cleaning, extraction and analysis. 
Skin conductance data was collected continuously throughout the IGT (to index 
both emotional response to reward and punishment as well as anticipatory somatic 
marking) and emotional videos tasks (to index objective emotional response to general 
emotional stimuli). The raw data recorded during these tasks was filtered and cleaned 
prior to analysis. The sections below outline the filtering of the raw SCR data and the 
methods of extraction and analysis for each task.  
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Cleaning of raw SCR data 
First, the raw skin conductance data for both tasks was filtered with a smoothing 
transformation to remove high-frequency noise. Second, the smoothed data was run 
through a moving-difference function to eliminate down-drift in the skin conductance 
signal (as outlined in Fernie & Tunney, 2013; Naqvi & Bechara, 2006). More 
specifically, the difference function converted every point of the raw skin conductance 
wave into a point representing the difference between its value and the value of a point 
located at a given interval before it (in this case 50msec, calculated based on a 200Hz 
sampling rate). This step was carried out to remove the drift in baseline skin 
conductance level that occurs over any period of time the SCR is recorded. Thus, a 
separate baseline is not needed when using this method of data extraction for the SCR 
(i.e., the SCR acts as its own baseline).  
SCR data extraction and analysis for the IGT 
Filtered skin conductance data was extracted for the 5 seconds preceding a choice 
and the 5 seconds following a choice on the IGT using the Area function in the 
AcqKnowledge software. Area values were then divided by 5 to calculate an area under 
the curve value in S/sec (see Fernie & Tunney, 2006; Naqvi & Bechara, 2006). 
Consistent with previous studies (Bechara & Damasio, 2002; Bechara et al., 1999; 
Cavedini et al., 2012; Elvemo, Nilsen, Landrø, Borchgrevink, & Håberg, 2014; Fernie 
& Tunney, 2013; Guillaume et al., 2009; Miu, Heilman, & Houser, 2008; Wagar & 
Dixon, 2006), anticipatory SCR was calculated separately for advantageous and 
disadvantageous deck selections for the 5 seconds preceding a choice on the IGT. Post-
choice SCR was calculated separately for deck selections resulting in gaining money 
without penalty (reward SCR) and selections resulting in gaining money followed by a 
loss (punishment SCR), also for the 5 seconds following a choice. In addition to this, a 
relative difference score was calculated for the anticipatory SCR. This was done in 
order to determine the magnitude of the difference between the anticipatory SCR before 
disadvantageous decisions, relative to the anticipatory SCR before advantageous 
decisions, using the following equation:  
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 =
Disadvantageous anticipatory SCR − Advantageous anticipatory SCR
Advantageous anticipatory SCR
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SCR data extraction and analysis for the emotional videos task 
Each video was divided into 5 second epochs and the area of the SCR was 
extracted for each of these epochs. Area values were then divided by 5 to calculate an 
area under the curve value in S/sec for each epoch. Epochs were excluded from 
analysis if movement artefacts were present. After cleaning the data, remaining epochs 
were used to calculate an average area under the curve value for each emotional video. 
These values were then used to calculate an average SCR for each category of 
emotional video (positive, negative and neutral). 
4.9.3 Heart beat: data extraction and analysis. 
Heart beat data was recorded continuously throughout the interoception task. 
Markers were set manually in the heart beat wave to signal the beginning and ending of 
each time period. Heart beats were manually counted for each time period and 
interoceptive accuracy was calculated using the formula described in section 4.7.3: 
‘Interoceptive accuracy task’. 
4.10 General Statistical Analyses 
Details of all statistical analyses are included within the methods section of each 
experimental papers in Chapters 5 and 6. The Statistical Package for the Social Sciences 
(SPSS), version 23.0 for Windows (IBM Corp), was used to conduct all statistical 
analyses for behavioural and physiological data. 
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CHAPTER 5: Study 2 - Investigation of Somatic Markers and Emotion 
Activation in Opiate Use 
5.1 Preamble 
As previously outlined in Chapter 2, the somatic marker hypothesis may be used 
to help explain the decision-making impairment in opiate users. While the meta-analysis 
presented in Chapter 3 clarified the magnitude of the decision-making impairment in 
opiate users, the mechanism for this impairment has not been thoroughly explored. The 
somatic marker hypothesis may be a good candidate to explain the mechanism 
underlying the decision-making impairment in opiate users. Opiate users are known to 
have structural and functional abnormalities in the areas of the brain responsible for 
responding to emotional stimuli (i.e., the orbitofrontal cortex), which in turn could lead 
to deficits in emotional processing. The somatic marker hypothesis contends that 
emotional responses to punishments and rewards are critical to the development of 
anticipatory warning signals or “somatic markers” which then inform choices during 
decision-making. Thus, the decision-making impairment in opiate users may be due to a 
reduced capacity to respond to emotion-inducing stimuli, such as punishments and 
rewards, thereby leading to an inability to produce somatic makers which should steer 
decision-making away from disadvantageous choices. Alternatively, opiate users may 
develop normal anticipatory somatic markers but, due to poor interoceptive ability, may 
be less able to “hear” or tune into these physiological changes, which may lead to 
impaired decision-making ability. The study presented in this chapter had two aims. The 
first aim was to assess whether deficient emotional responding and somatic marking (as 
indexed by the skin conductance response) contributed to the decision-making 
impairment in opiate users relative to a group of healthy controls. The second aim was 
to assess whether poor interoceptive abilities contributed to the decision-making 
impairment in opiate users relative to a group of healthy controls. It should be noted that 
the data presented in this chapter has fewer participants than described in the methods 
chapter, as not all participants completed both the Iowa Gambling Task for Study 2 and 
Balloon Analogue Risk Task for Study 3.  
This chapter is presented in two parts. The first part (sections 5.3 to 5.8), which 
assessed the first aim, has been published in the journal Psychopharmacology: 
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Biernacki, K., Terrett, G., McLennan, S. N., Labuschagne, I., Morton, P., Rendell, 
P. G. (2018). Decision-making, somatic markers and emotion processing in opiate users. 
Psychopharmacology, 235(1), 223-232. doi: 10.1007/s00213-017-4760-0 
The second part (section 5.9) addresses the second aim regarding interoception. 
This second set of results was not included in the published manuscript, and is presented 
after the discussion for the published paper.  
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5.3 Abstract 
Rationale Opiate use is associated with deficits in decision-making. A possible 
explanation for these deficits is provided by the somatic marker hypothesis, which 
suggests that substance users may experience abnormal emotional responses during 
decision-making involving reward and punishment. This in turn may interfere with the 
brief physiological arousal, i.e., somatic markers that normally occurs in anticipation of 
risky decisions. To date, the applicability of the somatic marker hypothesis to explain 
decision-making deficits has not been investigated in opiate users.  
Objectives This study assessed whether decision-making deficits in opiate users were 
related to abnormal emotional responses and reduced somatic markers. 
Methods Opiate users enrolled in an opiate substitute treatment program (n = 28) and 
healthy controls (n = 32) completed the Iowa Gambling Task (IGT) while their skin 
conductance responses (SCRs) were recorded. Participants’ emotional responses to 
emotion-eliciting videos were also recorded using SCRs and subjective ratings.  
Results Opiate users displayed poorer decision-making on the IGT than did controls. 
However, there were no differences between the groups in SCRs; both groups displayed 
stronger SCRs following punishment than following reward, and both groups displayed 
stronger anticipatory SCRs prior to disadvantageous decisions than advantageous 
decisions. There were no group differences in objective or subjective measures of 
emotional responses to the videos.  
Conclusions The results suggest that deficits in emotional responsiveness are not 
apparent in opiate users who are receiving pharmacological treatment. Thus, the somatic 
marker hypothesis does not provide a good explanation for the decision-making deficits 
in this group. 
Keywords: Opiate, heroin, decision-making, somatic marker, skin conductance, 
emotion experience 
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5.4 Introduction 
Opiates belong to one of the most addictive classes of drugs (Dacher and Nugent 
2011). In addition to numerous health issues (Pillari and Narus 1973; Ryan and White 
1996; Webster et al. 1979), opiate use has been associated with abnormalities in the 
structure and function of the frontal lobe of the brain (Pandria et al. 2016; Wollman et 
al. 2016; Wollman et al. 2015), and with a range of cognitive deficits (Baldacchino et al. 
2017; Baldacchino et al. 2012). Of these cognitive deficits, impaired decision-making is 
the most consistently reported (Baldacchino et al. 2012). In opiate users, poor decision-
making can manifest as problematic real life behaviours such as risky sexual practices, 
leading to increased risk of HIV (Wilson and Vassileva 2016), and to a reduced ability 
to maintain abstinence (Passetti et al. 2008). A better understanding of the factors that 
contribute to decision-making impairments is needed to provide more targeted support 
and better outcomes for opiate users. 
The somatic marker hypothesis (Damasio 1994) is a theoretical model that was 
developed to explain decision-making impairment in people with orbitofrontal cortex 
injuries, but has recently been argued to also have utility in explaining poor decision-
making in substance users (Bechara and Damasio 2002; Verdejo-Garcia and Bechara 
2009; Verdejo-Garcia et al. 2006; Verdejo-Garcia et al. 2007). The somatic marker 
hypothesis contends that orbitofrontal cortex dysfunction leads to abnormalities in 
emotional responding which, in turn, disrupts decision-making (Bechara 2004; Bechara 
et al. 2000). The somatic marker hypothesis outlines two distinct stages in the decision-
making process. First, it proposes that when decisions are followed by positive 
(rewarding) or negative (punishing) outcomes, these outcomes trigger emotional 
responses. These responses can be measured objectively via physiological indicators of 
autonomic arousal such as skin conductance responses (SCRs). The somatic marker 
hypothesis asserts that, in the second stage, after repeated exposure to similar decision-
making scenarios, emotional responses and their associated physiological arousal begin 
to emerge in anticipation of decisions. These brief periods of anticipatory physiological 
arousal are referred to as somatic markers (Damasio 2009). Somatic markers that occur 
in anticipation of disadvantageous decisions are believed to bias decision-making away 
from such choices (Damasio et al. 1991).  
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Research in healthy adults, largely using the Iowa Gambling Task (IGT; Bechara 
et al. 1994), has provided support for both of the stages described by the somatic marker 
hypothesis. First, a number of studies have demonstrated that SCRs following 
punishments are stronger than SCRs following rewards (Bechara et al. 1999; Crone et 
al. 2004; Mardaga and Hansenne 2012; Suzuki et al. 2003). Furthermore, several studies 
have reported that SCRs occur in anticipation of decisions, and have crucially shown 
that anticipatory SCRs are higher before high-risk decisions (i.e., disadvantageous 
decisions) compared to low-risk decisions (i.e., advantageous decisions) (Bechara et al. 
1999; Guillaume et al. 2009; Jenkinson et al. 2008; Suzuki et al. 2003). Furthermore, 
larger differences in anticipatory SCRs prior to disadvantageous, relative to 
advantageous, decisions have been associated with better decision-making ability 
(Carter and Smith Pasqualini 2004; Guillaume et al. 2009; Mardaga and Hansenne 
2012; Miu et al. 2012).  
Consistent with the somatic marker hypothesis, people with injuries to the 
orbitofrontal cortex lack the capacity to produce distinct anticipatory somatic markers 
when contemplating disadvantageous decisions, and they also demonstrate impaired 
decision-making performance (Bechara et al. 1999; Bechara et al. 1996). Only one 
study has assessed the applicability of the somatic marker hypothesis to substance users, 
and it focused on a mixed group of users of cocaine, alcohol, and methamphetamines 
(Bechara and Damasio 2002). The results of that study were consistent with the somatic 
marker hypothesis, showing that the substance users demonstrated lower anticipatory 
SCRs before disadvantageous decisions relative to controls and impaired decision-
making performance (Bechara and Damasio 2002). However, because opiate users were 
not included in this study, the relevance of the somatic marker hypothesis for this 
specific group is as yet unclear.  
If opiate users do indeed display abnormal responses to reward and punishment, 
and/or disrupted somatic marker production, it is possible that this may stem from 
abnormalities in their emotional responses more generally (Verdejo-Garcia and Bechara 
2009; Verdejo-Garcia et al. 2006). A neurological basis for this argument is provided by 
well documented findings of abnormalities in the orbitofrontal cortex in opiate users 
(Cheng et al. 2013; Lyoo et al. 2006; Ma et al. 2010; Qiu et al. 2016; Qiu et al. 2013), 
which is an area implicated in both emotional responding (Murphy et al. 2003) and 
sensitivity to reward and punishment consequences (Kringelbach and Rolls 2004; 
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O'Doherty et al. 2001). For example, patients with injuries to the orbitofrontal cortex 
display unusual patterns of emotional responding, such as decreased intensity of 
positive emotions and increased intensity of negative emotions (Anderson et al. 2006; 
Berlin et al. 2004). Currently, research into emotional responding in opiate users is 
limited, and the findings somewhat inconsistent. For example, there is some evidence 
suggesting that this group shows reduced pleasure in response to positive images and 
heightened ratings of unpleasantness in response to negative images relative to controls 
(Aguilar de Arcos et al. 2008; Gerra et al. 2003), but other studies have failed to identify 
differences between opiate users and controls on subjective emotional ratings (Carcoba 
et al. 2011; Smoski et al. 2011; Wang et al. 2010). Methodological issues, however, 
may to some extent account for the inconsistent findings. For instance, studies reporting 
null findings (Carcoba et al. 2011; Smoski et al. 2011; Wang et al. 2010) presented 
participants with static emotional stimuli for less than five seconds, while those 
reporting group differences presented emotional stimuli for longer (unlimited time or 
more than 30 seconds). Increasing the duration of stimuli presentation, and 
incorporating dynamic stimuli which may induce more intense emotional states than 
static stimuli (Rottenberg et al. 2007), would help clarify this issue, as would the use of 
more objective measurements, such as SCR, to assess emotional responses (Cheetham 
et al. 2010; Fernández et al. 2012).  
The aim of the current study was to assess whether the somatic marker hypothesis 
can explain decision-making deficits in opiate users. First, we tested the prediction that 
opiate users would demonstrate poorer decision-making on the IGT relative to controls. 
Second, we tested the prediction that opiate users would demonstrate abnormal 
emotional responses to dynamic stimuli (relative to controls) outside of the decision-
making context. We assessed subjective (self-ratings) as well as objective (SCRs) 
emotional responses to address this question. Third, we tested the prediction that opiate 
users would demonstrate reduced SCRs following punishments and rewards on the IGT, 
relative to controls. Fourth, we tested the prediction that opiate users would show 
reduced anticipatory SCRs prior to disadvantageous decisions on the IGT relative to 
controls. Finally, we sought to clarify the nature of the relationship between anticipatory 
SCR and decision-making performance in both opiate users and controls. Previous 
research suggests that a larger difference between SCRs prior to disadvantageous versus 
advantageous decisions is associated with better decision-making performance in 
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healthy controls (Carter and Smith Pasqualini 2004; Guillaume et al. 2009; Mardaga 
and Hansenne 2012; Miu et al. 2012). Therefore, we expected a positive correlation in 
the current control group. However, given that the opiate users were expected to exhibit 
abnormal somatic markers, a weaker or absent correlation was anticipated in this group. 
5.5 Method 
5.5.1 Participants 
Twenty-eight long-term opiate users with a history of heroin dependence were 
recruited (years of heroin use M = 16.88, SD = 8.09), as were 34 controls with no 
history of alcohol or drug dependence. All but one of the opiate users were currently 
participating in an opiate substitution program (methadone n = 18, suboxone n = 7, 
buprenorphine n = 2). The average dose was 55.39 mg (SD = 31.02) for methadone; 10 
mg (SD = 8.41) for suboxone; and 9 mg (SD = 1.41) for buprenorphine. As is typical, 
the opiate users had a history of poly-drug abuse and some were still currently using 
other licit and illicit substances (see Table 4). All participants included in the study, 
except for one opiate user, reported that they were HIV negative. 
Opiate users were recruited using fliers distributed to pharmacies, needle 
exchange sites, and drop-in clinics for drug users. Control participants were recruited 
using personal networks, advertisements on volunteer job sites, and by placing flyers in 
local community settings such as gyms and sports clubs. Opiate users had to have been 
stable on an opiate agonist for at least 2 weeks prior to testing and to have abstained 
from opiate agonist use for a minimum of 3 hours prior to testing. Opiate users were 
excluded if they had a severe psychiatric diagnosis (e.g., schizophrenia or bipolar 
disorder), however current diagnoses of depression and anxiety did not lead to 
exclusion, as these are common co-morbid disorders in this population. Controls were 
excluded if they were heavy users of alcohol (defined as 28 standard drinks per week 
for men and 14 for women; Australian National Health and Medical Research Council 
2001), if they reported a history of drug dependence, or if they were diagnosed with a 
severe psychiatric disorder. Exclusion criteria for both groups were a history of 
neurological illness, and diagnosis of a traumatic or acquired brain injury.  
The opiate user and control groups were matched on age and did not differ on 
gender distribution, χ2(1) = 3.10, p = .079. Groups differed on premorbid IQ as 
measured by the National Adult Reading Test (NART; Nelson 1982); opiate users had a 
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slightly lower IQ than controls (see Table 4). Groups also differed in years of education; 
opiate users had fewer years of education than controls (see Table 4). Levels of 
depression and anxiety were assessed using the Hospital Anxiety and Depression Scale 
(HADS; Zigmond and Snaith 1983). The HADS has been shown to be a valid and 
sensitive indicator of depression and anxiety in both clinical and healthy samples 
(Bjelland et al. 2002). Opiate users scores for depression indicated a possible mood 
disorder, based on the standard HADS cut-offs (see Table 4).  
Informed consent was obtained from participants, and they were tested 
individually in one session. Participants were asked not to use illicit drugs in the 24 
hours before testing and were reminded of this requirement via text message at least a 
day in advance of their testing time. Abstinence was confirmed via self-report on the 
day of testing. Regular breaks were provided. After completing the brief background 
questionnaire and the NART, all participants were prepared for SCR measurement then 
completed the IGT and the subjective emotional videos task. All participants were 
reimbursed up to AU$30 (∼USD$25) for their time. This study was approved by the 
Australian Catholic University ethics committee and conformed to the ethical standards 
set out in the 1964 Declaration of Helsinki. 
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Table 4.  
Group Characteristics of Opiate Users and Controls included in the Study 
 
Opiate Group 
n = 28 
 
Control Group 
n = 34 
 
 
 
Proportion of men (%) 82%  62%    
 M SD  M SD  t(60) d 
Age (years) 41.71 7.79  39.91 8.53  0.86 0.22 
Education (years) 12.57 2.33  16.00 2.36  5.72*** 1.46 
Estimated IQa  101.15 9.56  106.57 8.17  2.38* 0.61 
Mental Health         
Depressionb  6.59 3.47  2.91 2.09  5.15*** 1.28 
Anxietyb  9.68 3.54  6.06 3.23  4.21*** 1.07 
Substance use 
Nicotinec 25 -  1 -    
Alcoholc 13 -  27 -    
Cannabisc 13 -  - -    
Heroinc 19 -  - -    
Amphetaminesc 5 -  - -    
Cocainec 1 -  - -    
a Pre-morbid IQ score as predicted from the number of errors made on the NART. NART 
data was not available for two control participants. 
b Hospital Anxiety and Depression Scale subscale scores for anxiety and depression—range 
of scores was 0–21 for each subscale, 0–7 normal, 8–10 possible disorder and 11–21 
presence of disorder 
c Number of participants reporting “at least once a month” or more current use of the 
substance 
* p < .05, *** p < .001 
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5.5.2 Material and apparatus 
Iowa Gambling Task 
Decision-making was assessed using a computerised version of the IGT (Bechara 
et al. 1994), presented via Presentation Version 18.0 (Neurobehavioral Systems, Inc.). 
Participants were instructed to maximize the amount of imaginary money won by 
selecting from 4 decks of cards (A, B, C, D) over 100 trials. Continuous selection from 
disadvantageous decks (A and B) resulted in high wins ($100), but also high losses, 
leading to an overall net loss. Conversely, continuous selection from advantageous 
decks (C and D) led to small wins ($50) and small losses, but a net gain. The schedule 
of wins and losses replicated that used by Bechara et al. (1994). Following selection 
from each deck, a message appeared on the computer screen that detailed the amount of 
money won and/or lost, and participants’ cumulative total. Trial duration was set at 12 
seconds, and participants could not move on to the next trial until this time had elapsed. 
The relatively long interval between trials ensured that there was no overlap in post-
choice and anticipatory SCR recordings between trials (Dawson et al. 2011). Decision-
making ability was indexed using the net score, calculated by subtracting the number of 
choices from disadvantageous decks from the number of choices from advantageous 
decks (i.e., net score = [C+D]-[A+B]) (Lemenager et al. 2011; Wang et al. 2012; Wilson 
and Vassileva 2016). Possible net scores ranged from -100 to 100, with higher scores 
indicating better decision-making performance. 
Emotional Videos Task 
Subjective and objective responses to general emotional stimuli were measured 
using an emotional videos task. Participants were presented with eight short video clips 
designed to elicit pleasant, unpleasant and neutral emotions (two positive, two negative, 
four neutral) using Presentation 18.0 software. The video clips were obtained from 
movies, TV shows and YouTube, and were 30-120 seconds in duration. Three of the 
clips (from “The Champ”, “Mr Bean” and “I Love Lucy”) had been used in previous 
research to elicit emotions (Gross and Levenson 1995; Mergl et al. 2005; Nasoz et al. 
2004; Smith et al. 1996). All of the videos were piloted on a separate group of 8 healthy 
control participants within our laboratory and were shown to elicit the target emotions. 
Video clips were presented in a set order such that a neutral video always preceded and 
followed positive and negative videos. Following the viewing of each video clip, 
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participants were given two 9-point Self-Assessment Manikin (SAM) scales to rate how 
pleasant they felt and their level of emotional arousal. 
Skin conductance response (SCR) 
The Biopac MP150 data acquisition system (Biopac Systems, Inc, Goleta, CA) 
was used to record skin conductance via Ag/Ag-Cl GSR reusable electrodes attached to 
the distal phalanges of the index and middle fingers of the left hand. AcqKnowledge 
software package version 4.2 (Biopac Systems, Inc, Goleta, CA.) was used to collect 
skin conductance raw data while the participants completed the IGT, and while they 
watched the emotional video clips. This raw data was filtered with a smoothing 
transformation to remove high-frequency noise, and was then run through a moving-
difference function to eliminate down-drift in the skin conductance signal (Naqvi and 
Bechara 2006). Filtered skin conductance data was then extracted via the Area function 
in the AcqKnowledge software. This data cleaning procedure followed that of Fernie 
and Tunney (2013) and Naqvi and Bechara (2006). 
For the IGT, filtered skin conductance data was used to generate anticipatory and 
post-decision SCRs. Data was extracted for the 5 seconds preceding each choice and the 
5 seconds following each choice. These values were then divided by 5 to calculate an 
area under the curve value in amplitude units per second (µS/sec). Markers were set 
automatically during data collection so that whenever a decision was made (i.e., button 
pressed), a marker was set in the SCR wave. Trials with artefacts due to movement or 
deep breathing were excluded from analyses. Anticipatory SCRs (used to index somatic 
markers) were calculated separately for advantageous and disadvantageous deck 
selections for the 5 seconds preceding a choice on the IGT. Post-decision SCRs (used to 
index emotional response to reward and punishment) were calculated separately for 
deck selections resulting in gaining money (reward SCRs), and deck selections resulting 
in losing money (punishment SCRs) for the 5 seconds following a choice. The relative 
difference in anticipatory SCR before choosing from advantageous versus 
disadvantageous decks was indexed by subtracting the mean anticipatory SCR before 
choices from disadvantageous decks from the mean anticipatory SCR before choices 
from advantageous decks. This value was then divided by the mean anticipatory SCR 
before choices from advantageous decks to take into account individual differences in 
skin conductance reactivity (Dawson et al. 2000). 
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The objective measure of emotional response was operationalized as autonomic 
arousal (i.e., SCRs) during the emotional videos task. Filtered skin conductance data 
was extracted for 5 second epochs during each video. The area of each epoch was 
divided by 5 to calculate an area under the curve value in µS/sec for each epoch. These 
values were used to calculate an average area under the curve value for each video, and 
the values were then averaged across each type of stimuli valence (positive, negative, 
and neutral). Epochs with artefacts due to movement or deep breathing were excluded 
from analyses. 
5.5.3 Data analysis 
All statistical tests were two-tailed and were conducted using IBM SPSS Statistics 
for Windows, version 23.0 (IBM Corp). An alpha level of p < 0.05 was considered 
statistically significant, and effect sizes were estimated using partial eta squared (η2) and 
Cohen’s d. Expectation maximisation was used to replace missing values. Outliers were 
replaced with scores + or -2 SD of the mean as appropriate. Greenhouse-Geisser 
adjustments were applied in analyses where the assumption of sphericity was violated. 
Due to a technical error, data from the emotional videos task was lost for one control 
and three opiate users. 
5.6 Results 
5.6.1 Decision-making ability (performance on the Iowa Gambling Task) 
Due to group differences in IQ and education, correlations between these 
variables and IGT net scores were examined separately for each group. All correlations 
were non-significant (all p’s >.05). Therefore, these variables were not included as co-
variates in further analyses (Tabachnick and Fidell 2013). Performance on the IGT was 
significantly different between the two groups, with opiate users’ decision-making 
ability (M = -9.43, SD = 15.00) significantly worse than controls’ (M = 6.67, SD = 
30.66; t (60) = 2.54, p = 0.014, Cohen’s d = 0.67)c. 
 
                                                 
c We replicated this analysis comparing decision-making performance in opiate users who were using 
heroin concurrently with opiate substitutes (current users, n = 19) with opiate users not concurrently 
taking heroin (past users, n = 9). There was no significant group difference in decision-making 
performance: t (26) = 0.30, p = 0.976, d = 0.01. 
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5.6.2 Subjective emotional responses to emotional videos 
Ratings of pleasantness were analysed using a mixed ANOVA, with the between-
subjects factor of group (opiate, control) and within-subjects factor of stimuli valence 
(positive, negative, neutral). The main effect of group was not significant, F(1, 56) = 
0.03, p = 0.875, ηp2 < 0.01, but there was a significant main effect of stimuli valence, 
F(1.64, 91.84) = 150.80, p < 0.001, ηp2 = 0.73, where the pleasantness ratings of 
positive (M = 7.03, SD = 1.43), negative (M = 2.98, SD = 1.34) and neutral videos (M = 
5.82, SD = 1.07) all significantly differed from each other (all p’s < 0.01). There was no 
significant interaction between stimuli valence and group, F(1.64, 91.84) = 2.57, p = 
0.092, ηp2 = 0.04. 
Ratings of emotional arousal were analysed using a mixed ANOVA, with the 
between-subjects factor of group (opiate, control) and within-subjects factor of stimuli 
valence (positive, negative, neutral). The main effect of group was not significant, F(1, 
56) = 2.21, p = 0.143, ηp2 = 0.04, but there was a significant main effect of stimuli 
valence, F(2, 112) = 27.37, p < 0.001, ηp2 = 0.33, where the arousal ratings of positive 
(M = 6.41, SD = 1.41), negative (M = 5.84, SD = 1.55) and neutral videos (M = 4.86, 
SD = 1.39) all significantly differed from each other (all p’s < 0.05). There was no 
significant interaction between arousal and group, F(2, 112) = 0.02, p = 0.982, ηp2 < 
0.01. 
5.6.3 Objective emotional response to emotional videos (SCRs) 
The level of physiological arousal (SCR area under the curve) in response to the 
emotional videos was analysed using a mixed ANOVA, with the between subjects 
factor of group (opiate, control) and the within-subjects factor of stimuli valence 
(positive, negative, neutral). The main effect of stimuli valence was significant [F(1.75, 
97.84) = 8.22, p < 0.001, ηp2 = 0.13] where the SCR associated with positive videos (M 
= 0.09, SD = 0.08) significantly differed from the SCR associated with negative videos 
(M = 0.07, SD = 0.07, p = 0.002, Cohen’s d = 0.30). The SCR associated with neutral 
videos (M = 0.08, SD = 0.06) did not significantly differ from that of positive (p = 
0.080) or negative videos (p = 0.161). The main effect of group [F(1, 56) = 1.12, p = 
0.295, ηp2 = 0.02] and the interaction of group and stimuli valence [F(1.75, 97.84) = 
1.99, p = 0.142, ηp2 = 0.03] were not significant.  
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5.6.4 Objective emotional response to reward and punishment during the 
IGT (Post-decision SCRs) 
Emotional response to reward and punishment during the IGT was analysed using 
post-decision SCRs in a mixed ANOVA, with the between-subjects factor of group 
(opiate, control) and within-subjects factors of outcome (reward, punishment). Results 
indicated no significant main effect of group [F(1, 60) = 0.20, p = 0.653, ηp2 < 0.01), but 
there was a significant main effect of outcome [F(1, 60) = 8.42, p = 0.005, ηp2 = 0.12], 
where the SCRs in response to punishment (M = 0.12, SD = 0.14) were higher than the 
SCRs in response to reward (M = 0.10, SD = 0.10, p = 0.005, Cohen’s d = 0.14). There 
was no significant interaction between group and outcome [F(1, 60) < 0.01, p = 0.923, 
ηp2 < 0.01]. 
5.6.5 Somatic markers production during the IGT (Anticipatory SCR)  
Anticipatory SCRs were analysed using a mixed ANOVA, with the between-
subjects factor of group (opiate, control) and within-subjects factor of decision 
(advantageous, disadvantageous). The results showed that the main effect of group was 
not significant, F(1, 60) = 1.55, p = 0.218, ηp2 = 0.03, but there was a significant main 
effect of decision [F(1, 60) = 7.28, p = 0.009, ηp2 = 0.11], where the SCRs were higher 
before disadvantageous decisions compared to advantageous decisions (see Figure 1). 
There was no significant interaction between choice and group, F(1, 60) = 0.07, p = 
0.790, ηp2 < 0.01de.  
5.6.6 Relationship between IGT performance and anticipatory SCRs 
The relationship between decision-making ability and the relative difference 
between anticipatory SCRs for advantageous compared to disadvantageous choices (as 
indexed by first calculating the difference between the mean SCR prior to choices from 
                                                 
d We replicated the SCR analyses comparing opiate users who were using heroin concurrently with opiate 
substitutes (current users, n = 19) with opiate users not concurrently taking heroin (past users, n = 9). 
There were no group differences in SCR (all p’s ≥ 0.587, all F’s ≤ 0.30) and the Cohen’s d effect sizes for 
the group differences were small (0.12 ≤ d ≤ 0.22). 
e It is possible that participants may not produce anticipatory somatic markers in the early stages of the 
IGT due to a lack of repeated exposure to the rewards and punishments associated with each deck. We 
therefore re-ran the analyses of anticipatory SCR while excluding the first 20 trials of the IGT. The results 
replicated of the original analyses. Specifically, we found that there was no main effect of group and no 
interaction between group and decision (all F’s ≤ 1.76, all p’s ≥ 0.190). There was a main effect of 
decision, with the anticipatory SCR prior to disadvantageous decisions (M = 0.08, SD = 0.09) 
significantly higher than the SCR prior to advantageous decisions (M = 0.07, SD = 0.07; F (1, 60) = 8.09, 
p = 0.006). 
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disadvantageous decks and mean SCR prior to choices from advantageous decks, then 
dividing by the mean SCR prior to choices from advantageous decks) was analysed 
using Pearson correlations. The relative difference in anticipatory SCRs for opiate users 
(M = 0.14, SD = 0.32) did not differ significantly from that of controls (M = 0.09, SD = 
0.29; t (60) = 0.59, p = .559, Cohen’s d = 0.15). The correlation between the relative 
difference in anticipatory SCRs and IGT net score in controls was positive, but not 
significant (r = .23, p = .191). For opiate users this correlation was negative and 
significant (r = -.43, p = .023). 
 
Figure 8. Anticipatory SCR for opiate users and controls prior to different decision 
types on the IGT.  
 
5.7 Discussion 
We assessed whether the decision-making deficit observed in opiate users could 
be explained by abnormalities in emotional responses (in a decision-making context or 
more broadly) and/or by difficulties generating somatic markers. Although opiate users 
demonstrated significantly poorer decision-making ability than controls, they did not 
demonstrate the hypothesised differences in emotional responses to reward and 
punishment, nor did they respond differently to emotional videos. Furthermore, the two 
groups displayed a similar pattern of anticipatory SCRs during the IGT which 
distinguished disadvantageous from advantageous decisions, thus indicating that opiate 
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users did not have difficulties generating somatic makers. These results suggest that 
abnormal emotional responding and impaired somatic marker production cannot explain 
the decision-making deficit in opiate users. 
As predicted, opiate users demonstrated impaired decision-making on the IGT. 
That is, they chose more often from decks that appeared to provide short term gains but 
ultimately led to long term losses. These results align with previous research indicating 
that opiate users display poorer decision-making ability than healthy controls (Biernacki 
et al. 2016), with the magnitude of the deficit in opiate users in the current study (d = 
0.67) similar to that seen in prior research (d = 0.70; Biernacki et al. 2016). 
In relation to somatic markers, contrary to predictions, opiate users produced 
larger anticipatory SCRs (i.e., relatively stronger somatic markers) before 
disadvantageous decisions than before advantageous decisions which, as noted, 
mirrored the pattern seen in the controls. Thus, opiate users’ autonomic activation was 
no different from controls’ and they were able to produce distinct somatic markers 
before disadvantageous decisions. The current results set opiate users apart from other 
groups with reduced decision-making capacity (e.g., pathological gamblers, people with 
orbitofrontal cortex injuries, and in some cases people with obsessive compulsive 
disorder) who do not appear to produce prominent somatic markers before 
disadvantageous decisions (Bechara et al. 1999; Cavedini et al. 2012; Elvemo et al. 
2014; Goudriaan et al. 2006). The current results also contrast with those of Bechara 
and Damasio (2002) who found that the SCRs before disadvantageous decisions in a 
mixed group of substance users were significantly lower than those seen in healthy 
controls. Interestingly, however, that study did identify a subgroup of substance users 
who demonstrated SCRs that were no different from controls, suggesting that at least 
some substance users generate normal somatic markers.  
The results of the current study also showed no differences in emotional responses 
between the opiate users and the control group either in the context of, or separate from, 
decision-making. More specifically, during the IGT, emotional responses to rewards 
and punishments as indexed by SCRs were similar, with both groups exhibiting 
relatively small changes in SCRs after receiving imaginary monetary rewards, and 
relatively larger changes in SCRs after punishments involving imaginary monetary 
losses. Outside of the decision-making context, when opiate users watched emotionally 
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evocative videos, their emotional responses again mirrored those of the controls when 
measured objectively using SCR. This was also the case when emotional responses 
were measured using subjective ratings. Importantly, both the objective and subjective 
measures were sensitive to differences in the valence of the stimuli (particularly happy 
versus sad stimuli), indicating that the stimuli successfully evoked different emotional 
states. The findings suggest that the opiate users in the current study did not experience 
blunted positive or heightened negative emotional responses as observed in some other 
studies of opiate users (Aguilar de Arcos et al. 2008; Gerra et al. 2003). Taken together, 
the current findings are more consistent with those demonstrating that opiate users’ 
emotional responsiveness is comparable to that of controls (Carcoba et al. 2011; Smoski 
et al. 2011; Wang et al. 2010) and as such, do not support the claim that the decision-
making impairment often observed in opiate users is due to abnormalities in emotional 
responding (Verdejo-Garcia and Bechara 2009; Verdejo-Garcia et al. 2006). 
After examining group differences, the final analyses focused on the relationship 
between decision-making ability and the relative difference between anticipatory SCRs 
before advantageous compared to disadvantageous decisions in each group. 
Specifically, we were interested in whether people who produced much larger SCRs 
before disadvantageous decisions than before advantageous decisions (i.e., more distinct 
somatic markers), displayed better decision-making overall. Contrary to prior research 
(Carter and Smith Pasqualini 2004; Guillaume et al. 2009; Miu et al. 2012), this 
relationship was not observed in the control group. However, in opiate users the 
correlation was negative, indicating that those with relatively large anticipatory SCRs 
prior to disadvantageous decisions compared to advantageous decisions (i.e., more 
distinctive somatic markers) displayed worse decision-making performance. This result 
is not consistent with the predictions of the somatic marker hypothesis, which argues 
that relatively larger somatic markers prior to disadvantageous decisions should lead to 
better decision-making. This finding therefore suggests that a different relationship 
between somatic marker production and decision-making may exist in opiate users. For 
example, one possibility is that while opiate users may produce normal somatic markers 
when a decision is being contemplated, they may be less able to “tune in” to those 
markers (i.e., display a lack of interoceptive awareness; Craig 2002) leading to reduced 
decision-making capacity. However, given that there was a moderate negative 
relationship (rather than an absence of a relationship) between somatic marker 
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distinctiveness and decision-making ability, this explanation seems unlikely. Instead, it 
may be that opiate users are aware of the somatic markers that occur prior to 
disadvantageous decisions, but respond to them by choosing riskier options, rather than 
the ‘safer’ options that the somatic marker hypothesis would predict. If this is the case, 
the question is then raised as to whether this tendency to choose ‘riskier options’ in 
response to somatic marker production is a consequence of long-term opiate use, or may 
in fact have been apparent prior to opiate use. In keeping with this latter possibility, 
previous research has identified a group of healthy controls with normal somatic 
markers who behave disadvantageously on the IGT, classifying them as “risky” 
decision-makers (Bechara and Damasio 2002; Crone et al. 2004). Taken together, the 
current results indicate that additional research should be conducted to further explore 
the nature of the relationship between somatic marker production and risky decisions in 
opiate users. Future research should also consider adopting other approaches such as 
computational modelling to provide insight into other cognitive and emotional factors 
that may contribute to impaired decision-making in this group, especially given recent 
findings using this approach showing that impaired decision-making in ex-opiate users 
was characterised by reduced loss aversion (Ahn et al. 2014). 
It should be noted that the current sample of opiate users was relatively high-
functioning, with higher levels of education (12.56 years) than in other studies of 
decision-making in this group (8.37 years to 12.25 years; Ma et al. 2015; Mintzer et al. 
2005; Pirastu et al. 2006; Upton et al. 2012). In addition, the opiate users were enrolled 
in a treatment program and were living independently in the community. As such, the 
generalisability of the results to a broader sample of opiate users is currently unclear, 
and the possibility that the somatic marker hypothesis may be more applicable to other 
subgroups of opiate users cannot be ruled out. Furthermore, it should be noted that 
although screened for, no formal assessment of psychiatric disorders was conducted. 
Therefore, it is possible that externalising traits and disorders, such as antisocial 
personality disorder or ADHD, which are highly co-morbid in substance using 
populations, and are independently associated with deficits on the IGT (Bowden-Jones 
et al. 2004; Mazas et al. 2000; Mowinckel et al. 2015; Ruiz et al. 2008), may also have 
contributed to impaired decision-making in the opiate-using group.  
In conclusion, the current study supports previous findings that opiate use is 
associated with relatively severe decision-making impairment. However, the 
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impairment seen in the current sample does not appear to be driven by reduced 
emotional responding or by an inability to form somatic markers in anticipation of poor 
choices. Interestingly, more distinct somatic markers were associated with worse 
decision-making in this group. This suggests other cognitive processes may intervene 
between the activation of a somatic marker and the selection of a choice, leading opiate 
users to make more risky decisions. Future research should focus on how these 
cognitive processes interact with somatic markers. 
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5.8 Additional Analyses of Interoceptive Accuracy and its Relationship to Decision-
Making in Opiate Users and Controls 
The following results were not included in the submission to 
Psychopharmacology, but follow on from the data presented in the published 
manuscript. 
The ability to perceive changes in bodily states (i.e., interoception) may play a 
role in the ability to perceive somatic markers (Craig, 2009; Dunn et al., 2010). Indeed, 
at least one study has shown that more accurate perception of heartbeats in healthy 
adults is associated with better decision-making ability (Werner et al., 2009). In the case 
of opiate users, it may be suggested that reduced ability to perceive changes in 
physiology (i.e., somatic markers) may contribute to impaired decision-making in this 
group. To date, only one study has analysed interoceptive accuracy in substance users 
(including opiate users), and found that substance users were impaired in their ability to 
perceive heartbeat, relative to controls (Sönmez et al., 2016). However, the relationship 
between interoception and decision-making capacity in substance users was not 
assessed. Therefore, the additional analyses of interoceptive accuracy presented in this 
section aimed to determine whether the ability to “tune in” to physiological signals (as 
measured by the heart beat counting task) was related to decision-making ability in both 
opiate users and controls. Based on previous research, we expected to see reduced 
interoceptive accuracy in opiate users, relative to controls, and a positive correlation 
between interoception accuracy and decision-making ability in both groups. The 
methods for measuring interoceptive accuracy are detailed in the Methods Chapter 
(section 4.7.3). The results of these analyses are detailed below. 
Contrary to expectation, opiate users (M = 0.69, SD = 0.18) were able to perceive 
heartbeat more accurately on the interoceptive accuracy task than controls (M = 0.56, 
SD = 0.26; t (58) = 2.05, p = .045, Cohen’s d = 0.58). However, there was no significant 
correlation between decision-making ability and interoceptive accuracy in controls (r = 
.28, p = .111) or opiate users (r = .07, p = .728).  
The results showing that opiate users were more accurate than controls in their 
ability to “tune in to” physiological signal, contrast with those of Sönmez et al. (2016), 
who used the same interoceptive accuracy task as was used in the current study. 
Although it has been argued that better interoceptive accuracy is correlated with better 
94 
DECISION-MAKING AND OPIATE USE 
decision-making ability, only one study has found that more accurate perception of 
heartbeats in healthy adults is associated with better decision-making ability (Werner et 
al., 2009), while two other studies have found no correlation between interoceptive 
accuracy and decision-making capacity in healthy adults (Werner et al., 2013). The 
results of the current analyses support the latter, as interoceptive accuracy was unrelated 
to decision-making ability in both opiate users and controls.  These results, in addition 
to the findings that anticipatory somatic markers were negatively correlated with 
decision-making in opiate users (in the submitted manuscript), suggest that 
interoceptive awareness is not important in the decision-making process in opiate users. 
However, given that relatively few studies have analysed the relationship between 
interoceptive accuracy and decision-making capacity, and this is the first to conduct 
such analyses in a clinical group with known decision-making impairment, further 
research is warranted. 
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CHAPTER 6: Study 3 - Risky Decision-Making in Opiate Use  
6.1 Preamble 
Study 1 demonstrated that both current and ex-users of opiates have relatively 
severe decision-making impairments. Study 2 demonstrated that this decision-making 
impairment is not underpinned by reduced emotional responsiveness, or by an inability 
to form anticipatory warning signals prior to poor decisions. However Study 2, which 
used the IGT, focused on decision-making under conditions of ambiguity, which is the 
most commonly investigated type of decision-making. Given that decision-making is a 
multi-faceted construct, it remains to be seen whether opiate users also make poor 
decisions under other circumstances, in particular under conditions of calculable risk. 
Poorer decision-making in opiate users relative to controls under conditions of 
calculable risk might, at least in part, be due to underlying differences in the personality 
of opiate users, which drives behaviour towards risky, but rewarding, options. The aim 
of Study 3 was therefore to assess decision-making under conditions of calculable risk 
in opiate users and controls, using a relatively new measure of decision-making that 
involves choosing between risky or safe options. An additional aim of Study 3 was to 
analyse whether decision-making under conditions of calculable risk in opiate users is 
related to underlying personality differences in reward responsiveness.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
104 
DECISION-MAKING AND OPIATE USE 
6.2 Introduction 
Opiate use is associated with a propensity for high risk behaviours, often leading 
to negative consequences such as imprisonment for drug-related crime (Degenhardt et 
al., 2014) and HIV infection due to needle-sharing and high risk sexual practices 
(Gossop, Griffiths, Powis, & Strang, 1993; Gyarmathy, Neaigus, Miller, Friedman, & 
Des Jarlais, 2002). The tendency to display such behaviours in daily life may reflect 
impairment in higher-order cognitive functions, in particular decision-making (Bechara 
et al., 1999; Kohno, Morales, Ghahremani, Hellemann, & London, 2014; Waters-Wood, 
Xiao, Denburg, Hernandez, & Bechara, 2012), which, as previously noted, appears to be 
the most consistently impaired cognitive function in opiate users (Baldacchino, Balfour, 
Passetti, Humphris, & Matthews, 2012).  
Decision-making occurs in a number of different situations and theorists have 
differentiated these decision-making situations based on the probability of outcomes 
(Bechara, 2004; Einhorn & Hogarth, 1985; Ellsberg, 1961). Specifically, in situations of 
ambiguity, decision-makers do not have explicit knowledge of the probability of 
receiving a reward or a punishment. On the other hand, in situations of risk, the 
probability of a punishment or reward can be predicted. That is, in situations of risk, 
decision-makers must choose between a safe option, where the probability of reward is 
high but the value of that reward is relatively low, or a risky option, where the 
probability of reward is low but the value of the reward is relatively high (Bechara, 
2004; Euteneuer et al., 2009; Krain, Wilson, Arbuckle, Castellanos, & Milham, 2006). 
Given that decision-making is not a unitary construct, it has been suggested that 
decision-making performance under conditions of ambiguity and decision-making under 
conditions of calculable risk could vary (Brand, Labudda, & Markowitsch, 2006; 
Euteneuer et al., 2009).   
One of the most commonly used measures to investigate decision-making 
impairment in clinical populations is the Iowa Gambling Task (IGT; Bechara et al., 
1994; Steingroever, Wetzels, Horstmann, Neumann, & Wagenmakers, 2013). The IGT 
claims to measure decision-making under conditions of ambiguity (Bechara & Damasio, 
2005; Brand et al., 2006) as it is presumed that participants never fully acquire 
knowledge about the probabilities of punishment and reward for choices made on this 
task (Bechara & Damasio, 2005). Specifically, participants are presented with four 
105 
DECISION-MAKING AND OPIATE USE 
decks of cards that are associated with both reward and punishment. Two of these decks 
present the decision-maker with a high reward for each choice ($100), but over the 
course of the task, choices from these decks also occasionally lead to larger 
punishments (-$150 to -$1250), and these decks are therefore deemed 
“disadvantageous”. The other two decks present the decision-maker with a lower reward 
for each choice ($50), but also occasionally lead to smaller punishments (-$25 to -$250) 
over the course of the task, and are therefore deemed “advantageous” decks (see 
Chapter 4 for a breakdown of the schedule of reward and punishment). Thus, good 
decision-making on the IGT is exemplified by more choices from advantageous relative 
to disadvantageous decks, while impaired decision-making is characterised by a 
tendency to choose more often from disadvantageous decks. The IGT has been shown to 
be a valid indicator of decision-making impairment, with poorer decision-making on the 
IGT associated with more unsafe sexual practices (Golub, Thompson, & Kowalczyk, 
2016), as well as with increased rates of relapse (Stevens et al., 2013; Stevens et al., 
2015) and more medical, legal, and alcohol and drug related problems in substance 
users (Verdejo-Garcia, Bechara, Recknor, & Perez-Garcia, 2006). The IGT has also 
been used to demonstrate poor decision-making in a range of clinical populations, 
including people with injuries to the frontal lobe, schizophrenia, obsessive compulsive 
disorder, ADHD, as well as pathological gamblers (e.g. Brevers, Bechara, Cleeremans, 
& Noel, 2013; Cavedini et al., 2012; Lee et al., 2007; Malloy-Diniz, Fuentes, Leite, 
Correa, & Bechara, 2007; Waters-Wood et al., 2012), and is now one of the most widely 
used tools in decision-making research (Bull, Tippett, & Addis, 2015; Dunn et al., 
2006). Although an often-used measure, the IGT has received some criticism regarding 
its validity. In particular, it has been argued that deck B may appear the more 
advantageous deck given the frequency with which punishment is delivered (Lin, Chiu, 
Lee, & Hsieh, 2007), and the deck contingencies may be more cognitively penetrable 
than first thought, leading to substantial variation in control performance on the task 
(Dunn et al., 2006). Nevertheless, the IGT is a sensitive measure of decision-making 
impairment and is a useful approach in a range of clinical populations.  
Given the ubiquity of the IGT, it is not surprising that a substantial number of 
studies have used this instrument to measure decision-making impairment in opiate 
users (e.g., Barry & Petry, 2008; Lemenager et al., 2011; Ma et al., 2015; Pirastu et al., 
2006; Rotheram-Fuller et al., 2004; Upton et al., 2012; Verdejo-Garcia, Perales, et al., 
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2007). The vast majority of these studies (see Biernacki et al., 2016 for a review) have 
demonstrated that opiate users performed significantly worse than controls on this 
measure, with opiate users tending to select more often from disadvantageous, 
compared to advantageous decks. Thus, the widely held belief that decision-making is 
impaired in opiate users is largely based on studies analysing decision-making under 
conditions of ambiguity.  
An alternative situation in which decision-making impairment may manifest is 
under conditions of predictable risk. In such a decision-making scenario, such as during 
the Balloon Analogue Risk Task (BART; Lejuez et al., 2002), outcomes can be 
predicted to some degree (Leigh, 1999; Rao, Dunn, Zhou, & Li, 2015; Tversky & Fox, 
1995). The BART presents decision-makers with a visual representation of a balloon, 
which needs to be “pumped” in order to gain imaginary money. Participants receive a 
small reward (5 cents) for each pump, which is stored in a temporary bank. Each 
balloon is randomly allocated an “explosion point” when the balloon will explode. If a 
participant chooses to “collect” the money stored in the temporary bank before the 
balloon explodes, this money is transferred to a permanent bank. If, however, the 
balloon pops before the money is safely stored, the participant loses the money in the 
temporary bank. As such, the BART places decision-makers in a situation of calculable 
risk, as continued pumping increases the value of the potential reward but 
simultaneously reduces the probability of winning that reward. While the external 
validity of other measures of risky decision-making such as the Cambridge Gambling 
Task and the Game of Dice Task has not been established, the BART has been shown to 
be a valid indicator of risky decision-making in real life, with higher propensity for risk-
taking on the BART correlating with real life risky behaviours in healthy adults and 
adolescents, such as smoking, poly-drug use, gambling, and risky sexual behaviours 
(Aklin, Lejuez, Zvolensky, Kahler, & Gwadz, 2005; Lejuez et al., 2003; Lejuez et al., 
2002). More risky decisions during the BART have also been correlated with more risky 
real life behaviours in poly-substance users (Aklin et al., 2005; Hopko et al., 2006; 
Lejuez, Simmons, Aklin, Daughters, & Dvir, 2004). Furthermore, studies have found 
that performance on the BART does not correlate with performance on the IGT in 
healthy adults (Aklin et al., 2005; Buelow & Blaine, 2015; Skeel, Neudecker, Pilarski, 
& Pytlak, 2007) or in substance using populations (Bishara et al., 2009; Lejuez et al., 
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2003), leading to the suggestion that the BART taps a unique aspect of decision-
making. 
In contrast to the large number of studies that have assessed opiate users’ 
decision-making abilities under conditions of ambiguity on the IGT, only two studies 
have analysed their decision-making abilities under conditions of predictable risk on the 
BART. In the first study, illicit opiate users (n = 25) demonstrated more risky decision-
making behaviour than a group of matched controls on the BART (Khodadadi et al., 
2010). However, a subset of opiate users from this group who were subsequently 
assessed after completing 6 months of methadone treatment (n = 19), no longer showed 
impairment on the BART relative to controls. This suggests that there may be some 
improvement in this type of decision-making ability when illicit opiates are substituted 
by methadone. However, the possibility that the observed reduction in risky behaviour 
may have been due to risky decision-makers dropping out before completing 6 months 
of treatment was not assessed by the authors. Additionally, a lack of characterisation of 
the opiate-using sample (e.g., education, opiate use duration and dose) also makes it 
difficult to rule out whether other factors influenced the pattern of results observed after 
6 months of treatment. In the second study, ex-opiate users (who had stopped using all 
forms of opiates, including methadone) were compared to controls on the BART and 
performance did not differ between the groups (Ahn & Vassileva, 2016). Overall, 
however, given the paucity of studies, further research is necessary to develop a clearer 
picture of opiate users’ decision-making ability under conditions of calculable risk.   
The possibility that opiate users may display a propensity to make riskier 
decisions could be linked to underlying personality traits such as reward responsiveness 
(i.e., the experience of pleasure in anticipation or in the presence of reward-related 
stimuli; Taubitz, Pedersen, & Larson, 2015). It has been proposed that higher 
responsiveness to reward may precipitate drug use (Dawe & Loxton, 2004; 
Dissabandara et al., 2014). Consistent with this idea, opiate users have been found to be 
more reward responsive than controls (Dissabandara et al., 2012; Dissabandara et al., 
2014; Khosravani, Mehdizadeh, Dortaj, Alvani, & Amirinezhad, 2017) and differences 
in this aspect of personality are associated with earlier onset of opiate users’ drug use 
(Dissabandara et al., 2014). In the context of decision-making under conditions of 
calculable risk, higher reward responsiveness may drive opiate users to choose options 
which may lead to high reward, regardless of the known probability of punishment. In a 
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study that used computational modelling to identify the cognitive processes underlying 
the pattern of choices that opiate users made on the BART, it was found that opiate 
users valued gaining a reward, regardless of the actual anticipated outcome, thus 
arguably leading to impaired performance on this task (Khodadadi et al., 2010). This 
suggests that increased reward responsiveness in opiate users may be related to more 
risky decision-making on the BART. However, to date, only three studies have 
examined the relationship between reward responsiveness and risk-taking propensity on 
the BART in any group. While these studies of adolescents (Braams, van 
Duijvenvoorde, Peper, & Crone, 2015), people with ADHD (Barnhart & Buelow, 
2017), and those vulnerable to bipolar disorder (Collett, 2016) found no significant 
relationship between this personality trait and risky decision-making in these groups, no 
research has yet analysed whether a relationship exists in opiate users.  
The current study had two aims. The first was to assess whether opiate users’ 
decision-making impairment extended to decision-making in a situation where risk was 
predictable. While previous evidence is limited and somewhat inconsistent, it was 
anticipated that opiate users in the current study would make riskier choices on the 
BART. The second aim was to investigate whether opiate users were more reward 
responsive than controls, and to analyse the extent to which opiate users’ performance 
on the BART was related to reward responsiveness. It was anticipated that opiate users 
would demonstrate higher reward responsiveness, relative to controls, and that there 
would be a positive correlation between performance on the BART and reward 
responsiveness in both groups.  
6.3 Method 
6.3.1 Participants included in Study 3 
Thirty long-term opiate users with a history of heroin dependence were recruited 
(years of heroin use M = 16.70, SD = 7.98), as were a group of 43 controls with no 
history of alcohol or drug dependence. Twenty-nine of the opiate users were currently 
participating in an opiate substitution program (methadone n = 19, suboxone n = 8, 
buprenorphine n = 2), and had been using their opiate substitute for an average of 5.97 
years (SD = 4.93). One opiate user had recently stopped taking their opiate substitute 
and was only using street heroin. Groups did not differ significantly in age (opiate users 
M = 42.10, SD = 7.75; controls M = 39.05, SD = 8.20; t(71) = 1.60, p = .114, Cohen’s d 
109 
DECISION-MAKING AND OPIATE USE 
= 0.38). Groups differed in years of education (opiate M = 12.57, SD = 2.25; control M 
= 16.65, SD = 2.66; t(71) = 6.86, p < .001, Cohen’s d = 1.66) and on premorbid IQ, as 
measured by the NART (Nelson, 1982) (opiate M = 101.34, SD = 9.34; control M = 
107.21, SD = 7.95; t(65) = 2.78, p = .007, Cohen’s d = 0.68). Participants were recruited 
in the same manner as presented in Study 2 (see Chapter 5). The participants included 
all of those who participated in Study 2 (28 opiate users, 34 controls) plus an additional 
11 participants (2 opiate users, 9 controls) who completed the measures for Study 3 but 
did not complete the IGT for Study 2. 
6.3.2 Measures 
Balloon Analogue Risk Task (BART) 
Risky decision-making was measured using the BART (Lejuez et al., 2002). The 
current study used the 30-trial BART, where participants were presented with 30 
balloon trials. For each trial, participants ‘pumped’ a balloon by clicking on a button 
(Pump Balloon), with each pump earning the participant 5 cents of imaginary money. 
This money was held in the temporary ‘bank’, indicated on the screen. For each balloon, 
a random point of explosion was allocated. If the participant decided to ‘collect’ that 
money (by clicking on the Collect $$$ button below the balloon) before the balloon 
exploded, the money earned for that balloon was transferred to a permanent bank where 
it was stored until the end of the task. If the participant reached the explosion point, 
however, the balloon exploded and the participant lost the money accrued in their 
temporary bank for that balloon. The average number of pumps across unexploded 
balloons (i.e., the adjusted score) was used as the measure of risky decision-making, 
with a higher number of pumps indicating riskier decision-making. The BART has 
demonstrated good incremental and construct validity in healthy and clinical 
populations (Hunt et al., 2005; Lejuez et al., 2002). 
Behavioural Activation System and Behavioural Inhibition System 
(BAS/BIS) Scale  
Sensitivity to reward and punishment was measured using the 24-item BAS/BIS 
scale (Carver & White, 1994), using three subscales of reward sensitivity: Reward 
Response (BAS-RR), Fun Seeking (BAS-FS) and Drive (BAS-D). The BIS subscale 
measured sensitivity to punishment. Higher scores on each subscale indicated greater 
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levels of reward or punishment sensitivity. The BAS/BIS scale has demonstrated good 
reliability and validity as a measure of personality traits (Cooper et al., 2007; Jorm et 
al., 1998). 
6.3.3 Procedures  
Informed consent was obtained from participants, and they were tested 
individually in one session lasting approximately three hours. Regular breaks were 
provided. After completing the brief background questionnaire, NART and BAS/BIS, 
participants were administered the protocols specific to Study 2 (IGT and emotional 
video task) and Study 3 (the BART). 
6.3.4 Data analysis 
All statistical tests were two-tailed and were conducted using IBM SPSS Statistics 
for Windows, version 23.0 (IBM Corp). All statistical tests were two-tailed. An alpha 
level of p < 0.05 was considered statistically significant, and effect sizes were estimated 
using Cohen’s d. Outliers were replaced with scores + or - 2SD of the mean where 
appropriate.  
6.4 Results 
6.4.1 Decision-making ability under conditions of calculable risk (BART) 
Due to group differences in IQ and education, correlations between these 
variables and BART adjusted pumps scores were examined separately for each group. 
All correlations were non-significant (all p’s >.05). Therefore, these variables were not 
included as co-variates in further analyses (Tabachnick & Fidell, 2013). There was no 
significant difference in performance on the BART between opiate users (M = 26.34, 
SD = 12.64) and controls (M = 27.33, SD = 11.32), t(71) = 0.35, p = .728, Cohen’s d = 
0.08.  
When the sample was restricted to the same opiate-using participants who 
completed the IGT in Study 2 (where they showed deficits relative to controls; opiate n 
= 27, control n = 34), the group comparison again revealed no group differences on the 
BART: opiate users M = 26.34, SD = 13.31; controls M = 27.67, SD = 11.38; t(59) = 
0.42, p = .676, Cohen’s d = 0.11. 
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6.4.2 Reward and punishment sensitivity (BAS/BIS) 
There were no significant differences between opiate users and controls on the 
Drive and Fun Seeking subscales of the BAS, or on the BIS (see Table 5). However, 
controls reported significantly higher reward responsiveness than opiate users on the 
Reward Responsiveness subscale of the BAS (see Table 5).  
 
6.4.3 Relationship between decision-making under conditions of risk and 
reward and punishment sensitivity 
There were no significant correlations between performance the BART and any of 
the subscales of the BAS or the BIS, in either group (see Table 6). 
 
Table 5.  
Mean Scores and Group Differences on the BAS/BIS Subscales 
 
Opiate Group 
n = 30 
 
Control Group 
n = 43 
 
 
 
 M SD  M SD  t d 
BAS-D 11.24 1.94  11.28 2.57  0.07 0.02 
BAS-RR 16.06 2.50  17.22 1.96  2.21* 0.52 
BAS-FS 12.55 2.07  12.00 2.22  1.08 0.26 
BIS 20.88 3.66  21.04 3.64  0.18 0.04 
Note. * p > .05; BAS = Behavioural Activation System; BAS-D = BAS Drive subscale; 
BAS-RR = BAS Reward Responsiveness subscale; BAS-FS = BAS Fun Seeking 
subscale; BIS = Behavioural Inhibition System. 
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Table 6. 
Correlations Between BART Scores and Subscales of the BAS/BIS 
  BART BAS-D BAS-RR BAS-FS BIS  
BART  - .21 -.11 .33 .02 
O
p
iate u
sers 
BAS-D 
C
o
n
tr
o
ls
 
-.03 -   .40*   .50** -.19 
BAS-RR -.02 .44* - .31 .25 
BAS-FS -.04 .24     .55*** - -.05 
BIS .16 .04  .41* .18 -  
Note. * p > .05, ** p > .01, *** p > .001;  BAS = Behavioural Activation System; 
BAS-D = BAS Drive subscale; BAS-RR = BAS Reward Responsiveness subscale; 
BAS-FS = BAS Fun Seeking subscale; BART = Balloon Analogue Risk Task; BIS = 
Behavioural Inhibition System. Opiate users above diagonal, controls below diagonal 
 
6.5 Discussion 
The current study aimed to determine whether the decision-making impairment 
under conditions of ambiguity observed in opiate users in Study 2, extended to decision-
making under conditions of calculable risk. Contrary to expectations, the results 
indicated that the opiate users in the current study did not show impairment in decision-
making under these conditions, as measured by the BART. Furthermore, contrary to 
expectations, opiate users in the current study were not more reward responsive than 
controls, and there was no relationship between reward responsiveness and decision-
making under conditions of calculable risk in either group.  
Based on the results of the current study, it appears that the decision-making 
impairment of opiate users is not apparent under conditions of calculable risk, as 
measured by performance on the BART. When the analysis was restricted to the 
subgroup that completed both the IGT and the BART, performance on the BART again 
did not differ between groups, suggesting that opiate users are specifically impaired in 
decision-making under conditions of ambiguity, but not risk. The failure to detect a 
group difference on the BART does not appear to be the result of low power; the effect 
size was very small, whereas the effect size for group differences on the IGT (see Study 
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2) was moderate to large. These results are consistent with those of Khodadadi et al. 
(2010), who found no difference on the BART between opiate users who had received 
methadone maintenance treatment for 6 months, and controls. The opiate users in the 
current study, although not totally abstinent from heroin, had also been receiving 
methadone and other pharmacological treatment, albeit over a longer period (5.97 
years). The fact that Khodadadi et al. (2010), however, did report a difference on the 
BART between opiate users and controls prior to commencing treatment, raises the 
possibility that decision-making under conditions of calculable risk may be impaired  
when people are using street heroin, but this impairment may be attenuated when they 
receive pharmacological treatment (i.e., methadone). Khodadadi et al. (2010) suggest 
that methadone treatment “normalises” opiate-users’ valuation of reward. Methadone 
given as a stable dose acts to stabilize the plasma levels of opiates, which has follow-on 
stabilizing effects for other neurological and hormonal functions (Bart, 2012). While the 
exact mechanism is unclear, it seems possible that the stabilizing effects of methadone 
may reduce risky behaviour by reducing the fluctuations in brain chemistry (and 
withdrawal symptoms) associated with short-acting opiates such as street heroin. 
Alternative explanations however, are also possible. For example, considering the 
findings of both the current study and the Khodadadi et al. (2010) study, it may instead 
be that opiate users who chose to enter (and remain in treatment) are less prone to 
making risky decisions than those who do not enter or drop-out of treatment. These 
possibilities require further empirical investigation.  
The second aim of the current study was to investigate the role of reward 
responsiveness in decision-making under conditions of risk. More specifically, the study 
aimed to investigate whether opiate users were more reward responsive than controls, 
and to determine whether the level of reward responsiveness was related to the level of 
decision-making performance in a risky scenario. Contrary to expectations, the opiate 
users in the current study were not more reward responsive than controls. These results 
deviate from previous findings, where opiate users have been found to be more reward 
responsive than controls on the BAS (Dissabandara et al., 2012; Dissabandara et al., 
2014; Khosravani et al., 2017). In fact, in the current study, controls’ ratings of reward 
responsiveness were higher than opiate users’, suggesting that the controls may have 
been more sensitive to rewards than the opiate users. If reward responsiveness 
underpins decision-making under conditions of risk, the higher level of reward 
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responsiveness shown by the control group might have been expected to lead to more 
risky decision-making on the BART in controls, relative to the opiate users. This was 
not the case, however, with no group differences found. Thus, the current findings are 
not consistent with the claim that reward responsiveness is a major contributor to 
performance on a decision-making task involving calculable risk. 
The finding that sensitivity to reward was not correlated with BART 
performance in either group further reinforces the argument that reward responsiveness 
does not play a major role when making decisions under conditions of predictable risk. 
The suggestion that decision-making ability under conditions of calculable risk may be 
associated with sensitivity to reward has been the subject of limited empirical 
investigation to date. Indeed, only three studies have examined the relationship between 
the two measures (Barnhart & Buelow, 2017; Braams et al., 2015; Collett, 2016), and 
each reported no relationship. The current results are consistent with these findings. 
However, because of the small sample included in this (and the previous) studies, these 
results should be considered exploratory and require further replication. Further 
research may also consider the possibility that aspects of personality, other than reward-
sensitivity, may be more important predictors of poor decision-making in risky 
situations. For example, sensation seeking has been found to be related to BART 
performance (Lauriola, Panno, Levin, & Lejuez, 2014). Given that a previous study 
(Dissabandara et al., 2014) has reported that opiate users scored higher on a measure of 
sensation seeking than controls, future research may investigate whether personality 
traits such as sensation seeking have stronger relationships with decision-making under 
risk in this group.     
Overall, although the number of studies is small, available evidence suggests that 
the decision-making impairment in opiate user appears to manifest mostly in situations 
of ambiguity, and not under conditions of predictable risk (Ahn & Vassileva, 2016; 
Khodadadi et al., 2010). This pattern differentiates opiate users from people dependent 
on other substances, such as amphetamines, cocaine or cannabis, who demonstrate 
impaired performance on both the IGT and the BART (Bechara et al., 2001; Bishara et 
al., 2009; Bolla, Eldreth, Matochik, & Cadet, 2005; Bornovalova, Daughters, 
Hernandez, Richards, & Lejuez, 2005; Gonzalez, Schuster, Mermelstein, & Diviak, 
2015; Hopko et al., 2006; Kohno et al., 2014). However, the reason that opiate users 
show impaired decision-making in ambiguous, but not risky conditions is not well 
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understood. It could be argued that task complexity may differentiate performance on 
the IGT and BART in opiate users. Specifically, the IGT is a more complex task 
requiring a learning component (Dunn et al., 2006; Dymond, Cella, Cooper, & Turnbull, 
2010), whereas the BART does not involve this element of complexity, which has been 
shown to be impaired in opiate users (Myers et al., 2016). Thus, reward-based learning 
on the IGT may be more impaired than the simple decision-making process required on 
the BART. In order to better understand the cognitive (or personality) factors driving 
particular patterns of behaviour (i.e., impaired decision-making) in this group, a 
computational modelling approach may be applied (Ahn, Dai, Vassileva, Busemeyer, & 
Stout, 2016). More specifically, computational modelling may be used to analyse the 
pattern of responses made on the IGT and BART to better understand why opiate users 
are particularly impaired when making decisions in conditions of ambiguity, but not 
risk. This may help to determine the underlying cognitive processes, and how they are 
impaired, in each of these decision-making contexts. 
While it is important to investigate decision-making in opiate users under 
conditions of calculable risk and conditions of ambiguity, given that problems in each of 
these may translate to significant problems for an opiate user in everyday life (e.g., 
Wilson & Vassileva, 2016), it should be noted that these situations represent only two 
aspects of decision-making ability that can be measured. Further investigation of 
additional types of decision-making, ideally within a single sample of opiate users, 
would provide a better understanding of the conditions under which decision-making is 
impaired in this group. For example, the Ultimatum Game measures decision-making in 
a social context, where decisions must be made to “split” monetary rewards with a 
hypothetical other player under fair and unfair conditions (Van’t Wout, Kahn, Sanfey, 
& Aleman, 2006). To date, only one study has analysed this type of decision-making in 
opiate users. The findings indicated that opiate users were more willing to accept unfair 
offers when the value of the reward was relatively high, but not when the value of the 
reward was low, highlighting how decision-making changes depending on reward value 
and social context (Hou, Zhao, Yao, & Ding, 2016). Similarly, moral decision-making 
has been explored in users of other substances, with results indicating that substance 
users tend to choose more utilitarian options in personal moral dilemmas (Carmona-
Perera, Verdejo-García, Young, Molina-Fernández, & Pérez-García, 2012; Khemiri, 
Guterstam, Franck, & Jayaram-Lindström, 2012; Kornreich et al., 2013). This type of 
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decision-making has not been investigated in opiate users, and presents an additional 
line of research for future studies.  
Overall, the results of this study do not align with previous suggestions that opiate 
users may be prone to making risky decisions (Baldacchino et al., 2015; Brand et al., 
2008; Ersche et al., 2005). In conditions where risk can be calculated, opiate users who 
are receiving pharmacological treatment made choices in the same way as controls. 
Future research should, however, continue to investigate the profile of decision-making 
impairment across the spectrum of decision-making situations and amongst opiate users 
who are not in treatment. By understanding where specific impairments in decision-
making ability lie, therapy may be tailored to provide the most appropriate support to 
opiate users. 
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CHAPTER 7: General Discussion  
7.1 Summary of the main findings 
From the literature review presented in Chapter 2, it was apparent that opiate use 
was associated with decision-making impairment. However, the consistency of this 
impairment, and whether any other factors contributed to the impairment, was unclear. 
Therefore, the aim of Study 1 was to quantify the decision-making impairment in opiate 
users via meta-analytic techniques, and to analyse whether other factors may have some 
impact on the magnitude of this impairment. Consistent with the hypotheses, Study 1 
showed that current opiate users demonstrated a significant decision-making 
impairment (d = -0.70) across a range of neuropsychological decision-making tasks, 
relative to healthy controls. Contrary to expectation, however, longer duration of opiate 
use was not associated with more severe decision-making impairment. Furthermore, 
other co-morbid factors thought to impair decision-making over and above opiate use, 
namely poly-substance dependence and head injury, did not significantly alter the 
severity of the deficit. It was also hypothesised that studies that analysed decision-
making in ex-users of opiates would demonstrate a reduced impairment compared to 
studies that included current users of opiates. However, results indicated that abstinence 
was not associated with a significant reduction in the decision-making impairment. 
Furthermore, longer duration of abstinence was not associated with better decision-
making capacity. Overall then, the decision-making impairment in opiate users appears 
to be relatively severe, and is not mitigated or worsened by other factors common in 
opiate users. 
Study 2 aimed to determine whether reduced emotional responding provided an 
explanation for impaired decision-making in opiate users, as suggested by the somatic 
marker hypothesis model of decision-making. This model contends that abnormal 
emotional processing may lead to an inability to respond normally to the outcomes of 
choices (i.e., rewards and punishments), thereby leading to an inability to form 
anticipatory somatic markers which would otherwise guide decision-making. The 
results of Study 2 demonstrated that, although opiate users were impaired in their 
decision-making capacity relative to controls (d = -0.67), they did not demonstrate 
blunted emotional responses outside of a decision-making context relative to controls, 
either in subjective ratings or through objective measures of emotional arousal (see 
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Chapter 5, sections 5.6.2 and 5.6.3). Furthermore, opiate users did not differ in their 
capacity to respond to punishment and rewards in a decision-making context. Most 
notably, opiate users demonstrated normal anticipatory somatic marking. However, 
stronger marking prior to disadvantageous decisions (relative to advantageous 
decisions) was associated with worse decision-making performance in this group (see 
Chapter 5, section 5.6.6). In an extension to this study, it was also found that opiate 
users were no less accurate than controls in their ability to perceive physiological 
changes (i.e., they did not have reduced interoceptive accuracy). Overall, the findings of 
Study 2 confirm a decision-making impairment in opiate users, and suggest that they 
may make disadvantageous decisions.  
The results of Study 2 demonstrated that decision-making was impaired under 
conditions of ambiguity, but could not clarify whether opiate users also made poor 
decisions in other contexts. Therefore, the aim of Study 3 was to analyse whether opiate 
users made poor decisions under conditions of calculable risk as opposed to ambiguous 
situations, and whether this behaviour was associated with underlying differences in 
personality, namely increased responsiveness to reward. The results of Study 3 
demonstrated that opiate users did not differ from controls in their capacity to make 
decisions under conditions of calculable risk and that they were no more responsive to 
reward than controls. Furthermore, reward responsiveness was not associated with more 
risky decision-making in opiate users or controls.  
Taken together, the results of this thesis suggest that opiate users demonstrate 
impaired decision-making in situations of ambiguity, but not risk, and that this 
impairment is not driven by an inability to emotionally respond to the consequences of 
their choices. 
7.2 Contributions and implications of the research 
The results of this PhD thesis contribute to the literature surrounding opiate use, 
both in terms of decision-making and emotional processing capacity. In addition, the 
results of these studies also have important implications for the treatment of opiate 
dependence and provide at least some explanation for opiate users’ continued 
engagement in the addiction cycle and therefore their poor quality of life. The sections 
below outline the contributions and implications of this research. 
119 
DECISION-MAKING AND OPIATE USE 
7.2.1 Cognitive and emotional processing in opiate users 
Opiate use has been associated with a range of cognitive deficits (Baldacchino et 
al., 2012; Ersche & Sahakian, 2007) which may stem from neurological abnormalities 
of the frontal lobes (Wollman et al., 2016). However, previous research suggests that 
decision-making is the most consistently and severely impaired cognitive function, with 
less consistent impairment demonstrated in other cognitive functions (Baldacchino et 
al., 2012). This pattern is supported by the results of the meta-analysis in Study 1 as 
well as the results regarding executive function in the current sample, presented in 
Chapter 4 (see section 4.6). In the meta-analysis, both current (d = -0.70) and ex-users 
of opiates (d = -0.43) demonstrated significant decision-making impairment relative to 
healthy controls while, as reported in in Chapter 4, opiate users performed no differently 
to controls in two of three measures of executive function, with only a moderate 
difference between groups on a measure of working memory. Furthermore, opiate users 
also demonstrated impaired decision-making on the Iowa Gambling Task (IGT) in 
Study 2, relative to controls. Thus, the pattern of results of the empirical studies 
presented in this thesis extends, and is consistent with, the literature regarding cognitive 
function and decision-making in opiate users.  
The current research also adds to the relatively small body of literature 
surrounding emotion processing capacity in opiate users. While some previous research 
has found that opiate users demonstrate reduced emotion processing capacity (Aguilar 
de Arcos et al., 2008; Gerra et al., 2003), others have not found an impairment (Carcoba 
et al., 2011; Lubman et al., 2009; Smoski et al., 2011; Wang et al., 2010). The results of 
Study 2 are consistent with the latter. Therefore, this research adds to the sparse 
literature regarding the emotion processing capacity of opiate users and adds weight to 
the argument that opiate use is not associated with reduced emotion processing capacity. 
However, some caution must be applied to these conclusions, given that the opiate users 
included in this study were treated with opiate substitutes. Indeed, in the previous 
studies of opiate users’ emotional responsiveness, almost all opiate users were also 
receiving pharmacological treatment. Thus, these results may only apply to this group 
and not to untreated users of illicit opiates. Nevertheless, these results shed some light 
on the emotion processing capacity and decision-making ability of opiate users 
currently in treatment. 
120 
DECISION-MAKING AND OPIATE USE 
While the current research contributes to the literature regarding cognitive and 
emotional processing in opiate users, this and most other studies of addicted populations 
cannot address the key issue of causality. That is, cross-sectional studies of people with 
substance dependence and cognitive impairment cannot tease out whether cognitive 
impairment pre-dated drug dependence (placing this group of people at risk of making 
poor decisions, ultimately leading to drug dependence), or whether neural and cognitive 
change occurred after the initiation of opiate use. Indeed, a third pathway also seems 
possible, whereby a pre-existing impairment may be exacerbated by heavy drug use. 
Ideally, this question could be answered by longitudinal research, which would track the 
cognitive abilities of at-risk populations prior to initiating heavy drug use, during 
dependence, and then after abstinence. For example, populations at risk of developing 
opiate dependence may be identified by psychosocial markers in childhood and 
adolescence  (Darke, 2011; Verdejo-Garcia et al., 2008), and then cognitive abilities 
may be monitored continuously throughout adulthood. Alternatively, the cognitive 
function of clinical groups who may be at higher risk of developing substance 
dependence, such as people with schizophrenia (Chambers, Krystal, & Self, 2001) or 
ADHD (Chilcoat & Breslau, 1999), could be assessed at the onset of the disorder and 
monitored over time. However, longitudinal research is difficult, given the expense of 
recruiting and then following drug-using populations for long periods of time, the high 
likelihood of dropouts, and the fact that heroin-using participants are often lost from 
research due to death (up to 50% after 30 years; Grella & Lovinger, 2011; Hser et al., 
2007). Thus, cross-sectional research is the norm, but is nevertheless valuable in that it 
can be pooled and meta-analysed, as in Study 1, to systematically examine a number of 
factors and analyse their impact on cognitive functioning.  
7.2.2 Implications of the current findings for the treatment of opiate 
dependence  
Impaired decision-making in everyday life outside the laboratory may contribute 
to the poorer quality of life and the cycle of addiction that opiate users are often 
engaged in. More specifically, impaired decision-making may lead to reduced 
compliance with treatment programs, possibly leading to relapse, and therefore to the 
negative outcomes that are often experienced by this group, such as disease and death. 
The research presented in this thesis provides some insight into the factors that may (or 
may not) contribute to impaired decision-making in this group, and can be used to 
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understand what forms of support opiate users need in order to manage and/or overcome 
this addiction. 
As outlined in Chapter 2 (see section 2.2: ‘Cycle of addiction in opiate users’), 
opiate users who enter treatment often cycle through phases of heavy use, treatment, 
abstinence, and relapse (Darke, 2011; Darke et al., 2009). For example, studies have 
shown that, on average, heroin users entering treatment have done so at least 5 times 
previously (Hser et al., 2007; Substance Abuse and Mental Health Services 
Administration, 2017). Many (67.7%) of the opiate users included in Studies 2 and 3 
also reported having been through multiple treatment cycles, and reflect the general 
population of opiate users who go through multiple treatment and relapse episodes over 
the course of their “career”. This suggests that while many opiate users are able to 
engage positively with treatment services, they may struggle with continuing to make 
good decisions that will help maintain their engagement in treatment, and may 
ultimately relapse. Indeed, poor performance on laboratory-based measures of decision-
making has been shown to predict relapse during treatment (Passetti et al., 2011; 
Passetti et al., 2008), and may therefore undermine the successful maintenance of 
abstinence.  
Pharmacological treatment of opiate dependence is often supplemented with 
psychological intervention (Gowing, Farrell, Bornemann, Sullivan, & Ali, 2011) and 
research demonstrates that psychological interventions such as cognitive behavioural 
therapy (CBT), motivational interviewing, and contingency management can reduce 
drug taking in opiate users (Bernstein et al., 2005; Carroll, Ball, Nich, & et al., 2001; 
Scherbaum et al., 2005; Schottenfeld et al., 2005). However, given that opiate users in 
treatment often continue using heroin (Bloor, McIntosh, McKeganey, & Robertson, 
2008) and often relapse into heavy use (Darke et al., 2016; Jimenez-Trevino et al., 
2011), psychological therapies may not provide the support that opiate users need to 
continue making good decisions in particular situations, which may contribute to the 
continued cycle of addiction. For example, CBT aims to teach opiate users to avoid 
high-risk situations where they may be vulnerable to drug use, and to use cognitive and 
behavioural strategies to cope effectively when these risky situations occur (Carroll & 
Onken, 2005). However, the results of Study 3 suggest that opiate users may be able to 
recognise and avoid making poor choices in these risky situations. Instead, relapse may 
stem from an inability to make adaptive choices in ambiguous situations. For example, 
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an opiate user who chooses to use heroin for the first time since commencing treatment 
may not know how this will interfere with their prescribed pharmacological treatment. 
Thus, failure to make good decisions in these ambiguous situations could lead to poor 
choices which may consequently lead to relapse. Indeed, most decision-making 
scenarios are ambiguous in real-life situations. Therefore, successful treatment of opiate 
dependence may require a focus on strategies for ambiguous situations. For example, 
CBT may be modified to help opiate users identify any decision-making scenario where 
they may be likely to make a poor decision (ambiguous or risky), with therapists role-
playing likely scenarios so that these situations may become less ambiguous through 
experience.  
The results of Study 2 demonstrated that opiate users are able to produce 
physiological warning signals prior to bad decisions, and are aware of these changes in 
physiology, i.e., opiate users had good interoceptive accuracy. Therefore, these results 
suggest that a greater focus on helping opiate users to tune into their physiology may be 
helpful. Mindfulness therapy teaches people to be more aware of their feelings and 
bodily sensations (Marcus & Zgierska, 2009). Thus, mindfulness therapy may help 
opiate users better interpret physiological signals and more effectively factor their 
emotional state into decision-making. Research has shown that mindfulness meditation 
on its own can reduce substance use and cravings in substance users (Bowen et al., 
2014; Grow, Collins, Harrop, & Marlatt, 2015; Witkiewitz, Bowen, Douglas, & Hsu, 
2013), and when used in conjunction with Goal Management Therapy, a cognitive 
remediation therapy which trains cognitive control processes, mindfulness can improve 
decision-making capacity in poly-substance abusers (Alfonso, Caracuel, Delgado-
Pastor, & Verdejo-García, 2011). Mindfulness has been shown to effectively reduce 
opiate craving and misuse in chronic pain patients (Garland, Froeliger, Zeidan, Partin, & 
Howard, 2013). However, future research could analyse the use of mindfulness in long-
term users of heroin to determine whether this may be an effective alternative modality 
for psychological intervention. Specifically,  mindfulness may be used to help opiate 
users recognise the heightened physical and emotional reactions that follow making a 
disadvantageous decision. They may then better understand what an anticipatory 
somatic marker before a disadvantageous decision “feels” like and use this to avoid 
making a disadvantageous decision again in the future. 
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It should be noted, however, that the success of any treatment, whether 
pharmacological or psychological in nature, is dependent on the motivation of the opiate 
user to reduce or terminate illicit opiate use. Although enrolment in a treatment program 
may suggest some level of motivation to become abstinent, maintaining that motivation 
can create another barrier to treatment. Specifically, the drug user must shift their 
motivation away from seeking drugs (and their rewarding properties) towards new 
activities such as seeking support and other more adaptive behaviours (Verdejo-Garcia, 
Chong, Stout, Yücel, & London, 2017). Indeed, lack of motivation to perform well on 
decision-making tasks in the laboratory may negatively skew results in opiate users.  
Future studies may therefore benefit from the inclusion of a test of motivation or even 
the use of real money incentives for decision-making tasks. Previous research has 
demonstrated real money incentives can remediate cognitive control deficits in other 
populations such as aging and Parkinson’s disease (e.g., Harsay, Buitenweg, Wijnen, 
Guerreiro, & Ridderinkhof, 2010). Studies of contingency management in opiate users, 
where users are rewarded for adaptive behaviours with incentives such as vouchers, 
have also demonstrated this is an effective therapeutic technique.  Thus, more research 
needs to focus on the motivational drives of opiate users and target these in conjunction 
with decision-making processes (Verdejo-Garcia, Chong, et al., 2017).  
7.3 Limitations of the current research 
While the current research provides novel information regarding decision-making 
and emotion processing in opiate users, it is not without its limitations. One limitation 
was that self-report was used to collect information regarding abstinence from drug use 
in the 24 hours prior to testing. Self-report was also used to report psychiatric co-
morbidities. This may have led to the unwitting inclusion of participants who were 
intoxicated at the time of testing or who did not meet the exclusion criteria relating to 
psychiatric diagnoses. The presence of co-morbid psychiatric conditions may cloud the 
interpretability of the decision-making capacity of opiate users, given that psychiatric 
conditions such as schizophrenia are independently associated with deficits on the IGT 
(e.g., Lee et al., 2007; Shurman, Horan, & Nuechterlein, 2005). Similarly, acute 
intoxication with illicit opiates or other drugs may have impeded cognitive function 
throughout the testing session. While steps were taken to minimise the inclusion of 
participants who had significant co-morbid psychiatric conditions or who were acutely 
intoxicated, it would have been preferable to conduct a drug-screen analysis using a 
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urine test or similar, to confirm abstinence from drug use on the day of testing, and to 
have access to psychiatric reports of all opiate users, given the common co-morbidity of 
drug and psychiatric issues in this population. However, opiate users were recruited 
from the community, so verified psychiatric diagnoses were not available. Similarly, it 
would have been valuable to collect time since prescription-opiate dose to disentangle 
the acute effect of opiates from those that are longer term. It may therefore be valuable 
for future studies to collect this information to better understand the acute effect of 
opiates on cognition.   
A second limitation is the exclusion of the control group based on a clinical 
diagnosis of depression or anxiety. While opiate users were only excluded for severe 
psychiatric diagnoses, controls were excluded if they reported depression and anxiety, 
which may have biased the sample distribution. However, control participants were not 
excluded based on scores on the HADS (a commonly-used measure of depressive and 
anxiety symptoms, Bjelland et al., 2002), with scores on this measure indicating a wide 
variability in mood states in controls (depression range: 0-11; anxiety range: 0-17) that 
was not correlated with decision-making performance. 
The final limitation is the nature of the tools used to assess decision-making in the 
laboratory. Although decision-making tasks such as the IGT and the BART aim to 
simulate decision-making in real life conditions of ambiguity and risk, the consequences 
of actions on these measures are necessarily artificial. In other words, these tasks do not 
provide an opportunity to experience ‘real’ consequences (i.e., lose large sums of 
money), given the ethical requirement not to cause harm to participants. Thus, decision-
making tasks conducted in the laboratory can only provide an indication of how 
decision-makers might behave in a real-life situation (Collett, 2016). Research into the 
ecological validity of the IGT and other decision-making tools is limited but generally 
supported (Buelow & Suhr, 2009; Dunn et al., 2006), with performance on the BART 
and IGT correlating with real life risk taking behaviour (Aklin et al., 2005; Golub et al., 
2016; Hopko et al., 2006; Lejuez et al., 2003; Lejuez et al., 2002; Lejuez et al., 2004). 
To better understand decision-making in real life, future research may adopt ecological 
momentary assessment methods to track decisions made in real-time via a mobile app, 
with previous research demonstrating relatively high compliance in opiate users (Serre 
et al., 2012). 
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7.4 Strengths of the current research 
In addition to the contribution to the literature regarding decision-making in opiate 
users, there are a number of other strengths of the current research. Firstly, this study 
expands on previous studies of emotional experience in opiate users by incorporating 
dynamic emotion-eliciting stimuli (i.e., films), which may elicit a stronger and longer 
lasting emotional response than static images (Bos, Jentgens, Beckers, & Kindt, 2013). 
Secondly, given that emotional response goes beyond subjective awareness (Fernández 
et al., 2012), the inclusion of skin conductance arousal provides an additional line of 
evidence that supports the idea that opiate users experience emotions in a similar way to 
controls. In addition, including an objective measure of emotional arousal (i.e., the 
SCR) during decision-making provides an additional source of evidence regarding 
emotional arousal during-decision-making. The involvement of emotional arousal in 
decision-making is often ignored in studies of cognition. Thus, by incorporating an 
objective measure of emotional arousal, this study expands knowledge of how emotion 
is linked (or not linked) to decision-making in a group with severe decision-making 
impairment. 
A third strength of the current research is that the current opiate-using sample was 
representative of typical opiate users functioning independently in the community who 
enter treatment. Opiate users were recruited from the community via pharmacies that 
dispensed opiate substitutes and from organisations that provided support to opiate users 
living in the community. Participation in these studies was reliant on study participants’ 
motivation and ability to attend testing sessions. Therefore, the opiate users recruited 
represented a high-functioning and motivated subset of the wider clinical group. The 
nature of the sample means that the results of Studies 2 and 3 are directly relevant to the 
real life functioning and decision-making capacity of treatment-maintained opiate users 
living in the community.   
7.5 Directions for future research 
The findings presented in this thesis highlights new avenues for future research. 
More specifically, as outlined below, future research should explore decision-making in 
ex-opiate users in more detail; use computational modelling to better understand 
cognitive processes that may be involved in decision-making; and investigate other 
types of decision-making in opiate users. By better understanding the scope of the 
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decision-making impairment and other factors which may contribute to this deficit, 
existing treatment options for addiction may be adapted, or new treatment modalities 
may be implemented, to further support opiate users through treatment and abstinence.  
7.5.1 Further investigation of decision-making in ex-users 
The first key avenue for research is further study of decision-making in ex-users 
of opiates. The meta-analysis from Study 1 demonstrated that, although ex-users had a 
significant decision-making impairment relative to controls, there was a trend for 
improved decision-making capacity following a mean of 0.89 years of abstinence. 
However, it is possible that those people included in the studies of ex-users were made 
up of a combination of opiate users who had previously been abstinent on multiple 
occasions, and “first timers” who had not previously reached abstinence. Ex-users who 
had been abstinent on multiple occasions may be able to draw on skills learnt in 
previous treatment episodes to inform decision-making, while “first timers” may have 
more impaired decision-making capacity. Thus, more research is necessary in ex-users, 
investigating the impact of the number of times opiate users have achieved abstinence, 
as well as the impact of longer periods of abstinence on decision-making capacity, 
especially as a study by Zhang, Shi, et al. (2011) found that, after two years of 
abstinence, decision-making in opiate users was comparable to that of controls. Given 
that the average abstinence duration of ex-users included in the meta-analysis in Study 1 
was relatively short, the ability to draw conclusions regarding the issue of length of 
abstinence is somewhat limited. Thus, future research should undertake further cross-
sectional and longitudinal research in people who become completely abstinent to 
determine how decision-making capacity changes over time, and whether any 
meaningful recovery in this cognitive process occurs.  Furthermore, very few studies 
have analysed risky decision-making in ex-users of opiates. As demonstrated in the 
meta-analysis in Study 1, the majority of studies analysing decision-making in ex-users 
focus on decision-making under conditions of ambiguity (via the IGT), with only one 
study analysing risky decision-making via performance on the Cambridge Gambling 
Task and the BART. Future research therefore also needs to further analyse the 
decision-making capacity of ex-users in risky situations, which may help determine 
whether poor decision-making in these situations contributes to relapse in this 
population.  
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7.5.2 Cognitive processes involved in the decision-making capacity of opiate 
users 
The results of Study 2 demonstrated that the decision-making impairment in 
opiate users was not due to reduced emotional responding. This suggests that other 
cognitive processes may intervene between the activation of a somatic marker and the 
selection of a decision. Thus, future research may investigate what cognitive processes 
occur between the activation of a somatic state, and the choice to pick disadvantageous 
options.  
To address this, computational modelling methods may be adopted to 
mathematically model the cognitive processes underlying decision-making in opiate 
users. Computational modelling allows researchers to analyse the pattern of choices that 
people make during decision-making tasks and break down the complex cognitive 
processes involved in making decisions. These processes may include learning from 
experience and what value an individual places on a particular outcome (Ahn et al., 
2016; Verdejo-Garcia, Chong, et al., 2017). Researchers have started to adopt this 
analysis technique to better understand the cognitive processes that contribute to 
impaired decision-making substance users (Bishara et al., 2009; Fridberg et al., 2010; 
Vassileva et al., 2013), including opiate users (Ahn et al., 2014; Khodadadi et al., 2010). 
The only study to date that has conducted computational modelling of performance on 
the BART in opiate users suggests that people under the acute influence of illicit opiates 
place more intrinsic value on rewards (Khodadadi et al., 2010), while modelling of 
choices on the IGT suggests that ex-users pay less attention to losses (Ahn et al., 2014). 
However, further research is required using computational modelling to better 
understand cognitive processes underlying decision-making in opiate users across the 
spectrum of the addiction cycle.  
In addition, future research may look at other fields of cognition to understand 
how deficiencies in decision-making may relate to other aspects of impaired cognition. 
For example, previous research has found that opiate users are impaired in their ability 
to mentally travel forward in time, referred to as episodic foresight or future thinking 
(Mercuri et al., 2015). Similarly, opiate users are impaired in their ability to remember 
to perform intended actions in the future (prospective memory; Terrett et al., 2014). 
Both of these capacities may be important for making decisions which will have long-
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term consequences. In other words, if opiate users are unable to “see into the future”, 
this may have some impact on their decision-making capacity. Research to date has not 
analysed the relationship between future thinking, prospective memory, and decision-
making in opiate users. Thus, this represents another area for further research into the 
cognitive processes underlying decision-making in opiate users.  
7.5.3 Alternative types of decision-making in opiate users 
Future research may also start investigating other types of decision-making in 
opiate users. For example, as noted in Study 3, only one study has analysed the 
decision-making capacity of opiate users in more social situations, using the Ultimatum 
Game. It found that opiate users were more willing than controls to accept unfair offers 
when the value of the reward was relatively high (Van’t Wout et al., 2006). More recent 
research has shown that substance users’ willingness to accept unfair offers may be 
related to reduced emotional responding via neural abnormalities in the orbitofrontal 
cortex (Verdejo-Garcia, Verdejo-Roman, Albein-Urios, Martinez-Gonzalez, & Soriano-
Mas, 2017). Future research could analyse whether poor decision-making in social 
situations is underpinned by the same neural abnormalities which arguably contribute to 
poor decision-making in ambiguous situations.  
Opiate users’ performance on measures of moral decision-making may also help 
to clarify the role of emotion in decision-making. So far, no research has analysed 
decision-making in moral situations in opiate users. However, research has shown that 
substance users tend to make more utilitarian decisions than controls (Carmona-Perera, 
Reyes del Paso, Pérez-García, & Verdejo-García, 2013; Carmona-Perera et al., 2012; 
Khemiri et al., 2012; Kornreich et al., 2013). More utilitarian decision-making in moral 
contexts may be indicative of reduced emotional responsiveness (Moretto, Làdavas, 
Mattioli, & Di Pellegrino, 2010). Given that the results of Study 2 demonstrated that 
opiate users’ emotional responsiveness was no different to controls, future research 
should investigate whether opiate users also demonstrate a pattern of moral decision-
making comparable to that of controls.  
7.6 Conclusions 
This research project is the first to systematically analyse the decision-making 
impairment in opiate users. Prior to this research, it was unknown whether co-morbid 
factors such as head injury and polysubstance dependence had a significant impact on 
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the decision-making capacity of opiate users, and it was assumed that abstinence from 
opiates would lead to better decision-making capacity.  The findings from the meta-
analysis in the first study clarified that the decision-making impairment in opiate users 
is not significantly mitigated by abstinence, at least in the short term, nor is it 
significantly worsened by head injury or poly-substance dependence. The second study 
was the first to analyse the applicability of the somatic marker hypothesis to opiate 
users, with results demonstrating that the decision-making impairment in opiate users 
was not due to impaired emotion processing capacity. These results also demonstrated 
that opiate users were able to produce somatic warning signals which should steer 
decision-making away from poor long-term outcomes, but were unable to appropriately 
use this information. Finally, the third study demonstrated that poor decision-making in 
opiate users was not due to more risky behaviour on the part of opiate users, suggesting 
a specific impairment in situations of ambiguity. This research makes a significant 
contribution to the literature relating to the decision-making capacity of opiate users, 
and provides a platform for future investigation into the cognitive processes underlying 
impaired decision-making in opiate users. Ultimately, these results may contribute to 
tailored treatment options in a drug-using population highly vulnerable to relapse. 
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